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ABSTRACT 
 
The focus of this thesis is tear dynamics and the regulation of tear secretion by the 
Lacrimal Functional Unit (LFU), a collection of functions that control tear secretion and 
maintain a healthy ocular surface.  
Tear secretion was assessed with the Schirmer test and tear osmolarity (tOsm), in 
standardised environmental conditions achieved using a controlled environment chamber 
(CEC).  The experiments involved normal and dry eye disease (DED) subjects, including 
Sjögren Syndrome DED.  
A novel approach to sheathing the Schirmer strip was tested for the first time in a 
regulated range of relative humidities achieved in the CEC.  This was designed to 
highlight an artefact of measurement, and free the test from its dependence on ambient 
conditions. 
A period of evaporative suppression, achieved innovatively by eye closure, was shown to 
drive tOsm down, in normal and DED subjects, to a basal level that fell within the range of 
plasma osmolarity.  This basal tear osmolarity value could be used as a non-invasive 
measure of systemic dehydration, particularly of use in a care home setting and as a 
reference against which to gauge the severity of DED in an individual.   
Using the sheathed Schirmer strip the existence of ‗cross-connections‘ in humans was 
investigated for the first time using unilateral anaesthesia in an attempt to answer the 
question of whether afferent corneal inputs from one eye may have some influence on the 
lacrimal output of the fellow eye.  Previously only studies involving animals had reported 
positive findings in this area.  The relative contributions of each eye to the reflex tear 
response are relevant in unilateral trigeminal sensory loss cases since sensory input from 
the healthy eye could reinforce tear secretion of the affected fellow eye. 
Lastly, an experiment was designed to strengthen our understanding of the mechanism of 
the LFU in providing a compensatory response in desiccating conditions. This approach 
differed from previous studies as it included both normal and DED subjects and involved 
creating a sensory blockade using topical anaesthesia to increase the stress level 
experienced by the LFU.   
 
 
 
 
Key words: Lacrimal Functional Unit; Basal Tear Osmolarity; Sensory cross-connectivity; 
Sheathed Schirmer; Tear osmolarity; Plasma osmolality. 
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Chapter 1: 
INTRODUCTION 
 
The focus of the research presented in this thesis is tear physiology and its relationship to 
dry eye disease (DED), a common, symptomatic disorder responsible for chronic disability 
on a global scale. Regardless of aetiology, its key mechanism is tear hyperosmolarity, 
which causes inflammation and damage to the ocular surface.  In the normal eye osmolar 
homeostasis of the tears is closely regulated by the lacrimal functional Unit (LFU) and the 
research reported here was directed at the mechanism of this control system and how it is 
disturbed by DED. An approach was also developed to determine a basal level of tear 
osmolarity for an individual which can be an index of their body hydration state and also a 
guide to the severity of dry eye in the presence of tear hyperosmolarity.  The subject of 
DED has been reviewed recently in depth in the Tear Film and Ocular Surface Dry Eye 
WorkShop II report (Nelson et al., 2017) of particular interest are the chapters on 
pathophysiology, the tear film and epidemiology. 
 
1.1 The ocular surface 
The ocular surface is a mucous membrane, lined by a continuous sheet of epithelium, 
which covers the cornea, the anterior globe and tarsi and extends peripherally to the 
mucocutaneous junctions (MCJs) of the lid margins. Gipson (2007) defined an ocular 
surface system, which includes the epithelial surface and glandular epithelia of the 
cornea, conjunctiva, lacrimal and meibomian glands, their apical (tears) and basal 
(connective tissue) matrices, the eyelashes with their associated glands, those 
components of the eyelids responsible for the blink and finally, the nasolacrimal duct. ―All 
components of the system are linked functionally by continuity of the epithelia, and by the 
endocrine, vascular, and immune systems‖ (Gipson, 2007).  
The ocular surface is one of the most exposed mucosal surfaces in the body, and the 
ocular surface system ensures that it is wetted at all times, despite constant exposure to a 
desiccating environment.  This ensures that the vital, refractive corneal surface is always 
covered by a protective and optically smooth tear film.  Like other mucosal tissues the 
ocular surface houses an immune response system capable of defending against 
microbial and other insults (Knop and Knop, 2002; Streilein, 2003; Dong et al., 2011; 
Barabino et al., 2012).  
Maintenance of homeostasis in response to an ever-changing external environment is 
achieved by adjustments to the tear flow on a moment to moment basis, and is an 
important requirement for ocular surface health. Disruption of this closely integrated 
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system can have system-wide consequences that are relevant to the multifactorial 
condition of DED (Bron et al., 2017).   
 
1.2 The tears 
The tears serve a multitude of functions for the ocular surface providing nourishment, 
lubrication, immune defence and, above all, an optically smooth, precorneal surface, 
critical for retinal image formation and stable vision (Reiger, 1992; Montés-Micó, Alió, and 
Charman, 2004; Denoyer, Rabut and Baudouin, 2012).  Maintenance of the tear film is a 
constant task, a balance between the production, evaporation and drainage of tears 
(Tsubota, 1998). 
 
1.2.1 Tear compartments 
In the open eye the tears are distributed between three compartments: the cul-de-sac 
(fornix and retrotarsal space), the preocular tear film and the menisci (Yokoi et al., 2004). 
The preocular tears form a layer over the exposed cornea and conjunctiva and therefore 
have precorneal and prebulbar elements. The upper and lower tear menisci, formed by 
surface tension forces in the upstroke of the blink, lie in the groove between the globe and 
lid margins. The peripheral apices of the menisci are located just behind the MCJs of the 
lid margins while their central apices are found at zones of meniscus–induced thinning, 
seen as ‗black lines‘ on fluorescein staining, which separate the menisci from the tear film, 
(Miller, Polse and Radke, 2002). The menisci provide conduits to the lacrimal puncta and 
nasolacrimal system necessary for tear drainage.  It is thought that the tear osmolarity 
(tOsm) is not distributed uniformly across these three compartments, for instance, based 
on modelling considerations, meniscus osmolarity is predicted to be lower than tear film 
osmolarity (Gaffney et al., 2010).  Not only this, but an osmolarity gradient within the 
meniscus itself is thought to exist, being at its highest at the apex where it makes contact 
with the MCJs and is purported to be the basis of Marx‘s line; epithelial cells that stain with 
lissamine green (Bron et al., 2011a; b).  
 
1.2.2 The tear film 
Hydration of the ocular surface is maintained by the tears, which bathe it continuously and 
provide an unbroken film over its exposed surface. The open eye is constantly subjected 
to desiccating stress through evaporation of the tears, but is protected from damage by 
homeostatic mechanisms that regulate tear secretion and distribution in response to 
signals from the ocular surface.  In DED, a failure of these mechanisms leads to a 
quantitative or qualitative deficiency of tears that typically induces tear film instability, 
wetting defects and hyperosmolar stress, increased friction and chronic mechanical 
irritation at the ocular surface. This initiates a chain of inflammatory events and surface 
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damage that characterise the disease. 
 
1.2.3 The precorneal tear film 
Wolff‘s (1946) early concept of the precorneal tear film was of a three-layered structure 
consisting of a superficial lipid layer, an aqueous layer and a deep mucin layer (Wolff, 
1946) and this is still a reasonable approximation of the current view.  Holly and Lemp 
(1971) later proposed that the mucin of goblet cell origin was distributed in two phases, a 
deep viscous phase associated with the corneal epithelium and a more dilute, aqueous 
phase interacting with the lipid layer (Holly and Lemp, 1971). This concept of a 
coacervate, implying an aggregate held together by hydrophobic bonding, is no longer 
thought to be tenable. Instead it is considered that secretory mucin is present as a distinct 
but dynamic gel layer, the mucoaqueous subphase, held together by weak non-covalent 
interactions, hydrogen bonds, Van der Waals attractions and steric interactions, between 
the polymer molecules (Yokoi, Bron and Georgiev, 2014). This mucoaqueous subphase in 
turn, is thought to be loosely associated (Cher, 2008) with the water-wettable glycocalyx 
(Cope et al., 1986) of the surface epithelium. The thickness of the tear film lipid layer 
(TFLL) is in the region of 15 -157 nm with an average of 42 nm (King-Smith, Hinel and 
Nichols, 2010) while that of the precorneal tear film, based on evidence from reflection 
spectra, is about 2-3 µm (King-Smith et al., 2000, 2004; Wang et al., 2003). The tear film 
thickness over the conjunctiva is not known. 
 
1.2.4 Sources of the tears 
The aqueous tears are secreted chiefly by the lacrimal glands, with additional 
contributions from the conjunctiva, including the goblet cells and a small fraction from the 
corneal epithelium. The meibomian glands are the source of the TFLL.  Using 
fluorophotometry it has been calculated that the normal tear volume is in the region of 7µL 
(Mishima, 1965), with the maximum capacity of the conjunctival sac without spillover, 
about 30µL (Mishima et al., 1966).  The secretory rate has been estimated at 1.03 ± 0.39 
µl/min with a tear turnover of 16.19 ± 5.10% (Tomlinson, Doane and McFadyen, 2009).  
Yokoi et al., (2004) using the radius of curvature of the tear meniscus as an index of total 
tear volume, calculated tear volume to be in the region of 9.6µl in normal subjects and 
6.7µL in a group of subjects with subjects with aqueous-deficient dry eye (ADDE) (Yokoi 
et al., 2004).  
 
1.2.5 Composition of the tears 
The aqueous tears contain hundreds of proteins (de Souza, de Godoy and Mann, 2006; 
Zhou et al., 2012) including maintenance proteins such as epidermal growth factor (EGF) 
which sustain epithelial cell renewal and defence proteins such as lysozyme, lactoferrin, 
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and immunoglobulins, involved with adaptive immunity (van Haeringen 1981; Paulsen, 
2006).  In inflammatory circumstances, plasma proteins (albumin) may diffuse into the 
tears due to an increased permeability of the conjunctival vessels (Sack, Tan and Tan, 
1992) and epithelium (Bron et al., 2017).  The chief mucin of mucoaqueous layer is the 
large gel-forming mucin (MUC5AC) secreted by the goblet cells which plays a role in 
lubrication and in the removal of cellular and microbial debris from the ocular surface.   
 
1.2.6 Contribution of the tear film to vision 
In order to maintain the optical quality of an image transmitted to the retina the tear film 
must be constantly replenished, since it provides one of the refractive elements in the eye 
(Craig, Blades and Patel, 1995). Higher order aberrations generated by the tear film in the 
blink interval can disturb the quality of the retinal image. These aberrations diminish 
steadily to an optimum level after a blink and then increase again until reset by the next 
blink cycle.  In one report the aberrations reached a minimum at 6.1 ± 0.5 seconds after a 
blink in normal subjects and at 2.9 ± 0.4 seconds in DED subjects and then rose 
thereafter (Montés-Micó, Alió, and Charman, 2004).  
 
1.3 The lacrimal gland 
The lacrimal gland is a serous gland composed mainly of acinar cells (80%), together with 
ductal and myoepithelial cells, the combination forming a tubular network (Obata, 2006).  
The main gland consists of a larger orbital and a smaller palpebral lobe.  The orbital ducts 
fuse with those of the palpebral gland and the lacrimal secretion is delivered into the 
superior fornix (Fernandez-Valencia and Pellico, 1990) via 6-12 orifices (Bron, 1986).  
Additionally, there are accessory lacrimal glands, located in the upper and lower fornix, 
(Wolff, 1946) which form about 10% of the overall tissue mass (Allansmith et al., 1976). 
The innervation of the accessory glands is similar to that of the main gland (Seifert and 
Spitznas, 1999) and they are assumed to respond similarly to direct and reflex stimulation. 
This is in contrast with an earlier view that the accessory glands were responsible for a 
basal level secretion, such as that measured after topical anaesthesia (Jones, 1966).  The 
lacrimal gland is richly innervated by parasympathetic, sympathetic, and sensory nerves 
(Burkett et al., 2006). Parasympathetic nerves, containing acetylcholine (ACh) and 
vasoactive intestinal peptide (VIP), and sympathetic nerves containing norepinephrine, 
provide a potent stimulus to lacrimal gland secretion (Hodges and Dartt, 2003) and the 
gland is influenced additionally by many hormones from the hypothalamic-pituitary-
gonadal axis (Sullivan et al., 1998).  In humans, the lacrimal gland is regarded as the 
major source of aqueous tears, probably responsible, in the absence of excessive ocular 
surface stress, for over 90% of the aqueous tear production. Cerretani and Radke (2014), 
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in their model of human tear dynamics concluded that the contribution of osmotically-
driven water flow to the total tear supply, from the conjunctiva and cornea, was in the 
region of 10% (Cerretani and Radke, 2014). However, Zhu and Chauhan (2012) have 
speculated, based on experimental measurements that conjunctival secretion could be as 
high as 1-2 μL/min and could account for the total resting tear secretion (Zhu and 
Chauhan, 2007). This question is not resolved. In the resting state, tear production is 
regulated mainly reflexly in response to afferent impulses from the ocular surface (Jordan 
and Baum, 1980; Gaffney et al., 2010; Willshire, Buckley and Bron, 2017a) and 
additionally by inputs from the nasal mucosa (Gupta, Heigle and Pflugfelder, 1997), the 
retina, pain sources and those from higher centres.  This tightly regulated and dynamic 
system constantly modifies tear flow to maintain a properly hydrated ocular surface at all 
times under varying environmental conditions. Flow rate increases dramatically in the 
reflex lacrimatory response to nociceptive stimuli (e.g. to a corneal foreign body), or in 
emotional tearing, (Murube, 2009) when lacrimal secretion can increase over 100-fold 
over that in everyday conditions (Jordan and Baum, 1980).  
1.3.1 Lacrimal secretions 
The lacrimal secretion, derived from the lacrimal acini, is modified as it passes through the 
lacrimal ducts and its composition differs from that of the lacrimal fluid that is delivered 
into the conjunctival sac. The duct epithelium adds water and electrolytes, particularly K+ 
and Cl- ions (Dartt, Moller and Poulsen,1981; Mircheff, 1989; Ubels et al., 1994; Dartt 
2009; Toth-Molnar et al., 2013). In the rabbit, it has been estimated that the duct cells 
secrete about 30% of the lacrimal fluid (Toth-Molnar et al., 2013) but the figure for human 
lacrimal fluid is not known.  It will be seen that the term lacrimal fluid is not synonymous 
with that of the tears.  The lacrimal fluid refers to the combined secretion of the lacrimal 
acini and ducts. To this are added the secretions of the conjunctiva and cornea which are 
mixed with the lacrimal fluid by blinking (Gaffney et al., 2010) and to a lesser extent by 
eye movements (Yokoi, Bron and Georgiev, 2014), and further, shed epithelial cells and 
neutrophils. Thus the tears contain proteins, carbohydrates, lipids and salts, aqueous fluid 
from three sources, goblet cell mucin and various mucin fragments, proteins, glucose and 
urea of plasma origin and cells, such as epithelial cells and polymorphonuclear leukocytes 
(PMNs), with TFLL being the major source of lipids. It is this mixture, usually low in cell 
content in normal eyes that is sampled from the lower tear meniscus for tOsm 
measurements.  Importantly the osmolarity of the lacrimal fluid cannot be assumed to be 
the same as that of the tears.  
 
1.4 The meibomian glands 
The meibomian glands are holocrine, tubulo-acinar, sebaceous glands whose acini 
discharge their whole contents in the process of secretion. Each gland consists of a series 
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of grapelike acinar clusters connected by fine ductules to a main duct, lying in parallel 
rows in the upper and lower tarsal plates (Foulks and Bron, 2003). There are about 25 
glands in the upper eyelid and 20 in the lower eyelid (Obata, 2002).  The meibomian 
glands are surrounded by a rich network of nerve endings that derive from 
parasympathetic (mainly cholinergic but also VIP-ergic), sympathetic and sensory fibres.  
Parasympathetic nerve terminals have been found in close contact with the basal lamina 
of the meibomian acini (Knop et al., 2011). The homologous sebaceous glands of Moll 
and Zeiss, present on the lid margin, also receive a parasympathetic innervation (LeDoux 
et al., 2001).  The rate of meibomian lipid synthesis is regulated by androgen sex steroids 
(Perra et al., 1990; Sullivan et al., 1998) and the rate at which acinar cells are ruptured 
and disgorge their contents is controlled by the release of neurotransmitters from the 
nerves surrounding the acini (Chung, Tigges and Stone, 1996); both can both influence 
secretion.  
Meibomian oil (or meibum) consists of a mixture of lipids which have a melting range 
between 19.5–32.9°C and is liquid at lid temperature (Tiffany, 1987).  Core lid temperature 
is in the region of 37°C.  Delivery of oil to the lid margin is due in part to a steady secretory 
process and in part to the delivery of small aliquots with each blink (Linton, Curnow and 
Riley, 1961; Chew et al., 1993; Bron and Tiffany, 1998). The lipid is secreted into a 
shallow reservoir on the lid margin skin, via orifices situated just anterior to the MCJs.  
From here, it is delivered to the TFLL in the upstroke of the blink (King-Smith et al., 2004; 
Bron et al., 2014) spreading rapidly over the aqueous layer and stabilising within 1-2 
seconds after the onset of the blink (Bron et al., 2004; Yokoi et al., 2008).  
 
1.4.1 Meibomian lipids-composition and secretion 
The meibomian lipids consist of a mixture of polar and non-polar lipids. The non- polar 
lipids make up about 95% of the total and comprise mainly wax and cholesterol esters, 
with a small amount of triglycerides.  The remainder consists of polar lipids, particularly 
the amphipathic lipid, O-acyl-ω-hydroxy-fatty acid (OAHFA), the major surfactant of the 
tears, and a small amount of phospholipids (Butovich, 2009; Brown et al., 2016). The 
relative amount of phospholipid compared to OAHFA is greater in the TFLL. Other 
components of meibum include hydrocarbons and free fatty acids (Tiffany and Marsden, 
1982; Dougherty and McCulley, 1986; Bron and Tiffany, 1998; Willcox et al., 2017). 
The thickness of the TFLL varies regionally and at various stages of the blink interval but 
averages at around 42 nm (King-Smith, Hinel and Nichols, 2010).  Holly (1973), and later 
McCulley and Shine (1997) proposed that it is a biphasic structure comprising a deep 
amphiphilic layer of polar lipids, capable of interacting with the aqueous phase of the tear 
film and a thicker, superficial, lipophilic, layer of non-polar lipids, in contact with the air 
(Holly, 1973; McCulley and Shine, 1997). It was envisaged that spreading of the TFLL, 
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driven by surface tension forces, is initiated by movement of the polar elements of the lipid 
layer over the aqueous phase of the tear film, while the non-polar lipids follow closely 
behind, interacting with the non-polar hydrocarbon tails of the polar lipids. Lipocalins of 
lacrimal gland origin, the dominant lipid-binding proteins of the tears, help to stabilise the 
tear film by scavenging lipids from the mucoaqueous phase and by interacting with the 
polar lipids of the TFLL to reduce surface tension (Nagyova and Tiffany, 1999).  This is 
important for the spreading of the tears over the ocular surface.  The TFLL plays an 
important role in stabilising the tear film and in the past was thought to play a direct role as 
a barrier to water loss from the eye, retarding evaporation by up to 90% (Tiffany, 1987; 
Bron and Tiffany, 2004; Knop et al., 2011).  However, recent experiments with meibomian 
lipid in vitro suggest that this figure is more like 10%.  The fact remains that in the clinical 
situation, a TFLL deficiency is associated with an increased evaporative loss (Craig and 
Tomlinson, 1997) and so it is surmised that the TFLL plays its role in retarding tear 
evaporation in part by its effect as a lipid barrier and in part stabilising the tear film 
(Willcox et al., 2017). 
1.5 The conjunctiva 
The conjunctiva is a transparent mucous membrane that lines the inner surface of the 
eyelids and covers the anterior surface of the eyeball.  It exhibits three distinct regions, 
palpebral, fornical and bulbar, all of which are moistened by the tears and act as a 
protective barrier against the external environment (Bron et al., 2004; Knop and Knop, 
2005).  Intercellular spaces between the conjunctival epithelium are thought to play a role 
in water transport across the epithelium (Bron et al., 2015).  Goblet cells are found 
throughout the conjunctiva except for a small patch just outside the temporal limbus 
(Kessing, 1966). Their numbers are greatest in the inferonasal bulbar conjunctiva. Goblet 
cell, gel mucin (Argüeso and Gipson, 2001) has a high water-binding capacity that 
facilitates the creation of the mucoaqueous phase of the tear film the major contributor to 
its thickness (Mantelli and Argüeso, 2008).  Conjunctival innervation is by the ophthalmic 
division (V1) of the trigeminal nerve, similar to that of the eyelids. 
1.5.1 Conjunctival secretions 
The mucous membrane of the conjunctiva extends from the corneal limbus, over the 
anterior globe, into the fornices, across the tarsal plates and ends at the MCJs of the lid 
margins. The strips of mucosa that form the posterior border of the lid margin are overlain 
by the tear menisci (Bron et al., 2011a). The conjunctival epithelium consists of two cell 
types, stratified squamous and goblet cells, which together secrete water, electrolytes, 
mucins and proteins into the tears (Dartt, 2002; Schmidt et al., 2013).  The most 
superficial, layer 1, cells of the epithelium are highly specialised, being connected to 
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neighbouring cells by occludens type cell junctions (tight junctions –TJs) and expressing 
the transmembrane mucins, MUC1, MUC4 and MUC16 at the apices of their epithelial 
microvilli. The exodomains of these mucins, extending as far as 500nm into the 
mucoaqueous layer of the tear film (MUC16) and crosslinked with galectin-3 (Argueso et 
al., 2009), form the glycocalyx of the epithelium which, together with that of the cornea, 
confers wettability on the ocular surface epithelium as a whole (Cope et al., 1986). The 
mucins of the glycocalyx interacting with the gel mucins of the tears, anchor the tear film 
to the ocular surface (Gipson, Hori and Argüeso, 2004).  MUC16, with galectin-3, in 
particular, is responsible for the exclusion of small molecules such as dyes, into the 
healthy epithelium and, with the TJs of layer 1, are responsible barrier properties of the 
conjunctival epithelium overall. The permeability of the conjunctival epithelium is 15-25 
times greater than that of the cornea (Hämäläinen et al. 1997) probably because of 
differences in the functional state of certain junctional proteins, such as the claudins 
(Yoshida, Ban and Kinoshita, 2009).   
Goblet cells are the source of the secretory, gel-forming mucin, MUC5AC which binds with 
the aqueous portion of the tears to form the mucoaqueous subphase of the tear film, 
(Argüeso and Gipson, 2001).  Functions of this secretory mucin include water-binding, 
lubrication and the trapping of inflammatory and shed epithelial cells and of 
microorganisms, inhibiting their attachment to the epithelium. Gel mucin also binds sIgA 
and several antimicrobial proteins and peptides (Gordon, Romanowski and McDermott, 
2005).  Mucin components found in the tears are a mixture of secreted and shed 
membrane-associated mucins (Spurr-Michaud et al. 2007).  The role of the mucoaqueous 
gel and of the epithelial glycocalyx in reducing friction between the lids and globe during 
the blink cycle and eye movements has been summarised by Pult et al., (2015) and Bron 
et al., (2017) (Pult et al., 2015; Bron et al., 2017).  Loss of this lubricative function is a 
source of cell shedding and symptoms in DED.  When two apposed surfaces move in 
relation to each other, the degree of friction depends on the nature of the surfaces, the 
speed of movement, load applied and presence of lubrication. Hydrodynamic lubrication 
occurs where surfaces are separated by a fluid layer and depends on the thickness of the 
layer and its physical properties. Tears are a viscoelastic fluid and in the normal eye, bulk 
tear fluid is supplied mainly by lacrimal and some conjunctival secretion. Goblet cell mucin 
imparts a non-Newtonian property to the mucoaqueous phase, so that, with increasing 
shear rate, as in the blink and saccade, the tear film shear-thins and effective lubrication is 
achieved.  Boundary lubrication applies when the relative motion is slow and there is 
minimal fluid between apposed surfaces.  For the ocular surface, this is when the eyes are 
almost stationary, or for the lids, probably at the return points of the blink cycle (Pult et al., 
2015). In these circumstances, the mucin exodomains of the healthy glycocalyx act as 
hydrophilic polymer brushes, which greatly lower friction between the lids and globe 
(Bielecki and Dohan Ehrenfest, 2012; Bielecki et al., 2013) and minimise frictional damage 
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(Johnson and Murphy, 2004). The action of the glycocalyx is further discussed by 
Sumiyoshi et al., (2008) and Cai and Wei (2013) (Sumiyoshi et al., 2008; Cai and Wei, 
2013).  Dartt (2002) summarised the neural and other factors influencing goblet cell and 
stratified conjunctival epithelial secretion (Dartt, 2002). Nerve terminals are found in 
proximity to but not in direct contact with the goblet cells and the stratified squamous 
epithelial cells receive sensory nerve endings. Dartt concluded that parasympathetic 
nerves stimulate goblet, but not stratified squamous, cell secretion. Sympathetic nerves 
stimulate stratified squamous, but not goblet, cell secretion, while purinergic (P2Y2), 
agonists stimulate secretion from both cell types (Dartt, 2002). Growth factors also 
regulate goblet cell secretion.  
 
1.6 The cornea 
The cornea is an avascular, transparent tissue that consists of the epithelium, Bowman‘s 
layer, stroma, the Descemet‘s and pre-Descemet‘s layers and the endothelium.  The 
cornea has a convex outer surface that provides the majority of the refractive power of the 
eye and the smooth quality of this optical surface is maintained by the overlying tear film.  
As in the conjunctiva, the layer 1 cells of the corneal epithelium are connected by TJs, 
which, here, confer the properties of an almost perfect semi-permeable membrane 
(Maurice, 1968). The TJs together with the epithelial glycocalyx form a barrier to the 
passage of ions and of water-soluble molecules from the tears into the cornea. As noted, 
a similar barrier within the conjunctival epithelium is 15-25 times more permeable than 
that of the cornea. The glycocalyx of the corneal epithelium plays a similar role in relation 
to the tear film as that of the conjunctiva, providing an anchoring system for the 
mucoaqueous layer.  The ATP-dependent transport of chloride by the corneal epithelium, 
from stroma to tears, is associated with the movement of fluid into the tears, thereby 
contributing to its composition. This contributes too, in a small way, to corneal 
deturgescence, achieved mainly by active transport of bicarbonate ions from stroma to 
aqueous, by the corneal endothelium (Klyce and Crosson, 1985). 
 
1.6.1 Staining of the corneal epithelium 
The existence of ocular surface punctate staining is used extensively in the diagnosis and 
management of DED and the distribution of micropunctate staining may provide 
information as to the cause of damage. Corneal and conjunctival staining provides 
information about the severity of DED status, but the level of correlation with the 
mild/moderate DED state is poor (Sullivan et al., 2010).  Normal corneas show a low level 
of punctate epithelial stain (Norn, 1970) attributed to the uptake of fluorescein dye into 
surface epithelial cells prior to shedding, after loss of their glycocalyx barrier (Bron et al., 
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2015). In DED there is, in addition, a failure of the TJs barriers, so that dye can diffuse into 
the inter or paracellular spaces to gain access to and stain the cells.  
1.7 Osmolarity and Osmolality 
The ocular surface is constantly bathed in tears whose composition is controlled to ensure 
a healthy environment for the epithelium. The terms osmolarity and osmolality are used to 
describe the concentration of dissolved solute particles within a solution such as the tears. 
Each ion, such as Na+ and Cl- counts as a separate particle. The term osmolarity 
describes the number of osmoles of solute per litre of solution while the term osmolality 
refers to the number of osmoles per kilogram of solution. Osmolarity is affected by 
temperature while osmolality is not. Of relevance to the research presented in this thesis, 
the term osmolarity is used with reference to tears, expressed as mOsm/L, whereas 
osmolality is used when referring to plasma, expressed as mOsm/kg. The term osmolarity 
is also used with reference to serum or plasma when the value is calculated from the 
concentration of selected solutes such as, Na+, K+, glucose and urea osmolarity (Hooper 
et al., 2015). The numerical difference between the two terms is small and is not generally 
of clinical significance. In this thesis the terms are used, where possible, according to the 
context. 
1.7.1 Tonicity 
The term tonicity differs from that of osmolarity or osmolality. It refers to the concentration 
of osmotically active particles in a solution and therefore, for the tears, on the 
concentration of charged particles, mainly ions, such as the cations, sodium, potassium 
and calcium and the anions, chloride, bicarbonate and phosphate.  Proteins, which are 
charged, and glucose, which is not, are present in the tears at low concentration and 
therefore make only a small contribution to tonicity (Murube, 2006).  Tear glucose can 
contribute about 0.2mOsm/L to tear osmolarity (Sen and Sarin, 1980). Urea, a permeate 
molecule which passes readily through cell membranes, is present in tears at a 
concentration almost identical to that of plasma, e.g. around 6 mOsm/L (Gavrilov et al., 
2000).  
1.7.2 Tear hyperosmolarity 
Tear hyperosmolarity is a cardinal feature of DED and implies an elevation of osmolarity 
above that of the tears in normal eyes. Tear hyperosmolarity sets up a series of damaging 
events at the surface of the eye that will be described later.  Hyperosmolar tears can also 
be designated as hypertonic, implying that the concentration of osmotically active 
molecules is higher than that of healthy, euhydrated, living cells. Exposure of such cells to 
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hypertonicity leads to the osmotic removal of water and cell shrinkage, which is one 
pathway to cell death.  Osmometers such as the TearLab® device, based on the 
measurement of electrical impedence, and hence the presence of charged particles, may 
be said to be measuring ‗effective osmolarity‘, almost equivalent to tonicity, and do not 
respond to the presence of urea and glucose in the tears. Therefore the measured 
osmolarity is likely to be underestimated by approximately 6-7 mOsm/L.  
1.8 The Lacrimal Functional Unit 
The secretion of tears must be highly regulated to provide a stable tear film and maintain 
tOsm within narrow limits. When the eyes are open, the ocular surface is constantly 
exposed to a changing external environment and a physiological system exists that 
adjusts tear flow to achieve homeostasis.  The concept of the lacrimal functional unit 
(LFU) was put forward as the mechanism responsible for the exquisite control of tear 
secretion in response to signals from the ocular surface (Stern et al., 1998).  The LFU 
consists of the ocular surface, its secretory appendages and the connecting innervation 
which reflexly maintains tear homeostasis (Stern et al., 2004). The ocular surface includes 
the epithelia of the cornea, conjunctiva and lid margins that receive a sensory trigeminal 
innervation and the secretory appendages are the lacrimal and meibomian glands, the 
conjunctival goblet cells and the lining epithelia, that receive an efferent, autonomic 
innervation. 
1.8.1 Afferent and efferent signalling 
The afferent limb of the reflex arc arises in the peripheral endings of the ophthalmic 
division of the Vth cranial nerve (the trigeminal nerve - V1), particularly those neurones that 
supply the cornea. The sensory innervation of the cornea is the highest in the body, with 
an innervation density about 10-20 times that of dental pulp (Rozsa and Beuerman, 1982). 
The sensitivity of the posterior lid margin is similar to that of the central cornea (McGowan, 
Lawrenson and Ruskell, 1994).  Centrally, these trigeminal neurones synapse in the 
superior salivatory nucleus (SSN) in the midbrain (Stern et al., 2004; Meng and Kurose, 
2013) with parasympathetic neurones that travel via the n. intermedius of the VIIth facial 
nerve to the pterygopalatine ganglion. Here, these neurones synapse with third order 
neurones which project to the lacrimal and meibomian glands and to the goblet cells of the 
conjunctiva.  Lacrimal secretion is stimulated by the release of neurotransmitters (Acetyl 
choline and vasointestinal peptide) from these neurones that modulate protein and water 
transport (Dartt, 2009).  The neurones of the efferent sympathetic pathway, influencing 
lacrimal secretion to a lesser degree, synapse in the superior cervical ganglion before 
joining the parasympathetic pathway to innervate the lacrimal gland (Boberg-Ans, 1955; 
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Stern et al., 1998; Dartt, 2009).  Other inputs to the lacrimal gland act via the SSN in 
conjunction with those from the cornea, from the nasal mucosa, skin (not only pain but 
also including lid margin and ciliary/lash region -‗tickle‘), retina (bright lights), acute pain 
and emotional stimuli. These influence lacrimal secretion from moment to moment and 
also determine the responsiveness of the gland to other sensory stimuli.  Belmonte et al., 
(2004) have documented the sensory modalities that supply the mammalian cornea, 
including the human cornea (Belmonte et al., 2004).  Of these, 20% are mechano-
nociceptors which respond to mechanical forces; 70% are polymodal-nociceptors which 
respond to extreme temperatures, exogenous irritant chemicals and endogenous 
inflammatory mediators and 10% are cold receptors, activated by evaporative cooling of 
the ocular surface (Belmonte and Gallar, 2011).  It has been suggested that cold 
thermoreceptors, which discharge spontaneously at rest, provide the main neural input 
regulating resting tear secretion. The polymodal-nociceptors have been found to 
contribute most significantly to the reflex tear secretion (Acosta et al., 2004). Blink rate, 
too, is inversely related to temperature, a fall in ambient temperature inducing a rise in 
blink rate (Nakamori et al., 1997). 
1.8.2 Loss of sensory drive 
A blockade to afferent signals, particularly from the cornea, that renders the ocular surface 
anaesthetic, can interrupt the feedback loop of the LFU.  This can occur with acquired 
conditions, as well as with anaesthesia induced by topical anaesthetics. Bilateral topical 
anaesthesia has been shown to reduce but not abolish both lacrimal secretion measured 
by the Schirmer Ib test (Lamberts, Foster and Perry, 1979; Jordan and Baum, 1980; Li, 
Deng and He, 2012) and that measured by fluorophotometry (Jordan and Baum, 1980), 
which confirms that tear secretion is normally maintained, when the eyes are open, not 
only by a sensory drive from the ocular surface, but an additional contribution from other 
sources (Lamberts, Foster and Perry, 1979; Li, Deng and He, 2012). This includes both 
higher centres and the nasal mucosa (Heigle and Pflugfelder, 1996; Gupta, Heigle and 
Pflugfelder, 1997).  Loss of sensory drive to the lacrimal gland also occurs in the 
trigeminal anaesthesia associated with neurotrophic keratitis (NK) (Heigle and Pflugfelder, 
1996). This results in both a reduction of lacrimal secretion, favouring the development of 
ADDE and a fall in blink rate (Bonini et al., 2003; Sacchetti and Lambiase, 2014), which, 
by extending the blink interval and increasing evaporative water loss, amplifies its 
severity. Additionally, removing the trophic support of sensory neurones (Blanco-Mezquita 
et al., 2013) impairs the maintenance of a healthy ocular surface epithelium and its repair, 
and renders it vulnerable to external trauma, a situation exacerbated by the loss of the 
protective blink reflex.  The extent to which sensory drive from a fellow, normal eye can 
compensate for and limit the risk of dry eye on the anaesthetised side is not established.  
In particular, the nature of any sensory input from a normal cornea to the contralateral 
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SSN is not known and hence its potential to influence contralateral lacrimal gland 
secretion is uncertain.  It is on this basis that the experiments presented in Chapter 5 were 
designed, to study the relative contribution of each eye to the reflex tear response, 
measured by the Schirmer test, in controlled environmental conditions, after unilateral and 
bilateral topical anaesthesia. 
1.9 Factors influencing tear osmolarity 
Tear film osmolarity is the central feature of DED pathogenesis and is a function of tear 
flow, evaporation and drainage (Gilbard and Farris, 1979; Tomlinson, Doane and 
Mcfadyen, 2009).  Water loss, caused by evaporation during the blink interval, creates a 
thinning of the tear film and concentrates solute, thereby increasing tear osmolarity 
(Nicholls, Mitchell and King-Smith, 2005).  A value of 302 ± 9.7 mOsm/L has been cited as 
the average tear osmolarity for normal eyes (Tomlinson et al., 2006), and a value as high 
as 365 ± 77 mOsm/L has been recorded in DED patients, with the depression of freezing 
point method (Gilbard and Farris, 1979).  It is likely that the true levels of osmolarity 
achieved at the ocular surface in DED are far in excess of this, especially in areas of tear 
thinning and break up, where ―hot spots‖ of hyperosmolarity are thought to occur (Begley 
et al., 2006; Liu et al., 2006; Harrison et al., 2008; Peng et al., 2014). These localised 
regions of increased evaporation also coincide with areas of ocular surface cooling (Li et 
al., 2015).   
1.9.1 Tear film lipid layer  
The presence of the lipid layer helps to retard water loss through evaporation. When the 
tear lipid layer is increased in thickness by meibomian gland expression (Craig, Blades 
and Patel, 1995) this can result in reduced evaporation in both normal and DED subjects 
(Arciniega et al., 2011). A qualitative or quantitative deficiency of the lipid layer can 
amplify evaporation (Craig and Tomlinson, 1997; Borchman, Yappert and Foulks, 2010), 
and it is likely that this can occur, too, with a deficient aqueous layer, when the spreading 
of the lipid layer is compromised (Yokoi et al., 2008).  Either situation can lead to tear 
hyperosmolarity.   
1.9.2 Palpebral aperture width 
The width of the palpebral aperture determines the surface area of eye exposed to 
evaporative loss.  In Caucasians, the average palpebral aperture height in primary gaze, 
is reported to be 8.3 ± 2.3 mm, equivalent to an exposed surface area of 1.25 cm2 
(Zaman, Doughty and Button,1998).  The anatomy of the superior eyelid differs in the 
Asian population with either the presence (‗double lid‘) or absence (‗single lid‘) of a 
superior palpebral crease.  A study by Craig et al., (2016) reported the vertical palpebral 
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aperture as 10 ± 2 mm in Asian subjects with a single eyelid (n=23) and an exposed 
ocular surface of 2.06 ± 6.2 cm2 and 11 ± 2 mm in Asian subjects with a double eyelid 
(n=28) with an exposed surface of 2.40 ± 5.8 cm2 (Craig et al., 2016). Since gaze position 
influences aperture width, it also influences water loss from the ocular surface. It was 
found that the rate of evaporative loss, measured at 40% RH and with a blink rate of 30 
per/minute, increased 3.4 times when looking up and 2.5 times when looking straight 
ahead, when compared to looking down (Tsubota and Nakamori, 1995).  
1.9.3 Blink interval 
The tear film is refreshed by blinking (Collins, Stahmer and Pearson, 1989). The time 
between blinks influences tOsm, prolonged exposure increasing the total water loss from 
the ocular surface. An increased blink interval i.e. a slower blink rate, is a source of 
desiccating stress, which, in the absence of compensation, should result in increased 
osmolarity.  The blink rate is reduced in response to a variety of factors including 
environment, visual tasks and behaviour.  In healthy adults a blink rate of 14.3 per minute 
and blink cycle of 4.2 seconds has been reported in standard conditions (Tsubota and 
Nakamori, 1995).  Visual concentration such as that adopted for VDU use (Patel et al., 
1991), reading (Ousler et al., 2015) and using hand-held video games (Tsubota and 
Nakamori, 1993; Jansen et al., 2010) has been found to reduce blink rate, whereas 
conversation (Doughty, 2001) and DED (Nakamori et al., 1997) are associated with an 
increased blink rate. Increased wind speed, a source of increased evaporation from and 
cooling of, the ocular surface, increases the blink rate (Nakamori et al., 1997).  The 
inferior portion of the ocular surface is at risk of remaining exposed to evaporation during 
an incomplete or partial blink.  This occurs when the upper eyelid fails to make contact 
with the lower lid in the downphase of the blink.  In this way on the ascension of the upper 
eyelid only the tears from the upper meniscus and superior cornea are re-distributed, with 
the further thinning of the inferior tears a consequence and a hyperosmolarity 
(McMonnies, 2007).  It has been reported that incomplete blinking accounts for between 
10-20% of the total number of blinks per minute (Abelson and Holly, 1977; Carney and 
Hill, 1982).  Rogriguez et al., (2013) put forward a further category of ‗rescue blink‘ 
(Rodriguez et al., 2013), a prolonged lid closure considered as a compensatory attempt to 
increase lipid expression and tear film thickness (Korb et al., 1994).  It has also been 
noted that in a proportion of people there is not always complete contact between the 
upper and lower lid margins during eye closure, despite a lack of lid pathology.  This 
would result in a potential failure of the eyelids to form an adequate moisture seal and 
protect against evaporation from the inferior portion of the ocular surface (Blackie and 
Korb, 2015).    
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1.9.4 Tear film break up (TBUT) 
Evaporation from the ocular surface leads to tear film thinning and instability, resulting in 
tear film break-up (TBUT), a major contributor to increased tOsm (Foulks, 2007).  In the 
majority of normal eyes the TBUT exceeds that of the blink interval (Lemp and Hamill Jr, 
1973), and the tear film is successfully replenished following each blink without disruption 
of the tear film (Mishima, 1965).  Localised thinning of the tear film can occur in areas 
where the ocular surface wettability is lost (Johnson and Murphy, 2004) and may have 
pathological effects when it persists with repeated blinks. The relationship between the 
blink interval and TBUT can be quantified by the ocular protection index (OPI), which is 
the TBUT divided by the blink interval. When the OPI is <1.0 the ocular surface is exposed 
to tear break up in the blink interval; the lower the value, the greater the risk of damage 
through desiccation (Ousler III et al., 2008).  When the tear film is formed in the upstroke 
of the blink, and separates from the tear menisci, it becomes ‗perched‘ and stable in the 
blink interval (Miller, Polse and Radke, 2002). Tangential flow out of the tear film then 
makes little contribution to tear film thinning and the major cause of thinning, and hence 
changes in tOsm, is tear evaporation (King-Smith et al., 2008). Based on tear film thinning 
rates reported by Nichols et al. (Nichols, Mitchell and King-Smith, 2005) and a tear film 
thickness of 3µm, it has been calculated that the tear film could thin to zero from the effect 
of evaporation in approximately nine seconds if not preceded by break up before this time 
(King-Smith et al., 2008).  Hyperosmolarity is amplified in the epithelium in areas of TBUT 
and extremely high levels of tOsm at the level of the pre-corneal tear film have been 
predicted mathematically. Based on a thinning of the tear film by a factor of 3 and a 
baseline tOsm of 300 mOsm/L, it has been calculated that tOsm could be expected to rise 
to 900 mOsm/L in these local areas of thinning during the blink interval (King-Smith et al., 
2008).   
1.9.5 Effect of ambient humidity 
Evaporation is the transfer of fluid by vaporisation into an unsaturated gaseous phase. For 
the tears this means the loss of water from the tear film into the ambient air when the 
relative humidity (RH) is less than 100%.  The rate of evaporation from the ocular surface 
is directly proportional to the ambient humidity (Figure 1.1) (Tsubota and Yamada, 1992).  
Environmental conditions such as low humidity or increased airflow increase evaporation 
from the ocular surface (Tsubota and Yamada, 1992; Tsubota, 1998; Uchiyama et al., 
2007) and evaporation is increased by higher temperature (Murakami, 2004).  
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Figure 1.1 The relationship between environmental humidity and tear film evaporation rate from the ocular 
surface (TEROS).  From Tsubota and Yamada (1992). Invest Ophthalmol Vis Sci 33(10): 2942-2950. 
A review of the rate of evaporation has been summarised in a paper by Borchman et al., 
(2009) with figures ranging from 0.0012 to 3.8 µm/min, with average evaporative rates 
being shown to increase at lower relative humidities (Borchman et al., 2009).  At a RH of 
between 35-45% the evaporative rate was between 0.029 ± 0.009 μL/cm2/min and 0.043 
± 0.016 μL/cm2/min, and at RH of between 25-35% the rate was between 0.044 ± 0.013 
μL/cm2/min and 0.058 ± 0.018 μL/cm2/min (McCulley et al., 2006).  In a normal un-
stimulated eye it has been found that up to 36% of the tear film is lost through 
evaporation, compared to 55% in a DED subject (Mathers, 2004), although a more recent 
study suggests evaporative rates could be at an even higher than this (King-Smith et al., 
2008).  It is a reasonable prediction that exposure of a subject to a low ambient humidity 
will result in a rise in tOsm, offset by any compensatory increase in tear flow stimulated by 
cooling and the rise in osmolarity at the ocular surface. This paradigm has been examined 
in several studies with some surprising results. 
In one study, exposure of normal subjects to prolonged desiccating stress, with an RH of 
5%, caused, as expected, a marked increase in tear evaporation compared to that 
measured at 40% RH, together with symptoms of increased discomfort (Abusharha and 
Pearce, 2013). Increased discomfort could be explained by surface cooling and a rise in 
tOsm, due to the increased evaporation. On the other hand, operation of the LFU would 
be expected to offset these effects of increased evaporation by reflexly stimulating a rise 
in lacrimal secretion. This would account for the finding that although the average tear 
osmolarity was higher at 5% RH, it was not significantly different from that at 40% RH.  
Surprisingly, however, the Schirmer test value at the end of the study, was reduced rather 
than increased, which conflicted with the expectation of a reflex increase in lacrimal 
secretion.    
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In a related study (Teson et al., 2013), DED patients were exposed for two hours, to an 
environment simulating in-flight airplane cabin conditions (23°C, 5% RH, localised air flow, 
and reduced barometric pressure of 750 millibars versus 930 millibars at sea level). 
Patients experienced an increase of symptoms; decrease in TBUT, an increase in corneal 
staining, a decrease in tear volume measured by the phenol red test (PRT) but an 
unchanged Schirmer test, measured at 5% RH at the end of the study. Here again, tOsm 
was not significantly altered.  
In a further study by these authors (López-Miguel et al., 2014), a group of DED patients 
and a group of normal subjects were exposed to the same desiccating environment of 5% 
RH, for two hours, with increased airflow and a visual task, at normal barometric pressure. 
The visual task would be expected to bring about a fall in blink rate. This resulted in a 
shortened TBUT and increased corneal staining and an increase in MMP-9 levels in both 
groups, but no increase in tOsm in either DED patients or controls; the Schirmer test was 
increased slightly in the DED group only, and there was no significant increase in 
symptoms (López-Miguel et al., 2014). 
Taken together, these studies support the expectation that prolonged desiccating stress, 
resulting in increased evaporation of the tears, leads to corneal epithelial damage by 
reason of presumed, induced tear hyperosmolarity. However, this was not supported by 
the meniscus tOsm measurements in any of the reports. Several factors may be at play 
and are the basis of some of the research presented in this thesis.  
One possible explanation is that, while tear film hyperosmolarity was the mechanism that 
induced corneal epithelial damage, insufficient time had elapsed for this local tear 
hyperosmolarity to be reflected in tear meniscus samples. A potential differential between 
the meniscus tOsm and tear film tOsm has been predicted from modeling considerations 
(Gaffney et al., 2010). A means of confirming this would be to measure tissue osmolarity 
directly at the surface of the cornea (or conjunctiva) during desiccation, but although a 
device is available (Reis, Grenier and Albuquerque, 2017), its reliability is contested 
(Rocha et al., 2017). 
An additional explanation could be that operation of the LFU resulted in a compensatory 
increase in tear production, leading to a dilution of the tears which offset the expected rise 
in meniscus tOsm. If ocular surface damage occurred only in the blink interval during 
exposure and dilution only occurred with mixing of the tears at the time of the blink, then 
this would be a reasonable explanation. A means of testing this hypothesis would be to 
block the afferent limb of the LFU using a topical anaesthetic, in which case it would be 
predicted that in the absence of compensatory reflex tearing, tOsm would rise in response 
to the desiccating stress. This forms the basis of the experiments reported in Chapter 6.   
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Again, if enhanced tear secretion occurred, as anticipated, why was there little evidence of 
this? In the Teson report (2013), the PRT was reduced and Schirmer test result was 
unchanged at the end of the study (Teson et al., 2013), and in the Lopez-Miguel report 
(2014) the PRT test was unchanged and the Schirmer test was slightly increased in the 
DED group only (López-Miguel et al., 2014). In the Abusharha study the Schirmer test 
was significantly reduced (Abusharha and Pearce, 2013). One explanation for these 
results is that they represent an artefact of measurement, caused by a high rate of 
evaporative water loss from the exposed Schirmer strips at 5% RH. This would explain the 
apparent reduction in the Schirmer wetting length. Such an effect of low humidity on the 
wetting length was demonstrated experimentally by Holly and colleagues, who showed 
that it could be overcome by sheathing the Schirmer paper in a plastic envelope, to 
prevent evaporative loss (Holly, Lamberts and Esquivel, 1982; Holly, 1994; Beebe, 
Esquivel and Holly, 1988). This concept is explored in Chapter 3, in which the influence of 
sheathing on the Schirmer wetting length was studied at a range of different relative 
humidities, from 5 – 45%. Because this approach is likely to afford a more standardised 
version of the Schirmer test, sheathed Schirmer strips were used in the study of the 
central sensory connections of the LFU, in Chapter 5. 
Evaporative water loss causes cooling (Craig et al., 2000), which is potentially a source of 
both symptoms and compensatory tear secretion driven by the activation of 
thermosensitive corneal cold fibres (Belmonte and Gallar, 2011).  Adverse conditions 
capable of stimulating increased evaporation can be encountered in natural, outdoor 
environments, or indoors, in the workplace, home and in enclosed places subjected to the 
influence of air-conditioning.    
A study by Khurana et al. (1991) in North India confirmed that dry eye symptoms were 
more prevalent in rural people exposed to high temperature, low humidity, and dust and 
hot air currents (Khurana et al., 1991).  In the office, complaints of eye discomfort 
associated with DED were increased in the afternoon (Begley et al., 2002), associated 
with an increase in temperature and reduction in relative humidity that occurred within the 
office environment throughout the day (Skov, Valbjørn and Pedersen, 1990).  Adverse 
conditions also exist in aircraft cabins, with levels of RH ranging from 9 to 28% and 
temperature ranging from 23-24ºC (Nagda and Hodgson, 2001), leading to increased 
symptoms of DED during flights even in people who were otherwise asymptomatic 
(McCarty and McCarty, 2000).  Additionally 72.3% of pilots were recorded as having an 
increase in self-reported dryness symptoms following an average of 18.5 hours per week 
in the low humidity conditions encountered on an aircraft (McCarty and McCarty, 2000). 
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1.10 Closed eye tears 
Eye closure withdraws the ocular surface from evaporative water loss and is equivalent to 
exposure of the open eye to an RH of 100%, representing total evaporative suppression. 
Prolonged eye closure, such as that which occurs in sleep, also leads to major changes in 
the protein composition and cellular content of the tears and a marked reduction in tear 
flow and drainage compared to that of the open eye (Baum, 1990; Sack et al., 2000). 
During sleep, special strategies are mounted at the ocular surface that provide an 
alternative defence against pathogens and an environment of sub-clinical inflammation is 
created via the up-regulation of immune and inflammatory systems (Sack, Tan and Tan, 
1992).
During eye closure there is a fall in pO2 (partial pressure of oxygen) leading to corneal 
hypoxia and oedema (Hill and Fatt, 1964; Sarver et al., 1981; Holden, Mertz and McNally 
1983) and a fall in tear pH (Carney and Hill, 1976).  This situation is reversed within an 
hour of eye opening when normal aerobic conditions are restored. Sack and colleagues 
(1992; 2000) demonstrated a significant increase in secretory IgA (rising from 2% to 58%) 
in closed eye tears and a build-up of tear albumin and other plasma proteins (Sack, Tan 
and Tan, 1992; Sack et al., 2000), due to vascular leakage (Zantos and Holden, 1978) 
and enhanced permeability of the conjunctiva. The concentration of proteins of lacrimal 
acinar origin, such as lactoferrin and lysozyme is markedly reduced, (from 85-88% to 
30%) reflecting the fall in lacrimal secretory rate.  A massive influx of PMNs occurs in 
closed eye tears, recruited to the ocular surface by leukotaxic mediators (Lan et al., 1998) 
and there is activation of the complement pathway (Sack et al., 2000).  Although the 
presence of these PMNs and several of their degranulation products may play a role in 
defence and the scavenging of micro-organisms, these cells have a refractory phenotype 
which limits their inflammatory responsiveness (Gorbet, Postnikoff and Williams, 2015).  
1.10.1 Increasing relative humidity 
Increasing RH, thereby decreasing evaporation from the ocular surface has been used as 
the basis for a therapy to treat DED.  Several studies have been conducted using 
swimming goggles to reduce evaporation of the tears (Tsubota, 1989; Korb et al., 1996). 
In these studies, patients with DED reported a reduction in symptoms of ocular discomfort 
by 99% after 20 minutes wearing the goggles (Korb and Blackie, 2013).  The ocular 
humidity created within the goggles was found to more than double that measured when 
wearing conventional spectacles, from 34.3 % ± 6.4 to 83.4% ± 5.5 (Tsubota, Yamada 
and Urayama, 1994).  Although the effect was transient, the study demonstrated the 
benefit of reducing evaporation in maintaining tear film stability.   
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1.11 Tear Osmolarity in Normal Eyes and in Dry Eye Disease 
For the tears, based on a meta-analysis of several studies using depression of freezing 
point, or vapour pressure measurement, tOsm has been reported to be 302 ± 9.7 mOsm/L 
in normal adults (Tomlinson et al., 2006). Similar values, using the TearLab® instrument  
were reported by several other groups, see table 1.1 (Sullivan et al., 2010; Eldridge et al., 
2010; Jacobi et al., 2011; Keech, Senchyna and Jones, 2013). 
Author Method n tOsm 
Eldridge et al., 2010 TearLab® 30 301.8±10.5 mOsms/L 
Li et al., 2012 TearLab® 10 298.0±14.2 mOsms/L 
Niimi et al., 2012 TearLab® 38 297 ± 15 mOsms/L 
Jacobi et al., 2011 TearLab® 133 301mOsmol/L 
(range 298–304 mOsmol/L) 
Sullivan et al., 2010 Tear Lab® 75 302.2 ± 8.3 
Keech et al., 2013 Tear Lab® 10 
15 
304.0 ± 8.4 mOsm/L 
301.2 ± 7.2 mOsm/L 
Tomlinson et al., 2006 Meta-analysis: Depression 
of freezing point; vapour 
pressure; 1978-2005 
815 302.0 ± 9.7 mOsm/L 
 
Table 1.1 Average tOsm values for normal subjects. 
Tear hyperosmolarity is a key feature of dry eye, values of 322.2 ±18.8 mOsm/L (Sullivan 
et al., 2010), and 326.9 ± 22.1 mOsm/L (Tomlinson et al., 2006), being reported in 
populations with mild to severe DED.  In the Sullivan report (2010) tOsm in mild/moderate 
DED was 315 ± 10 mOsm/L and in severe DED, 336 ± 22 mOsm/L (Sullivan et al., 2010).  
A tOsm of 308mOsm/L is considered to be most sensitive threshold to distinguish normal 
from mild/moderate forms of DED and 315mOsm/L, the most specific cut off (Lemp et al., 
2011).  
 
1.11.1 Variation and Inter-Eye Difference of Tear Osmolarity 
Increased variability and inter-eye difference in tOsm have both been shown to be 
features of DED disease.  This departure from the normal state contributes to the 
pathology of DED and serves as a marker, denoting the breakdown of compensatory 
mechanisms (Bron et al. 2009; Sullivan, Pepose and Foulks, 2015).  In the healthy eye 
tOsm is maintained within a narrow range, reflecting tight homeostatic control by the LFU.  
Oncel et al. (2012) demonstrated no significant difference in tOsm measured over the 
course of a day in normal subjects (n=30) (Oncel, Pinarci and Akova, 2012).  Conversely 
several studies have demonstrated increased variability in tOsm measured over a period 
of time in DED, considered to mirror progression of the disease.  Bunya et al. (2015) 
reported a variability in tOsm over the course of a day of 14.6 mOsm/L in blepharitis 
patients (n=11) and 15.8 mOsm/L in patients with Sjögren syndrome DED (n=18) 
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compared to 10.5 mOsm/L in normal subjects (n=18) (Bunya et al., 2015).   Similarly, 
Sullivan et al., (2012) found that variability was significantly increased in severe DED (10 
± 6.9%, n=36) compared to mild/moderate DED (5.9 ± 3.1%, n=16) (Sullivan et al., 2012).  
In addition the inter-eye difference in tOsm has been reported to increase in parallel with 
the severity of the disease.  Gilbard and Farris (1979) measuring tOsm by a depression of 
freezing point method, demonstrated an inter-eye difference of 29.7 mOsm/L in 
keratoconjunctivitis sicca subjects (n=30) compared to 6.6 mOsm/L in normal subjects 
(n=33) (Gilbard and Farris, 1979).  Lemp et al., (2011) reported similar a figure, of 6.9 ± 
5.9 mOsm/L in normal subjects (n=75), 11.7 ± 10.9 mOsm/L in mild/moderate DED 
(n=149) and 26.5 ± 22.7 mOsm/L in severe DED (n=75) (Lemp et al., 2011).  This 
variability between the two eyes can be utilised as another diagnostic indicator since it 
appears to reflect the progression of DED (Lemp et al., 2011; Szalai et al., 2012). 
 
1.12 Diurnal variation of tear osmolarity 
Tear osmolarity (tOsm) has been shown to fluctuate diurnally, Terry and Hill (1978) 
analysed 5µL samples collected from the lower cul-de-sac of six subjects with a 
thermocouple hygrometer to measures the dew point depression, and reported the 
average daytime tOsm in 6 young adults to be 310 ± 5.7 mOsm/Kg (range 299-323 
mOsm/Kg) (Terry and Hill, 1978), these values overlapping those currently associated 
with DED (Messmer, Bulgen and Kampik, 2010; Sullivan et al., 2010; Lemp et al., 2011).  
Terry and Hill (1978) also reported the average daytime tOsm in 6 young adults to be 310 
± 5.7 mOsm/Kg (range 299-323 mOsm/Kg) which compared to a tOsm of 285 ± 2.4 
mOsm/Kg (range 282-288 mOsm/Kg), measured immediately after a 6-8 hour period of 
eye closure (i.e. sleep) (Terry and Hill, 1978).  The closed eye values showed less 
variability and also, it may be noted, but not addressed by the authors, fell within values 
reported for plasma osmolality (pOsm).  This has been measured to range between 285-
295 mOsm/Kg in normally hydrated adults (Cheuvront et al., 2010a; Matz, 1996; Stookey, 
2005). A similar difference between post-sleep and waking tOsm was reported by Niimi et 
al., (2013) who found tears to be significantly hypo-osmotic after a period of sleep, 264 ± 
14 mOsms/L, compared with the pre-sleep value of 297 ± 15 mOsms/L (Niimi et al., 
2013).  Thereafter, tOsm rose quickly in the first 10 minutes after eye opening and 
reached the baseline level within 40 minutes of waking. There was a relatively 
hyperosmotic trend toward the end of the day. 
 
22 
1.13 Osmolarity of the Fluids that Comprise the Tears 
As noted earlier, the tears as sampled at the lower meniscus are composed of a mixture 
of fluids, mainly of lacrimal origin but also containing conjunctival fluid whose volume 
contribution is not fully established, plus a small contribution from the cornea. In normal 
individuals, tOsm is assumed to be higher than that of the secreted tears because of 
evaporative loss from the tear film (Mishima, 1965; Mishima et al., 1966; Mishima and 
Maurice, 1961a; b). The osmolarity of the tears is almost entirely dependent on its ionic 
content and that of a few other small molecules; the contribution of macromolecules such 
as proteins, in low concentration in the tears (van Haeringen and Glasius, 1977), is small. 
In both humans (Mircheff, 1989) and rabbits (Dartt, Moller and Poulsen, 1981), the 
concentrations of Na+ and HCO3
- are about the same in both tears and plasma (Krogh,
Lund and Pedersen-Bjergaard, 1945; Hind and Goyan, 1949; Thaysen and Thorn, 1954), 
whereas the concentrations of K+ and Cl- are significantly higher in the tears than in the 
plasma. Thus the composition of the primary secretion of the acinar cells differs from that 
of the lacrimal fluid delivered into the conjunctival sac.  The osmolarity of the conjunctival 
and corneal secretion is not known.  
1.14 Tear and plasma osmolarity and osmolality 
There is an historical interest in the measurement of osmolarity in bodily fluids and this is 
of relevance to the research presented in this thesis. An early study by Krogh et al., 
(1945) reported that tOsm, measured using a vapour pressure osmometer was ‗similar‘ to 
that of serum in a small group of subjects (308 mOsm/L in tears versus 294.32 mOsm/L in 
serum) (Krogh, Lund and Pedersen-Bjergaard, 1945). They concluded that the 
osmolarities of these two fluids might actually be the same, the higher tear value (which 
would otherwise, nowadays be regarded as indicative of DED), being dependent on 
evaporation during processing of the tears.   
Further evidence of a relationship between pOsm and tOsm was provided recently by 
Walsh and colleagues (Fortes et al., 2011; Walsh, Fortes and Esmaeelpour, 2011; Walsh 
et al., 2012) who reported a positive correlation between whole body hydration measured 
as pOsm, and tOsm, in subjects exposed to systemic dehydration (Fortes et al., 2011). In 
a study conducted in an environmental chamber, a group of young adults in their twenties 
were exposed to systemic dehydration, equivalent to 2 to 3% loss of body mass, 
generated by a combination of water-deprivation and a period of physical exercise. Tear 
osmolarity followed pOsm closely during the evolution of dehydration and, like pOsm, was 
restored to normal during rehydration. In this study the pre-exercise pOsm was 288 ± 5 
mOsm/kg. In two trials, the mean tOsm correlated strongly with mean pOsm at each time 
point (r = 0.93, P < 0.001), suggesting that tOsm could serve as a minimally invasive 
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surrogate for body hydration of potential use in the rapid detection of dehydration in sports 
medicine, infants (Bryce et al., 2005) and in the elderly. Fortes et al., (2011) using a tOsm 
reference value of 310 mOsm/L estimated a sensitivity of 80% and a specificity of 92% 
using this approach for the detection of suboptimal hydration (Fortes et al., 2011). 
 
In a subsequent study, the authors reported that pOsm may be raised in patients with 
DED with the implication that the raised tOsm could be a consequence of body 
dehydration (Walsh, Fortes and Esmaeelpour, 2011). In a following letter they expressed 
the view that this could lead to a misdiagnosis of dry eye in patients who suffered from 
systemic dehydration, (Walsh et al., 2012) but Tomlinson et al., (2011) in response, 
pointed out that the persistent presence of a tear hyperosmolarity within the range 
consistent with the diagnosis of DED, in conjunction with supportive clinical features, 
would imply the actual presence of DED (Tomlinson, Madden and Pearce, 2011).  
Importantly, as noted by Walsh et al., (Walsh, Fortes and Esmaeelpour, 2011), since the 
risk of both dry eye (Uchino et al., 2006; Moss, Klein and Klein, 2008; Guo et al., 2010) 
and systemic dehydration (Cheuvront and Kenefick, 2014), increases with age, the value 
of a raised tOsm in the diagnosis of systemic dehydration is the elderly will be reduced 
(Walsh, Fortes and Esmaeelpour, 2011; Walsh, et al., 2012; Tomlinson, Madden and 
Pearce, 2011).  It is evident that the occurrence of tear hyperosmolarity due to DED is a 
potential source of false positives when using tOsm to diagnose systemic dehydration, 
when based on the results of random, open eye tear samples. However, a way in which 
this obstacle might be overcome is suggested later.  
 
1.15 Body Hydration and Dehydration 
Systemic dehydration is a serious condition, associated with a considerable morbidity and 
mortality (Xiao, Barber and Campbell, 2004; Manz and Wentz, 2005) which, while unlikely 
to be overlooked in the hospital population, where serum osmolarity can be readily 
calculated from blood samples, is underdiagnosed in care-home residents (Wolff, Stuckler 
and McKee, 2015) and in the elderly population generally. A number of authorities have 
emphasised the need for a simple, valid, non-invasive screening test that can be used in 
the community, to diagnose water-loss dehydration in the elderly and aid in its 
management (US Panel on Dietary Reference Intakes 2004; Cheuvront et al., 2010; 
Hooper et al., 2015b). The measurement of tOsm is a candidate for the role. 
Regulation of water balance is fundamental to survival and is achieved by a combination 
of renal water conservation and water acquisition in response to thirst. In a hypo-hydrated 
individual, an increase in pOsm stimulates hypothalamic osmoreceptors and the release 
of arginine vasopressin (AVP or antidiuretic hormone) from the posterior pituitary. This 
causes renal water reabsorption, urinary concentration and water conservation 
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(Cheuvront et al., 2013; Baron et al., 2015). A rise in pOsm also stimulates an increase in 
water intake in response to thirst (Egan et al., 2003), independent of the action of AVP 
(Denton et al., 1999; Bourque, 2008). 
Systemic dehydration results when loss of body water, with or without salt, occurs at a 
rate greater than the body can replace it (Thomas et al., 2008).  Water-loss is 
accompanied by plasma hyperosmolarity, plasma hypernatraemia and intracellular 
dehydration (Cheuvront and Kenefick, 2014). Plasma or serum osmolality, measured 
directly, or estimated from the chemical composition of these fluids (Hooper et al., 2016, 
2015) has long been used as a clinical index of body hydration (Armstrong, 2007; 
Cheuvront et al., 2010a; Baron et al., 2015), serving as the gold standard against which 
other less invasive methods are compared in the diagnosis of dehydration. Plasma 
osmolality in normally hydrated adults measures between 285-295 mOsm/Kg (Matz, 1996; 
Stookey, 2005; Cheuvront et al., 2010a).  Thomas et al., (2008) cite a broader range for 
serum osmolality of 275 to <295 mOsmol/kg (Thomas et al., 2008).  Clinical or ‗current‘ 
dehydration is defined by a pOsm of >300 mOsm/kg and preclinical, or ‗impending‘ 
dehydration by a pOsm of >295 or ≤300 mOsm/kg. Note that a level of osmolality that 
represents clinical dehydration in the body as a whole is compatible with normality at the 
surface of the eye. The frequency of current dehydration in the elderly population is high, 
with impending dehydration reported as 40% in those aged 70-90 years, in the US 
NHANES III cohort, with a further 28% exhibiting current dehydration (pOsm >300mmol/L) 
(Stookey, 2005). Consequently, dehydration, contributing to the risk of chronic diseases 
such as urolithiasis, hypertension and coronary heart disease, (Xiao, Barber and 
Campbell, 2004), is a leading cause of hospitalisation and death in the elderly (Manz and 
Wentz, 2005; Oei et al., 2016).  The risk of dehydration is increased in elderly patients in 
long-term care.  Hooper et al., (2016) reported a frequency of 20% in a population of care 
home residents (n=188) with a mean age 86 years, with renal, cognitive and diabetic 
status consistently associated with the risk of dehydration (Hooper et al., 2016). Wolff et 
al., (2015) in another UK study, basing the diagnosis of dehydration on the presence of 
hypernatraemia on admission to hospital (plasma Na >145 mmol/L), found a 5-fold 
increase in the occurrence of dehydration in patients admitted to hospital from care homes 
(adjusted odds ratio [AOR]: 5.32, 95% CI: 3.85-7.37), compared to that in patients 
admitted from home, and roughly a two-fold greater risk of in-hospital death (AOR: 1.97, 
95% CI: 1.59-2.45) (Wolff, Stuckler and McKee, 2015). 
This background emphasises the need to detect dehydration in the elderly, both in the 
wider community and in individuals in care (Hydration for Health Initiative, 2012). 
Dehydration is less likely to be overlooked in the hospital population, where serum 
osmolarity can be readily calculated from blood samples.  The osmolalities of other body 
fluids such as urine and saliva, and urine specific gravity can provide good diagnostic 
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accuracy under ideal circumstances but are otherwise inferior to pOsm (Cheuvront et al., 
2013). Assessment by health or social care workers is more likely to be based on the 
demonstration of reduced thirst, sense of a dry mouth, furrowing of the tongue, loss of 
skin turgor, a dry axilla, slow capillary refilling after compression of the nailbed, and 
increase in urine colour, which appear to be poor indicators of dehydration in older adults 
(Hooper et al., 2016).  
1.16 Tear Osmolarity as an Index of Plasma Osmolality and 
Hydration Status 
As noted, a problem arises in adopting the measurement of tOsm in open eye conditions, 
to detect sub-optimal body hydration. Tear osmolarity is modified by evaporation and 
strongly influenced by environmental conditions. Measurement of tOsm in uncontrolled 
conditions of humidity, temperature and airflow invites variation of tOsm and this effect is 
amplified in DED (Sullivan, Pepose and Foulks, 2015). Further, since the prevalence of 
body dehydration rises with age (Xiao, Barber and Campbell, 2004) as does the 
prevalence of dry eye (Schein et al., 1997; Stapleton et al., 2017), there is an increased 
likelihood of misdiagnosing systemic dehydration with increasing age; a high tOsm could 
simply be due to DED and not to dehydration. 
A possible approach to overcome this limitation forms the background of the research 
presented in Chapter 4 of this thesis. It is hypothesised that evaporative suppression, 
achieved by a suitable period of eye closure or by exposure of the open eyes to an 
environment of high humidity, will drive down tOsm to a basal level that will be individual 
to a given person and independent of environmental conditions. It is further predicted that 
during the period of evaporative suppression, with continued tear turnover and mixing of 
the lacrimal, conjunctival and corneal fluids, supplemented by equilibration of these fluids 
across the ocular surface epithelia, particularly the conjunctiva, this basal level tear 
osmolarity (BTO) will approach that of the plasma (Willshire et al., 2018).  This basal tOsm 
is judged to be individual to the subject and independent of the presence of DED. 
Chapter 4 reports the effect of a period of either eye closure or exposure to high ambient 
humidity on tOsm, in a group of subjects with healthy eyes and in a group of patients with 
DED (Willshire, Buckley and Bron, 2017b).  
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1.17 Dry eye disease 
The research presented in this thesis addresses selected aspects of the LFU, whose 
dysregulation is a key feature of dry eye. This is recognised in the current definition of 
DED, reported in the TFOS International Dry Eye Workshop, DEWS II 2017 (Craig et al., 
2017) which highlights the homeostatic nature of the ocular system and acknowledges 
that disturbed neurosensory inputs contribute to the disease.  The definition now reads 
―Dry eye is a multifactorial disease of the ocular surface characterized by a loss of 
homeostasis of the tear film, and accompanied by ocular symptoms, in which tear film 
instability and hyperosmolarity, ocular surface inflammation and damage, and 
neurosensory abnormalities play etiological roles.‖  
1.17.1 Sub groups of dry eye disease 
There are two sub-groups of DED, aqueous-deficient dry eye (ADDE) and evaporative dry 
eye (EDE), which may occur independently, or in combination, in hybrid forms (Bron et al., 
2009, 2017).  Regardless of aetiology or subgroup, tear hyperosmolarity is the hallmark of 
the disease and injures the ocular surface directly or sets in train a chain of signaling 
events within surface epithelial cells, that leads to the release of inflammatory mediators 
and proteases. This results in ocular surface inflammation, glycocalyx damage, goblet cell 
loss and apoptosis of corneal and conjunctival epithelial cells.  This series of events is 
considered to perpetuate the disease, a concept that is embodied as the ‗vicious circle‘ of 
dry eye (Figure 1.2) (Baudouin, 2007; Baudouin et al., 2013; Lemp et al. DEWS I 2007; 
Bron et al., 2017).  
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Figure 1.2 Vicious circle theory of DED pathology.  From the Pathophysiology report of TFOS DEWS II. Bron 
et al. (2017). Ocul Surf 15(3): 438-510. 
1.17.2 Aqueous-Deficient Dry Eye 
Aqueous-deficient dry eye (ADDE) is due to evaporation from the tear film in the presence 
of a reduced lacrimal secretion.  Initially, tear hyperosmolarity results from evaporation at 
a normal rate from the tear film of reduced volume. Later, with the secondary occurrence 
of early tear film break up, an evaporative component may be added to the disorder.   
There are various causes of ADDE, the simplest of which is due to a dysregulation of the 
LFU, which blocks the sensory drive to the lacrimal gland – so-called reflex blockade. This 
can result in a reduction of both tear secretion and blink rate. Causes include ocular 
surface anaesthesia due to topical anaesthetics and trigeminal nerve damage from injury 
and surgery, including refractive surgery, and from clinical disorders such as neurotrophic 
keratitis (NK). The delivery of aqueous tears is also reduced by obstruction of the lacrimal 
gland ducts, which can occur in any form of cicatricial conjunctival disease, such as 
trachoma, erythema multiforme, graft-versus-host-disease and chemical burns. Drugs in 
systemic use, such as antihistamines, beta-blockers, antispasmodics, diuretics and some 
psychotropic drugs that cause a reduction in lacrimal secretion are also risk factors for 
DED (Bron et al., 2017). The most common cause of ADDE is inflammatory infiltration of 
the lacrimal gland, particularly by T-cells, encountered most severely in autoimmune 
disorders such as Sjögren syndrome dry eye (SSDE) and more frequently, but with lesser 
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severity overall, in age-related, non-Sjögren dry eye (NSDE). Inflammation causes both 
acinar and ductal epithelial cell dysfunction and/or destruction and a potentially reversible 
neurosecretory block. In SSDE, a receptor block may also be caused by circulating 
antibodies to the muscarinic, M3 receptor. Inflammation is favoured by low tissue 
androgen levels.  Sjögren Syndrome (SjS) is an auto-immune disease that attacks 
secretory glands, such as the lacrimal and salivary glands and other organ systems. It is 
termed primary when no other, defined systemic disease is present and secondary, when 
it is part of an additional, auto-immune connective tissue disease e.g. rheumatoid arthritis 
or lupus erythematosus.  Sjögren Syndrome is caused by a combination of genetic, viral, 
environmental and hormonal factors which, in SSDE lead to T-cell infiltration of the 
lacrimal glands, instigating acinar and ductular cell death and lacrimal hyposecretion 
(Coursey and de Paiva, 2014). Similar events, of lesser degree are responsible for NSDE.  
1.17.3 Evaporative Dry Eye 
Evaporative dry eye (EDE) occurs when there is excessive evaporation from the tear film 
in the presence of normal lacrimal function. In this situation there is an opportunity to 
compensate for tear hyperosmolarity by means of a reflex increase in lacrimal secretion 
(Pflugfelder, Solomon and Stern, 2000; Bron et al., 2009; Arita et al., 2015). 
Two forms exist, lid-related, or ocular surface-related.  The commonest form of lid-related 
(intrinsic) EDE is non-cicatricial meibomian gland dysfunction (MGD), in which the 
terminal ducts of the meibomian glands are obstructed by hyperkeratinisation (Knop et al., 
2011). Here, tear hyperosmolarity results from a quantitative and/or qualitative deficiency 
of the tear film lipid layer. It has been suggested that MGD-EDE is the commonest form of 
DED (Lemp et al., 2012; Korb and Blackie, 2015; Stapleton et al., 2017). Intrinsic EDE 
may also be the consequence of a prolonged blink interval, as in Parkinson‘s disease, or 
of poor lid/globe congruity, leading to defective tear film spreading. In ocular surface-
related (extrinsic) EDE, tear film instability is initiated by conditions that impair ocular 
surface wettability, including short break up DED, xerophthalmia, ocular allergy, cicatrising 
conjunctivitis, topical preservative use and contact lens wear. In this case, it is early TBUT 
that initiates the tear film hyperosmolarity.  
It will be noted that since tOsm can only rise in response to evaporative water loss, 
evaporation is the basis of tear hyperosmolarity in both ADDE and EDE and, in that 
sense, all forms of DED are evaporative; EDE is simply a hyper-evaporative state. 
1.17.4 Hybrid forms of DED 
There are various hybrid forms of DED, in which the salient features of both ADDE and 
EDE are present together and are summarised in the Pathophysiology section of the 
DEWS II report (Bron et al., 2017). This may be because the structural changes 
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responsible for each form occur together, as in SSDE, where lacrimal gland T-cell 
infiltration and obstructive MGD co-exist (Shimazaki et al., 1998), or in cicatricial 
conjunctivitis, where conjunctival scarring contributes both to ADDE and to a cicatricial 
form of MGD-EDE (Foulks and Bron, 2003; Radford et al., 2012). Additionally, the 
features of one form of DED may be added to that of another. Thus, it has been proposed 
that, in severe MGD-EDE, the compensatory reflex lacrimal response may be lost through 
the development of corneal insensitivity, and add a functional ADDE to the pre-existing 
EDE.  Similarly, in ADDE, spreading of the TFLL can be impaired by severe aqueous tear 
deficiency, adding a functional EDE to the existing ADDE (Bron et al., 2009). A final and 
most important hybrid form of DED occurs in ADDE, where the onset of a shortened 
TBUT adds an evaporative element to the dry eye, which is of increasing severity the 
shorter the TBUT. 
1.18 The vicious circle of DED 
A sequence of events is described in dry eye, whereby tear hyperosmolarity, by damaging 
the ocular surface and destabilising the tear film, exacerbates the existing tear 
hyperosmolarity and completes a vicious circle of disease (Lemp et al., DEWS I 2007; 
Baudouin, 2007; Baudouin et al., 2013; 2016). This perpetuates and amplifies the DED, 
potentially dissociating the pathological events from their initiating cause. The sequence of 
events is as follows: there is evidence from a number of sources that tear hyperosmolarity 
stimulates a cascade of events in the ocular surface epithelium, involving stress- and 
mitogen-activated kinases (SAPK and MAPK) and NFB signalling pathways (Li et al., 
2004; Pflugfelder et al., 2005), and the generation and release of inflammatory cytokines 
(e.g. IL-1α, IL-1β, IL-8, IFNγ, TNF-α) (Lam et al., 2006; Pflugfelder et al., 2015), and 
proteases, such as matrix metalloproteinase-9 (MMP9) (De Paiva et al., 2006).  
These activate and recruit inflammatory cells to the ocular surface which become an 
additional source of inflammatory mediators (Baudouin, 2001) and lead to a degradation 
and reduced expression of epithelial basal lamina, glycocalyx mucins, apoptotic death of 
surface epithelial cells (Yeh et al., 2003) and to loss of goblet cells.  Goblet cell loss is a 
feature of every form of dry eye (Brignole et al., 2000; Kunert, Tisdale and Gipson, 2002), 
reflected by reduced tear levels of MUC5AC (Zhao et al., 2001; Argueso et al., 2002). 
Altered expression of glycocalyx mucins and breakdown of epithelial TJs, is a likely basis 
for increased ocular surface staining in dry eye and of the compromised ocular surface 
wetting that leads to early TBUT. This amplifies ocular surface hyperosmolarity, completes 
the vicious circle and establishes the mechanism that perpetuates the disease.  
It has been emphasised by Baudouin et al., (2016) that the vicious circle offers entry 
points for any cause of DED (Baudouin et al., 2016); tear hyperosmolarity need not be the 
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starting point. Thus the chain of events leading to tear film instability may be initiated by 
several different disorders, such as ocular surface inflammation due to allergic eye 
disease, topical preservative toxicity, and loss of conjunctival goblet cells or altered mucin 
expression, due to xerophthalmia. 
1.19 Prevalence and burden of DED 
Stapleton et al., 2017 has recently summarised the prevalence of DED in the 
Epidemiology section of the TFOS DEWS II report, which based on symptoms, with or 
without signs, was between 5-50% (Stapleton et al., 2017). Studies based primarily on 
signs reported higher, although more variable rates, up to 75% in some populations. Asian 
ethnicity being a consistent risk factor, and prevalence was found to increase with age, 
with signs showing a greater increase per decade than symptoms.  As in previous reports, 
women were more frequently affected than men using the Women‘s Health Study criteria 
(Uchino et al., 2011; Um et al., 2014), the difference, in this report, becoming significant 
with age. The report stressed the psychological and physical impact of pain and of 
disturbed vision on quality of life and its influence on work productivity, representing an 
important economic burden.  The reported prevalence of DED varies markedly between 
studies on a global basis, varying geographically, and according to age and sex 
(Stapleton et al., 2017).  Part of the difference in frequency may depend on the diagnostic 
definition of DED used, along with different techniques used, or in the characteristics of 
the study e.g. age, ethnicity, lifestyle and environmental factors.
As evidenced above, the incidence of DED is reported in vast numbers and is known to 
affect people worldwide, leading to symptoms of DED (irritation, itching, burning, foreign 
body sensation) being common reasons for seeking a medical opinion.  This can 
represent a cause for increased health costs and reduced productivity at work that 
impacts on social and economic factors (Moss, Klein and Klein, 2000).  DED can 
represent a significant financial burden either to the patients themselves or to the Health 
Service (Mertzanis et al., 2005) with expenses associated with medication and time 
needed to attend visits to an eye care professional. Furthermore, certain workplace 
environments have been shown to exacerbate symptoms of DED (Wolkoff et al., 2005) 
leading to reduced productivity (Uchino et al., 2014).  The economic burden of DED in 
terms of cost of management has been calculated as $0.27 million in France to $1.10 
million in the UK per 1000 patients managed by Ophthalmologists (Clegg et al., 2006).  
The total annual cost in the US was reported to be $3.84 billion (Yu, Asche and Fairchild, 
2011) and in Singapore $0.15 million (Waduthantri et al., 2012). 
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1.20 Quality of life 
Quality of life (QoL) is a standard of health, happiness and comfort of an individual that 
results in successful functioning in life.   Several questionnaires have been used to assess 
the impact DED on the QoL, the most common of these being the utility assessment, a 
formal method for quantifying patient preferences for health outcomes (trading years of life 
for disease-free years) and the National Eye Institute Visual Function Questionnaire (NEI-
VFQ).  The latter questionnaire is a more general vision-related survey related to the 
subject‘s perception of their visual function and performance in relation to everyday tasks 
such as driving, watching television and using a computer.  Evidence suggests that DED 
has a significant impact on the QoL of a sufferer, by causing pain, irritation, affecting 
general health and well-being, and reducing visual function and performance (Miljanović 
et al., 2007; Paulsen et al., 2014; Na et al., 2015).  The ocular pain and decreased visual 
function experienced by DED sufferers has been stated to negatively affect function and 
daily activities, eventually leading to a correlation with anxiety and depression (Li et al., 
2011; Le et al., 2012). Utility assessments suggest that severe DED has been equated 
with angina and mild DED with chronic psoriasis, with patients stating that if they were to 
live 10 more years they would give up on average 1.6 years of that time to be rid of severe 
DED (Schiffman et al., 2003).  
1.21 Aims of the research 
This background forms the basis of the research presented in this study, centred around 
the workings of the LFU. The following areas are addressed in this thesis: 
 Development of a novel way to improve the utility of the Schirmer test,
 A study of the effect of evaporative suppression on tear osmolarity,
 A study to explore whether sensory drive from the surface of one eye influences
the lacrimal responses of the fellow eye, and lastly
 To explore the influence of desiccating stress on tear osmolarity in the absence
of, or in the presence of ocular surface anaesthesia.
Details of the methods used in various studies are summarised in Chapter 2. 
Chapter 3 describes a method to standardise the Schirmer test by eliminating a major 
source of variation.  Previous work by Holly et al., (1984) demonstrated a positive 
correlation between wetting length and RH i.e. lower RH resulted in reduced wetting.  This 
is an important observation since the Schirmer test is regularly conducted in non-
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standardised environmental conditions and outcomes could therefore underestimate the 
volume of tears actually produced in an individual.  The Schirmer test was modified using 
a novel design to produce a water-impermeable sheath along the lines proposed originally 
by Holly et al., (1984) to prevent evaporation during the test.  For the first time these 
experiments were conducted in standardised environmental conditions within the CEC, 
over a range of different RHs.  
A positive correlation between pOsm and tOsm has been previously reported, with tOsm 
shown to increase with systemic dehydration (Fortes et al. 2011; Walsh et al., 2011; 
Ungaro et al., 2015; Holland et al., 2017). This technique could have utility in detecting 
dehydration in the elderly.  However, the current method of sampling tears from the lower 
meniscus in the open eye could lead to a high level of false positives since evaporative 
effects could influence the sampled tOsm and DED, characterised by tear 
hyperosmolarity, is more prevalent with increasing age.  In Chapter 4 two conditions of 
evaporative suppression (eye closure and high relative humidity) were adopted to 
circumvent this problem, as an innovative way to drive down tOsm to a stable, basal level 
that could be used more reliably to reflect pOsm in a clinical setting. Additionally, it is 
proposed that this basal value could be used as a personal baseline of tOsm against 
which to gauge the severity of hyperosmolarity in a patient with DED.  
Lacrimal gland secretion is stimulated reflexly at a number of sites including the cornea 
and nasal mucosa.  Current research has shown that a level of cross-connectivity exists in 
humans from the nasal mucosa (Heigle and Pflugfelder 1996; Gupta et al., 1997) and 
there is also evidence of corneal cross-connectivity in animals (van der Werf et al., 1996; 
Clarke and Bowsher, 1962; Pfaller and Arvidsson, 1988; Jacquin, Chiaia and Rhoadest, 
1990); however, there is a lack of research on cross-connectivity in humans.  An approach 
to this question was undertaken in Chapter 5, where the modified Schirmer test was used 
to explore the central connections of the LFU, using an indirect approach, comparing the 
relative effects of unilateral and bilateral sensory blockade, on the tear response.  This is 
important in understanding of the effect that unilateral trigeminal nerve damage, such as 
that which occurs in neurotrophic keratitis can have on contralateral tear production.  Can 
the healthy, fellow eye offset the loss of sensory drive on the affected side?   
Several studies have demonstrated corneal staining and increased discomfort following 
exposure to desiccating stress with an unexpected absence in tear hyperosmolarity 
(Abushara and Pearce, 2013; Teson et al., 2013; Lopez-Miguel et al., 2014).  This 
paradoxical finding is likely to be due to the presence of a normally functioning LFU in 
exposed study subjects, which maintains osmolar tear homeostasis, at least in the tear 
meniscus.  In Chapter 6 the effect of desiccating stress on tOsm in both normal eyes and 
in patients with DED was investigated with a new methodology.  Tear osmolarity was 
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measured with and without the influence of topical anaesthetics.  This was used to block 
the afferent limb of the LFU and reduce compensatory, reflex tear secretion in an attempt 
to demonstrate the effects in the absence of a functioning homeostatic mechanism.  This 
is relevant to DED patients in whom the LFU will already be compromised, to discover if 
any further capacity remains to protect the ocular surface.  
All studies required experiments to be conducted under controlled environmental 
conditions of temperature, relative humidity and airflow and for this reason they were 
carried out in a controlled environment chamber (CEC). 
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Chapter 2: 
METHODOLOGY 
 
This chapter describes the methods and materials employed in the research reported 
here.  Experiments were carried out at the Vision and Eye Research Unit (VERU), Anglia 
Ruskin University, Cambridge, UK. Additional details are provided, where necessary, in 
the relevant chapters. 
2.1 Ethical approval 
All studies were performed according to the Declaration of Helsinki.  Ethical approval was 
obtained from the NHS Ethics Committee: South East Coast-Brighton and Sussex, and 
the University Ethics Committee.  All subjects were informed about the nature of the study 
and gave written informed consent to their participation (Appendix II).  They also received 
a letter about the study to take to their GP (Appendix III). 
2.2 Participants for all studies 
Participants were categorised into normal subjects and dry eye disease (DED) subjects, 
based on their responses to a symptom questionnaire (Appendix IV) and clinical 
assessment.  Normal subjects were individuals with a normal ocular surface by history 
and by examination, according to defined criteria, recruited chiefly from students and staff 
at Anglia Ruskin University.  DED patients were recruited from the cornea clinics of Mr 
Madhavan S. Rajan at Addenbrooke‘s Hospital and from the Cambridge group of the 
British Sjögren‘s Syndrome Association (BSSA).  All participants were paid a small fee for 
their travel or time.  Subjects of either sex, between the ages of 18 – 80 years, were 
recruited, according to the following criteria. 
2.3 Inclusion criteria 
2.3.1 Normal subjects 
To join the study, a normal subject had to: 
1. Be at least 18 years old and have full legal capacity to volunteer; 
2. Have read and signed the IRB Informed Consent Document; 
3. Be willing and able to follow participant instructions; 
4. Have clear corneas and corneal staining <grade 2 on the Oxford scale; 
5. Have a best corrected visual acuity of 6/6 or better in both eyes; 
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6. If a soft contact lens wearer, not to use their lenses for at least 8 hours before the 
procedure. 
2.3.2 DED patients 
DED patients who joined the study had to: 
1. Be at least 18 years old and have full legal capacity to volunteer; 
2. Have read and signed the IRB Informed Consent Document; 
3. Be willing and able to follow participant instructions; 
4. Have clear corneas other than the presence of punctate corneal staining ≥ grade 2 on 
the Oxford scale; 
5. Have a best corrected visual acuity of 6/6 or better in both eyes; 
6. If a soft contact lens wearer, not to use their lenses for at least 8 hours before the 
procedure. 
7. Fulfill the internationally accepted definition of DED (Lemp et al., DEWS I 2007) and 
where relevant, the definitions of ADDE and/or EDE. 
2.4 Exclusion criteria 
2.4.1 Normal subjects 
A normal subject who joined the study did not: 
1. Have any systemic disease affecting ocular health; 
2. Use topical medications and if receiving systemic medication was on a stable dose for 
the duration of the study; 
3. Have active ocular disease; 
4. Have any clinically significant lid or conjunctival abnormalities, neovascularisation, 
corneal scars or corneal opacities; 
5. Have limbal or bulbar injection or corneal staining that was clinically significant; 
6. Have worn hard or rigid gas permeable contact lenses within the previous 2 months; 
7. Have had eye surgery or an eye injury within the previous 6 months. 
2.4.2 DED patients 
A DED patient who joined the study did not: 
1. Have any systemic disease (other than Sjögren syndrome) affecting ocular health; 
2. Use any systemic or topical medications that could affect ocular health except for 
artificial tears.  Medication for a systemic condition that was stable and likely to remain so 
for the duration of the study was acceptable; 
3. Have an active ocular disease other than DED, including that associated with Sjögren‘s 
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syndrome (SjS); 
4. Have any clinically significant lid or conjunctival abnormalities, neovascularisation,
corneal scars or corneal opacities; Meibomian Gland Dysfunction (MGD), however, was 
not a basis for exclusion, and was graded; 
5. Have clinically significant limbal or bulbar injection, or conjunctival or corneal staining,
other than that due to dry eye; 
6. Have worn hard or rigid gas permeable contact lenses within the previous 2 months;
7. Have had eye surgery or an eye injury within the previous 6 months.
2.5 Further Classification of Dry Eye Disease patients 
To satisfy the diagnosis of DED, patients were required to have been diagnosed with the 
condition for at least six months, to have an Ocular Surface Disease Index (OSDI) 
(Schiffman et al., 2000) score of ≥20, a corneal staining grade of ≥2 using the Oxford 
grading scheme (Bron, Evans and Smith, 2003), and a tOsm reading of ≥308 mOsm/L 
using the TearLab® osmometer (Sullivan et al., 2010).  A TBUT of <10 seconds was 
considered as a DED indicator, but was not a requirement for inclusion. 
2.6 Apparatus 
2.6.1 Controlled Environment Chamber 
Environmental studies were carried out in a PSR ‗B‘ Series, Weiss Gallenkamp, controlled 
environment chamber (CEC), in which temperature, relative humidity and wind speed can 
be controlled and monitored.  In preliminary studies it was found that, following the entry 
of subjects into the chamber, a period of up to 10 minutes was required for the CEC 
conditions to be restored to their set values. Figure 2.1 shows an example of the time 
taken for the CEC to equilibrate after being switched on.  In this example the CEC 
reached its set values of 20ºC and 10% relative humidity (RH) within 10 minutes.  At time 
points of 65 and 70 minutes the door of the CEC was opened for 10 and 20 seconds 
respectively.  This did not affect the environmental conditions of temperature, RH with re-
equilibration occurring within minutes.  Therefore, for all the experiments, a period of 10 
minutes after entry was allowed for CEC equilibration, before commencing data collection. 
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Figure 2.1 A scattergraph showing the timescale of equilibration of the CEC once turned on (at time 0), set to 
20ºC and 10% RH.  The CEC door was opened at time points of 65 and 70 minutes (Data collected 14
th
January 2014).  
The CEC consists of a small chamber, with internal dimensions of 2.13m x 3.15m x 
2.04m, in which two subjects and one examiner can be housed comfortably, together with 
additional, required investigational equipment (Figures 2.2-2.4).  The air in the CEC 
circulates constantly with a laminar flow across the shorter width of the rectangular 
chamber, of 0.08 m/s. A unique feature of the CEC is an apparatus that produces a 
variable laminar flow, over a 0.6m square area in the range 0.15-1.1m/s, or over a 0.15m 
diameter area in the range 1.5-5.0m/s. This allows desiccating stress to be directed at the 
eyes and be modified for enhanced environmental conditions. Temperature can be altered 
between +5°C and +40°C with a fluctuation range of +/-2°C, and its relative humidity 
between 5% (at 10°C) and 70% (at 40°C) with a fluctuation range of +/-3%.   
ºC
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Figure 2.2 Dimensions and layout of the CEC. 
Figure 2.3 Subject sitting in the CEC facing the laminar airflow. 
39 
Figure 2.4 Subject sitting in the CEC for a slit-lamp examination. 
In the planned experiments, ‗standard workplace‘ conditions were set at a temperature of 
23°C, a relative humidity of 45% and a laminar flow of 0.08 m/s (based on guideline in the 
Workplace Health Committee, OHS Information Sheet no. 5 1998).  This latter flow rate is 
not negligible and the subject‘s placement in relation to the source of the laminar flow was 
standardised, with the subject facing the source (Figure 2.3).  The RH was set at 5% to 
represent marked ‗desiccating‘ conditions and 70% to represent a humid atmosphere with 
markedly ‗evaporative suppression‘ conditions. 
2.6.2 Slit-lamp examination 
All slit-lamp examinations were performed using a Keeler Symphony Q 40H.  This is a 
photo slit-lamp which was used for all clinical examinations of the anterior segment of the 
eye and to provide a permanent record of lid and ocular surface features, fluorescein 
TBUT and the ocular surface staining.  At the end of any series of experiments the eyes 
were examined with and without fluorescein and any findings related to the experiments 
were recorded in the subject‘s record.   
2.7 Clinical Assessments 
At the time of recruitment all participants were classified as normal subjects or as dry eye 
patients on the basis of the above inclusion/exclusion criteria.  All clinical history and data 
was documented on a recruitment record card (see Appendix VII).  At recruitment, 
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assessments were carried out in the following order, to minimise interactions between 
tests.  At other times, the order was determined by the specific protocol in use. 
1) Clinical history
2) Visual Acuity
3) Ocular symptom questionnaire Index (OSDI)
4) Tear osmolarity
5) Slit-lamp examination with white light, followed by fluorescein instillation
6) Tear break-up time (TBUT) (with fluorescein)
7) Grading of ocular staining
8) Schirmer test
9) Meibography
10) Grading the quality of expressed meibum from the lower lid
2.7.1 Clinical History 
Participants were interrogated according to a questionnaire (Appendix VII) regarding 
history of any eye or systemic conditions, including details of any medication and the 
duration of treatment, and also contact lens wear.  
2.7.2 Visual Acuity 
Visual acuity (VA) was measured using a Snellen chart at six metres (Pandit, 1994).  VA 
was measured in the right and left eyes uncorrected and with current spectacles if worn.  
2.7.3 Ocular Surface Disease Index (OSDI) 
In this study the Ocular Surface Disease Index (OSDI), a validated questionnaire 
(Schiffman et al., 2000) with three domains, was used for the assessment of the 
symptoms, the influence of environmental factors and the functional impact of DED. 
There are 12 questions and participants are required to indicate, on a scale of 0-4, how 
frequently each symptom category is experienced.  These choices are assigned numerical 
values, the total OSDI score is calculated on the basis of the formula OSDI = [(sum of 
scores for all questions answered) x 25] / (total number of questions answered) that are 
summed to create an overall score of symptom severity with a scale range of 0 to 100; in 
these studies a score for normal subjects was set at <20 (Schiffman et al., 2000).  A mean 
OSDI score for mild to severe DED of between 3.9 and 13.4 has been reported in several 
other studies (Miller et al., 2010; Tian, Qu and Sun, 2016). 
2.7.4 Tear Osmolarity 
Tear hyperosmolarity as a pathogenic factor of DED was first hypothesised over 50 years 
ago (Balik, 1952).  Since then several studies have demonstrated a positive correlation 
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between raised tOsm, a reduction in conjunctival goblet cell density and rose Bengal 
staining (Gilbard and Farris, 1979; Gilbard et al., 1988).  Tear osmolarity has been 
proposed as a gold standard for DED diagnosis (Farris, 1994) and its measurement is 
recommended prior to refractive surgery, since a dysfunctional tear film may impair the 
surgical outcome (Versura and Campos, 2013). Historically, the earliest studies of tOsm 
used depression of freezing point and vapour pressure methods.  Both techniques are 
dependent on the number of dissolved particles in the sample, ‗colligative‘ properties that 
do not depend upon the size, weight or identity of the particles.  In the freezing point 
method, tOsm is calculated from the depression of freezing point of the tear sample using 
the Clifton Nanolitre Osmometer (approximately 1 µL), which is directly proportional to the 
number of particles dissolved in the sample (Gilbard and Farris, 1979; Sullivan et al., 
2005).  Vapour pressure tOsm is calculated on the principle that, at the same temperature 
and pressure, the vapour pressure of a solution is depressed below that of the pure 
solvent, in proportion to the number of particles dissolved in the sample.  Both these 
methods require time, proficiency at performing the test and are often subject to errors 
due to evaporation from the samples and inducing reflex tearing when sampling that can 
over or under estimate tOsm respectively (Terry and Hill, 1978; White, Benjamin and Hill, 
1993). For the vapour pressure method, available sample volume (10µL) is a limiting 
factor, particularly in the study of aqueous tear deficiency (Tiffany, 2008).    
Recently a new method for determining tOsm has been developed, based on measuring 
the electrical impedence of the tears. The TearLab® osmometer (TearLab Corp, San 
Diego, CA) is a microfluidic system which measures the electrical impedence of a 50nL 
sample taken up from the tear meniscus into a ―lab on chip‖ test card, by capillary action 
(Figure 2.5) (Sullivan et al., 2005). This device (Figure 2.6) was used for all tOsm 
measurements made in the current studies.  The device applies a calibration curve to the 
steady-state, temperature-corrected, electrical impedance of the tear fluid, to derive, 
indirectly (Pedersen-Bjergaard and Smidt 1952), a quantitative value of tOsm, the 
numerical value ranging from 275 to 400 mOsm/L.  The osmometers used in this study 
were modified (in collaboration with the TearLab® company) to obtain values below the 
normal range of 270 mOsm/L, anticipated to be essential in Chapter 4.  This involved 
attaching a serial cable to the port inside the device and connecting the TearLab® 
machine to a computer with a USB-to-serial converter.  Establishing a HyperTerminal 
allowed the osmometer to communicate with the computer, and readings of low osmolarity 
numbers which ordinarily trigger a "Below Range" error on the device can then be viewed 
as a numerical value on the computer. There is no risk of evaporative loss during the 
sampling procedure using this machine, and since sampling can be completed within a 
few seconds the opportunity to induce reflex tearing is limited, although it is usual for the 
subject to experience a light sensation when the chip tip touches the lid margin.  The 
42 
 
TearLab® is an instrument that provides rapid and reliable results for ‗office use‘ rather 
than previously available equipment that was restricted to a research setting.  The 
machine‘s most useful role being cited is as an objective diagnostic tool with the potential 
to detect DED in the early stages and to monitor the efficacy of therapy (Versura and 
Campos, 2013).   
Procedure 
Two TearLab® instruments were used in these experiments (one situated inside the CEC 
and one situated in the clinic), and calibration was verified before any experimental 
session.  An electronic test card was used to run quality control measurements on both 
pens before any subject testing. A blue electronic test card was attached to a pen; a green 
light on top of the pen illuminates and the pen beeps when successfully attached. After 
approximately five seconds, the pen beeps again or the green light turns off. After the 
green light turned off, the pen was docked into the reader. The LCD displayed a code 
number. It was not necessary to enter a specific code for electronic check cards. To 
accept the code ‗OK‘ was pressed. The LCD displayed a test result that must be between 
331-337 mOsms/L to be acceptable. The same process was repeated with the other pen 
and notes of the date and the electronic check card test results recorded in a quality log.  
A TearLab® osmolarity control solution was then tested using each pen to verify the 
quantitative performance of the test card. This was carried out before every subject 
measurement on both instruments. A test card was attached to each pen, the pen would 
beep and the green light illuminate when the card was attached properly. The green light 
remained on until the control solution was collected. A sleeve was used to snap off the top 
of an ampoule which, was then turned upside down and the tip of the pen touched to the 
control solution. Once the pen had beeped again and the green light turned off, the pen 
was then returned to the reader within 40 seconds of collecting the sample and the code 
entered that matched the test card. After pressing ‗OK‘ the LCD displayed the results; for 
the high control solution this must be between 330-346 mOsms/L for a pass. The same 
process was repeated with the other pen and notes of the date and the control solution 
test results recorded in a quality log. 
To collect the tear sample the subject was instructed to direct the eye obliquely upwards 
and nasally, then a sample of tears was collected from the lateral tear meniscus by 
capillary action (Figure 2.7), into a disposable test chip (referred to as the ‗card‘ by the 
manufacturers) mounted on a pen.  The pen gave an audible and visible signal when 
sampling was complete and the impedance data collected.  The pen was then docked into 
a reader, which calculated and displayed the osmolarity result.  Sampling took about 1 
second with little time for stimulating reflex tear secretion.  In general, the subject 
experiences a slight tickle as the instrument tip comes into contact with the tear meniscus 
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and elements of the lid margin.  In this study the subject was asked to grade the sensation 
at the time of sampling on a scale of 1-3, representing a sense of light touch or tickle (1), 
mild discomfort (2) to moderate discomfort (3).  Readings of 3 were usually associated 
with difficulty in sampling and an increased risk of reflex tearing, and were discarded and 
not re-tested as a precaution.   Some investigators have employed an approach in their 
studies that involved the subjects squeezing the eyes shut three times to ‗create fresh tear 
fluid release from the lacrimal gland‘ before sampling tears from the meniscus (Fortes et 
al., 2011; Ungaro et al., 2015; Holland et al., 2017), but this was specifically avoided in 
present studies since it was important to record the osmolarity value of the unmodified 
meniscus tears. 
One limitation of this conductivity system is that it is dependent on the number of charged 
particles in a solution, rather than the total number of particles present and therefore does 
not register the full osmolarity of the solution. However, for the tears, since ions make the 
major contribution to osmolarity with a very small contribution from charged proteins, this 
accounts for most of the particles responsible for tOsm. Tear urea, which would not be 
registered, would amount to about 6 mOsm/L and tear glucose, in a non-diabetic subject, 
for about 0.2 mOsm/L, so that the discrepancy is small. Importantly, several studies have 
found that the tOsm measurements made with the TearLab® device are highly correlated 
with results from the freezing point technique using a Clifton osmometer (Tomlinson et al. 
2010) and with those from the Wescor 5520 Vapour Pressure Osmometer (Rocha et al., 
2017).   
The utility of the TearLab® osmometer used in this thesis is discussed further in Appendix 
XIII. 
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Figure 2.5 TearLab® disposable test card, displaying channel that collects tear meniscus sample. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6 Tearlab® pens and docking station. 
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Figure 2.7 Sampling of the tears from the meniscus with the TearLab® osmometer.  
2.7.5 Fluorescein instillation 
Fluorescein instillation was used for the measurement of TBUT and for the detection of 
ocular surface staining at the end of clinical studies.  A drop of single-dose sterile saline 
(Bausch and Lomb minims®) was applied to the Biotech® Fluoro, fluorescein ophthalmic 
strips U.S.P., each strip impregnated with 1.0mg of fluorescein sodium.  As soon as the 
saline had saturated the impregnated portion, the excess was shaken off vigorously, with 
a single shake, into a receptacle and, with the lower lid pulled downwards the wetted tip 
was then gently tapped against the lower tarsal conjunctiva.  This was carried out first on 
the right eye, to perform the TBUT and staining assessments, and then on the left eye. 
In this study staining was graded using the Oxford grading scale, which has a grade range 
from 0-15, represented by punctate dots (cornea 0-5: and 0-5 on each of the nasal and 
temporal segments of the exposed conjunctiva) (Appendix V).  For assessment of the 
cornea the upper lid was raised slightly to expose the whole cornea, with the eye in the 
primary position.  Measurement of the nasal conjunctiva was carried out with the eye 
looking temporally and of the temporal conjunctiva with the eye looking nasally. A grade of 
≥ 2 or over has been used as a diagnostic cut-off for DED (Bron, Evans and Smith, 2003; 
Bron et al. 2003; Bron et al., DEWS I 2007).  
2.7.6 Tear Break-Up Time 
The tear break-up time (TBUT) was performed after the instillation of fluorescein, using 
the slit-lamp at x16 magnification, with a blue light source and yellow absorbance filter in 
place.  The subject was instructed to blink several times in order to mix the fluorescein 
with the tears and to create a homogeneously-stained tear film.  Following this, the subject 
46 
 
was asked to blink three times and then instructed to stop blinking, at which point a stop-
watch was activated and the time between the last blink and the onset of tear break-up 
was recorded.  This was indicated by the appearance of an expanding dark zone or 
zones, within the stained film.  At the first signs of the TBUT, the timer was stopped.  If a 
blink occurred before the break-up of the tear film, the test was repeated.  Three readings 
were taken and the average was used as the TBUT value for that eye.  A value of <10 
seconds was the cut-off for dry eye diagnosis.  The TBUT and staining measurements 
were first performed on the right eye, then the left eye.   
2.7.7 The Schirmer Test 
The Schirmer test is a measure of tear production based on the wetting of an absorbent 
filter paper strip that is inserted over the lower lid margin at its outer third.  Full reviews of 
Schirmer testing, including its controversial aspects, are given by Cho and Yap and 
Senchyna and Wax (Cho and Yap, 1993; Senchyna and Wax, 2008).  
The Schirmer test Ia, without anaesthesia, is a measure of the reflex response of the 
lacrimal gland to ocular surface stimulation, acting via the lacrimal functional unit (LFU), 
the reflex system that regulates secretion on a moment to moment basis.  In most cases, 
where the sensory and motor elements of the reflex system are intact, it measures the 
responsiveness of the lacrimal gland.  Therefore, where glandular function is 
compromised by disease, as in ADDE (Lemp et al., DEWS I 2007), the responsiveness of 
the gland will be decreased and the Schirmer test result reduced.  It is important to realise 
that, unlike fluorophotometry, the Schirmer Ia test does not assess the function of the 
lacrimal gland just prior to initiating the test but rather, the gland‘s reflex response to 
sensory stimulation of the ocular surface, during the test. It therefore depends not only on 
the health and function of the lacrimal gland but on the integrity of the LFU. 
The Schirmer Ib test is performed in a similar manner, but after inducing topical 
anaesthesia in each eye.  Since the instillation of a topical anaesthetic induces reflex 
tearing and the instilled volume itself could contribute to wetting of the Schirmer strip, time 
is allowed to elapse between drop instillation and performance of the test and in many 
accounts, excess fluid is removed from the conjunctival sac with an absorbent tissue 
before the test is carried out (Lamberts, Foster and Perry, 1979; Bawazeer and Hodge, 
2003).  Bilateral topical anaesthesia reduces lacrimal secretion by blocking the sensory 
limb of the LFU and removing sensory drive from the ocular surface to the gland (Li, Deng 
and He, 2012; Jordan and Baum, 1980).  For this reason the Schirmer Ib value has been 
regarded as a ‗basal‘ value by some authors (Jones, 1966) although this is denied by 
others (Jordan and Baum, 1980; Clinch et al., 1983; Afonso et al., 1999), because there 
are other inputs to secretion. It is better to think of it more specifically as the level of tear 
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production, which results when the combined input from each ocular surface is withdrawn, 
under defined experimental conditions.  
The Schirmer II test is performed in a similar manner to the Schirmer Ib test, after inducing 
topical anaesthesia of the eye, but it is accompanied by stimulation of the nasal mucosa 
with a cotton swab.  Like the Schirmer Ia test, assuming that the sensory and motor 
elements of the reflex system are intact, the Schirmer II test assesses the reflex response 
of the lacrimal gland, in this case in the absence of a sensory input from the ocular 
surface but with a strong sensory input from the nasal mucosa (Tsubota, 1998).  
In response to some of the criticisms levelled at the Schirmer test, the Phenol Red Thread 
test (PRT) was designed: this is a cotton thread impregnated with phenol red.  A colour 
change from yellow to red is elicited as the tears wet the thread which is pH sensitive.  
The PRT requires a much shorter measurement time (15 seconds compared to 5 minutes 
for the Schirmer) and is reported to stimulate a significantly reduced amount of reflex 
tearing and therefore represent tear flow rate or basal production (Hamano et al., 1983).  
However reports have suggested that the PRT is in fact measuring the uptake of tears 
residing in the fornical compartment along with the absorption characteristics of the cotton 
thread (Tomlinson, Blades and Pearce, 2001) and as such is no longer readily available 
for use in practice, and has been withdrawn from the Japanese diagnostic criteria for DED 
(Uchino et al., 2012). 
Procedure 
The Schirmer test: Biotech® Schirmer strips, Whatman filter paper number 41 were used 
in all experiments.  The Schirmer strip was folded at the first mark (Figure 2.8), and the 
folded tip placed over the lower lid margin at its outer third.  For purposes of 
standardisation, the strip was put in place first on the right eye and then the left, noting the 
precise time interval between the two.  The subject was instructed to keep the eyes closed 
during the test; this is in accordance with European standard practice for the Schirmer test 
and also adopted in the USA.  The strip was removed at precisely five minutes, first on the 
right and then on the left, and the wetted length recorded by marking the leading edge of 
the wetted front with a black ballpoint and measuring from the fold.  If the strip was fully 
wetted before five minutes, the time to full wetting was recorded. The Schirmer strip was 
retained in the subject‘s file as a permanent record. 
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Figure 2.8 Unsheathed Biotech® Schirmer strip, with arrow showing where the strip is folded before insertion. 
The Modified Schirmer Test: Chapter 3 outlines the design of a water-proof sheath used 
to modify the Schirmer test in an attempt to remove the influence of ambient humidity and 
airflow on the wetting results. 
2.7.8 Meibography 
Assessment of meibomian gland drop-out and expressibility is employed in the diagnosis 
of meibomian gland dysfunction (MGD) and is relevant to the presence of EDE, a sub-
category of DED.  A thickening of the meibum or blockage of the glands is present in the 
early stages of the disease and is demonstrated by simply applying pressure to the 
inferior lid margin and assessing the ease which the meibum is expressed and the quality 
of the meibum.  As the condition progresses there can be a loss of meibomian glands due 
to increasing gland obstruction that may be irreversible (Bron and Tiffany, 2004).  Drop-
out of meibomian glands can be viewed using a Meibography pen (Arita et al., 2013).   
Meibography is a non-invasive technique used to assess the integrity of the meibomian 
glands.  In the present studies, a hand-held infra-red meibography device was used 
(Japan Focus Co., Ltd) (Arita et al., 2013; Arita, 2013), in which intact glandular tissue 
appears pale against a dark background.  With this method, images of the glands over the 
full extent of each lid, can be acquired and digitised for later analysis.  For this research, 
gland loss or ‗drop out‘ from the lower lid was graded, using the Arita schema (Appendix 
VI and Table 2.1).  This pen-shaped meibography system utilises an LED illumination 
source (wavelength: 940 nm, TLN119 [F], Toshiba, Tokyo, Japan) and a highly sensitive 
CMOS video camera (250,000 pixels - Scalar Corporation, Tokyo, Japan) for image 
acquisition. It can be linked to a personal computer with a USB converter to provide a 
panoramic view of all the meibomian glands of the everted lower eyelids.  The image was 
captured digitally with computer imaging software (EZCAP USB video grabber, 
Camsecure).  Less than 1 minute was needed to observe the meibomian glands of both 
sets of lower eyelids. 
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Grade 0 Represents no loss of MGs (white area) 
Grade 1 Represents a lost area (Black area) that is less than one-third of the total area 
Grade 2 Represents a lost area between one-third and two-thirds of the total area 
Grade 3 Represents a lost area more than two-thirds of the total area 
 
Table 2.1 Non-invasive Meibography grading scale.  From Arita et al. (2013). Cornea 32(3): 242-247.  
2.7.9 Meibomian gland expression 
The meibomian secretion, liquid at body temperature, is a clear, yellowish oily fluid known 
as meibum.  This clear liquid can be readily expressed from healthy meibomian orifices in 
young individuals.  In the presence of MGD, the expressed material becomes increasingly 
viscous and cloudy (Wojtowicz, Butovich and McCulley, 2009).  Grading of the quality of 
expressed meibum can be conducted in the upper and lower lids.  In the present studies, 
meibum quality was graded following the application of firm pressure to the outer surface 
of the central third of the lower lid only (approximately eight glands) with a cotton bud.  
The quality of the expressed secretion was graded using the Foulks/Bron scheme on a 
scale of 0-3 (Foulks and Bron, 2003).  The highest score from any of the expressed 
glands was taken as the overall score (Table 2.2). 
 
Quality of expression 
0 = clear 
1 = cloudy 
2 = granular 
3 = solid 
N.B. zero expression with normal MG is not scored 
        
Table 2.2 Grading of Meibomian expression.  From Foulks and Bron (2003). The ocul surf 1(3): 107-126. 
2.7.10 Topical Anaesthesia 
Topical anaesthesia was used in experiments conducted in Chapter 5 (Central 
Connectivity) and Chapter 6 (Sensory Blockade). In these studies it was necessary to 
achieve a prolonged period of anaesthesia of the ocular surface with a minimal degree of 
induced reflex tearing.  Topical anaesthetics are used routinely in ophthalmology to 
conduct diagnostic tests.  The two most commonly used are proxymetacaine 0.5% and 
tetracaine 0.5% and 1%, both available in single dose Minims®.  Proxymetacaine is a 
benzoic acid ester, while tetracaine is a para-aminobenzoic acid ester, both working by 
blocking sodium conduction across nerve cell membranes, preventing rapid influx of 
sodium ions and depolarisation, and producing a reversible blockade of the sensory nerve 
endings. To improve solubility, commercial preparations are usually acidic, soluble 
hydrochlorides (proxymetacaine pH 4.64 and tetracaine pH 4.54) (Bartlett and Jaanus, 
2008).  Because of this acidity these agents sting on instillation, slightly less so in the case 
of proxymetacaine.  Several studies using a visual pain scale have reported that 
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tetracaine is significantly more painful on instillation (Bartfield, Holmes and Raccio-Robak, 
1994; Shafi and Koay, 1998).  Shafi and Koay, (1998) reported that the stinging sensation 
lasted for 3.2 seconds with proxymetacaine and 22.1 seconds with tetracaine (Shafi and 
Koay, 1998).    
The other key area of importance is the onset and duration of anaesthesia following 
instillation of these agents.  Barfield et al., (1994) reported that both agents took effect 
approximately 30 seconds after instillation and that the duration of anaesthesia with 
proxymetacaine was 10.7 minutes, versus 9.4 minutes for tetracaine (Bartfield, Holmes 
and Raccio-Robak, 1994). In other reports, tetracaine has been reported to last in the 
order of 30 minutes (Lamberts, Foster and Perry, 1979; Lawrenson et al., 1998), and this 
was also confirmed in pilot studies (see Appendix XIII).  Shafi and Koay, (1998) concluded 
that tetracaine was likely to be a more effective anaesthetic agent (Shafi and Koay, 1998).  
In general support of these findings, Weiss and Goren (Weiss and Goren, 1991), reported 
the mean duration of anaesthesia with proxymetacaine, to be 35 minutes while Polse et 
al., (1978) reported a value of 45 minutes (Polse, Keener and Jauregui, 1978), the latter 
group also showing that stronger concentrations of the drops increased the duration of 
effect.   
A procedure was adopted in the current studies, to achieve the minimum of reflex tearing 
and the maximum level of anaesthesia with the anaesthetics used.  To minimise reflex 
tearing, a single drop of the short-acting anaesthetic 0.5% proxymetacaine (Minims®) 
(Jones, 1966) was instilled first; this drop stings only slightly.  The proxymetacaine drop 
was followed, 30 seconds later, by a drop of 1% tetracaine (Minims®).  This drop would 
normally sting markedly when instilled into an unanaesthetised eye, but since the ocular 
surface has been rendered anaesthetic by the proxymetacaine, the instillation is not 
sensed by the subject and no additional reflex tearing is induced; it provides an increased 
density of anaesthesia (Adriani and Zepernick, 1964; Jordan and Baum, 1980).  To 
maximise spreading and mixing of the drops and retention of the largest volume without 
overspill, the subject was asked to look up while each drop was instilled into the lower 
fornix and then asked to blink with the lower lid still drawn downwards.  Finally, the eyes 
were closed to allow excess fluid to be drawn off and dabbed away at the outer canthus 
and along the closed lid margins.  This sequence was followed by a period of up to 10 
minutes of spontaneous blinking to allow for the drainage of any excess of tears, prior to 
any experimental procedure.  The same general protocol was adopted for the instillation 
of saline drops, used as a control for topical anaesthetic drop instillation; in this case a 
drop of saline acted as a surrogate for each anaesthetic drop.  
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Chapter 3: 
PILOT STUDY IN DEPTH AND DURATION OF TOPICAL 
ANAESTHESIA AND THE EFFECTS OF ENHANCED 
DESICCATING STRESS 
Purpose: For two of the studies reported in this thesis, topical anaesthesia was used to 
investigate the responses of the lacrimal functional unit (LFU) to desiccating stress, in the 
absence of a sensory drive from the ocular surface (Chapters 5 and 6).  In Chapter 5 a 
protocol of topical anaesthetic instillation was developed to provide a suitable depth and 
duration of ocular surface anaesthesia, with a minimal amount of reflex tearing.  This 
involved the use of two different topical anaesthetics, commonly used in clinical practice.  
In Chapter 6 the effect of desiccating stress on the open eye, with and without sensory 
blockade was studied.  Before commencing data collection, the level of desiccating stress 
that would be included in the protocol was piloted using the enhanced airflow system of 
the controlled environment chamber (CEC) to amplify the desiccating stress. These two 
areas were piloted as follows: 
3.1 Pilot Study: Depth and duration of topical anaesthesia 
Methods: Two normal male subjects, aged 70 and 79 years were seated in the clinic in 
uncontrolled environmental conditions.  A single drop of 0.5% proxymetacaine (Minims®) 
was first instilled in the right eye and then in the left. This was followed, 30 seconds later, 
by 1 drop of 1% tetracaine (Minims®).  The technique of instillation is described in full in 
the Methodology section (Chapter 2).   
Corneal sensation was measured using a Cochet-Bonnet aesthesiometer (0.12 mm 
diameter filament) every five minutes for 45 minutes.  The area measured was at a 
paracentral region of the cornea approximately 3mm from the limbus at 6 o‘clock.  Corneal 
contact and the defined force applied was registered by the smallest visible bending of the 
nylon monofilament.  The filament length was reduced from its maximum (6 cm) in 1cm 
steps, until the subject indicated that the stimulus had been felt. ‗Total anaesthesia‘ was 
recorded when the subject was unaware of a touch sensation following contact of the 1cm 
length filament.  ‗Recovery‘ was recorded when the subject was aware of a touch 
sensation with the 1cm filament. 
Results: Depth of corneal anaesthesia for the two subjects is shown in Table A13.  At 
baseline the corneal sensation of both subjects was recorded as 6cm.  Total corneal 
anaesthesia was recorded in both subjects, at five minutes after instillation of the 
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anaesthetics, with recovery of corneal sensation being recorded, again in both subjects, at 
45 minutes. 
Time (minutes) Subject 1 Subject 2 
Length of filament (cm) 
R L R L 
Baseline 6 6 6 6 
Instillation of drops  
5 / / / / 
10 / / / / 
15 / / / / 
20 / / / / 
25 / / / / 
30 / / / / 
35 / / / / 
40  / / / / 
45 1 1 1 1 
 
Table 3.1 Corneal sensitivity before anaesthesia and measured at five minute intervals for 45 minutes after 
anaesthesia. [/] = No response to touch with 1cm filament. 
Discussion: In both subjects, total corneal anaesthesia was recorded at 5 minutes after 
the instillation of the anaesthetics, and recovery of corneal sensation by 45 minutes.  This 
is in line with an experiment by Lawrenson (1998) who reported total anaesthesia after 
one minute of instilling either amethocaine (i.e. tetracaine), oxybuprocaine or 
proxymetacaine, with recovery of corneal sensation occurring at 30 minutes; and a return 
to baseline sensitivity by 45 minutes.  The slightly extended period of time before recovery 
recorded in this study was attributed to the additive effect of using two anaesthetics in 
each eye.  In response to the results here, the protocols planned for the main experiments 
followed the drop instillation routine outlined above.  This minimised reflex tearing due to 
drop instillation, since the proxymetacaine drop stings only slightly, and tetracaine, that 
would normally sting markedly on instillation, is secondly instilled, into a previously 
anaesthetised eye.  The combination drop regime was considered to provide an increased 
density of anaesthesia (Adriani and Zepernick 1964; Jordan and Baum 1980).  
3.2 Pilot Study: Increased desiccating stress with sensory blockade 
In this pilot study an approach was explored in which the level of desiccating stress to the 
eyes was amplified by exposing the subject to an enhanced airflow while the subject was 
seated in the CEC at an RH of 5% (completed on 22nd January 2014).  
Methods: One normal male subject, aged 79 years was seated in the CEC set to 5% RH 
and 23ºC and with a laminar airflow of 0.08m/sec.  Additionally the subject was exposed 
to an increased airflow directed to the head, with the subject facing the source (Chapter 2, 
Methodogy) which was activated 10 minutes after the anaesthetic instillation. The 
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anaesthetic instillation procedure (see above) was initiated shortly after entering the CEC, 
and the enhanced airflow was activated 10 minutes after entry. The subject faced the 
enhanced airflow system with both eyes open and blinking spontaneously.  
The intention was to observe the eyes at 15 minute intervals, however at 5 minutes the 
subject volunteered a change in vision in the left eye and the experiment was concluded. 
Results: The appearance of the two eyes before the experiment and following 
fluorescein instillation, are shown in Figure A13 a and b. They were considered to be free 
of significant corneal staining. The image of the right tear film is imperfect since it shows 
the imprint of the upper lid and associated meniscus induced thinning prior to lid elevation.  
Therefore a further image of the right cornea, demonstrating normality, acquired on 
another occasion, is included in Figure A13 c (obtained 11th February 2015).  Figures A13 
d and e show the appearance of the right and left corneas 5 minutes after initiating 
enhanced airflow, and following a further instillation of fluorescein.  Each cornea showed 
extensive, confluent, punctate epithelial staining, occupying the exposed regions of the 
corneas.  The subject has a relative ptosis, and the upper extent of the stained region 
corresponded to the position of the upper lid margin.  The upper part of the cornea was 
protected by the upper lid.  
Discussion: Instillation of anaesthetic eye drops and exposure of the eyes to 5% RH for 
10 minutes followed by an additional exposure of the eyes to increased airflow of 2m/sec 
for a further five minutes, resulted in an diffuse and extensive punctate epithelial 
keratopathy (PEK) affecting the exposed cornea.  The subject underwent a slit-lamp 
examination again the following day, at a different site, and the PEK had resolved.  To 
gauge the compensatory levels of the LFU in conditions of desiccating stress, topical 
anaesthetics were used to block the afferent signals.  It was apparent from this study that, 
in a situation of dense corneal anaesthesia, during exposure to a combined source of 
desiccating stress (5% RH plus an enhanced, directional airflow), the absence of an 
adequate compensatory tear response resulted in corneal damage.  It cannot be excluded 
that some kind of toxicity due the topical anaesthetics might have interacted with the 
desiccating stress to cause this response.  Because of the speed of onset and severity of 
the tissue response, it was decided that the use of an enhanced desiccation approach 
represented a significant risk to subjects, and therefore this approach was not adopted for 
studies in general.  The protocol was therefore adapted to include a low RH (5%) with a 
laminar airflow of 0.08 m/sec as used in the other studies. 
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Figure 3.1 Fluorescein staining images of the right and left eye following instillation of anaesthetics and pre 
and post-exposure to enhanced desiccating stress.  The brightness and contrast of the images have been 
adjusted to highlight features of corneal staining. 
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Chapter 4: 
STANDARDISING THE SCHIRMER TEST BY ENCLOSING THE 
STRIP IN A WATERPROOF SHEATH 
 
These experiments were designed to study the effect of different relative humidity (RH) 
levels on the Schirmer test in closed eye conditions and to determine whether shielding 
the paper from evaporation, using a waterproof sheath would have an effect on wetting 
length in these conditions.  
4.1 INTRODUCTION 
Tear production can be measured accurately in standardised laboratory conditions by 
fluorophotometry, a dye-dilution technique in which a standard amount of fluorescein is 
instilled into the conjunctival sac and the fall in tear film dye concentration is measured 
photometrically over time (Tomlinson and Khanal, 2005). The purpose of this technique is 
to measure the steady-state level of tear production (predominantly lacrimal secretion) in 
controlled environmental conditions. Other dye-dilution techniques, of lesser accuracy, are 
also available (Macri, Rolando and Pflugfelder, 2000; Kaye et al., 2001).  In non-
specialised units or clinics, because of time constraints, cost and technical considerations, 
it is more usual to measure tear production by the Schirmer test.  This test is performed 
bilaterally and nowadays conducted with the eyes closed, which reduces light exposure 
and evaporative water loss from the ocular surface during the test.  According to how the 
test is performed, it has been stated that it can provide information about reflex or basal 
tear production.  Despite its reported shortcomings, the test has regularly been included 
among the battery of assessments advocated for the diagnosis of dry eye disease (DED) 
(Balik, 1952; Wright and Meger, 1962; Lemp, 1995; Tomlinson et al., DEWS I 2007; 
Wolffson et al., 2017).  The result provides information about the functionality of the 
lacrimal functional unit (LFU) and since it is generally assumed that the reflex neural 
pathways are intact, the Schirmer value is taken as a measure of the responsiveness of 
the lacrimal gland.  A normal Schirmer value is taken as evidence of a healthy lacrimal 
gland and an adequate aqueous tear supply.  The proportion of wetting of the Schirmer 
strip could be used to differentiate between phenotypes of DED; a reduced value being 
the usual diagnosis of aqueous-deficient dry eye (Bron et al., 2009). 
A full review of Schirmer testing, including its controversial aspects, is given by Senchyna 
and Wax (Senchyna and Wax, 2008).  In brief, the Schirmer test, without anaesthesia 
(referred to here as Ia), is a measure of the reflex response of the lacrimal gland to ocular 
surface stimulation, while the Schirmer test with topical anaesthesia in each eye (referred 
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to here as Ib) has been regarded as a ‗basal‘ value by some authors (Jones, 1966), 
although this is denied by others (Clinch et al., 1983; Afonso et al., 1999), because there 
are other inputs to secretion.  The Schirmer II test is performed after inducing topical 
anaesthesia of the eyes, but accompanied by stimulation of the nasal mucosa with a 
cotton swab.  Like the Schirmer Ia test, assuming that the motor elements of the reflex 
system are intact, the Schirmer II test assesses the reflex response of the lacrimal gland 
to a strong sensory input from the nasal mucosa, in this case in the absence of a sensory 
input from the ocular surface.  
Various authors emphasise the high variability and low reproducibility of the Schirmer test 
which undermines its value in the diagnosis of DED (Loran et al., 1987; Kallarackal et al., 
2002; Serin et al., 2007; Sullivan et al., 2010), except, perhaps in patients with moderate 
to severe aqueous deficient dry eye where there is greater reliability (Nichols et al. 2004). 
Part of the variation is likely to be technical and part biological, reflecting the sensitivity of 
the reflex system to small environmental changes.  Some portion of the tear production 
may be lost, by nasolacrimal drainage via the puncta (de Roeth, 1953; Norn, 1965). 
A reason for variability of the test in differing environmental conditions was identified by 
Holly and colleagues (Holly, Lamberts and Esquivel, 1982; Beebe, Esquivel and Holly, 
1988; Holly, 1994), who demonstrated that evaporative water loss from the Schirmer 
paper strip reduces the wetting length over the 5 minute course of the test, leading to an 
underestimation of reflex tear production.  This could render the test sensitive to the 
ambient conditions of the test, with the expectation that the wetting length will be 
particularly reduced in conditions of decreased humidity or high and/or turbulent, airflow. 
Holly et al., (1982) stated that an increased draft in the vicinity of the Schirmer strip could 
increase the evaporation rate ―several-fold‖ (Holly, Lamberts and Esquivel, 1982).  These 
authors showed that this artefact could be prevented by enclosing the Schirmer strip in a 
water-impermeable sheath to prevent evaporation (Holly, Lamberts, and Esquivel, 1982). 
According to their findings, in the absence of protective sheathing, for a given, true tear 
flow rate, wetting length would be positively correlated with relative humidity; and the 
lower the relative humidity, (therefore the higher the evaporative loss from the strip), the 
lower the predicted wetting length.  
In the studies by Holly and colleagues (1982; 1988; 1994), it was shown that the total 
evaporative loss from the wetted strip increased linearly with wetting length, due to the 
increased wetted area exposed (Holly, Lamberts, and Esquivel, 1982).  Eventually this 
reached a steady state in which the uptake rate was equal to the total evaporation rate.  It 
follows that in any given condition, the wetting length will be increased by cladding the 
paper strip in a water-impermeable sheath to prevent evaporation.  In the reports 
mentioned above by Holly and colleagues (Holly, Lamberts and Esquivel, 1982; Beebe, 
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Esquivel and Holly, 1988; Holly, 1994), Black Ribbon No. 589 filter paper was used for 
their Schirmer experiments, with and without sheathing.  The temperature and airflow 
levels used in the experiment were not disclosed, other than to state that it should be 
controlled, ―avoiding unpredictable air turbulence around the strip‖. In the experiments 
described below, the commercially available Biotech® Schirmer strips (Whatman No. 41) 
were used, Whatman No. 41 filter paper having been found to have a similar wetting curve 
to Black Ribbon No.589 (Figure 4.1) (Holly, Lamberts, and Esquivel, 1982), and the 
environmental conditions standardised using a controlled environment chamber (CEC).  
 
 
 
 
 
 
 
 
 
 
Figure 4.1 Wetting curves obtained for Black ribbon and Whatman 41 filter paper in free absorbtion, 
conducted in an environment where temperature and humidity could be controlled and airflow eliminated 
(conditions undisclosed).  From Holly et al. (1982). Curr Eye Res 2(1): 57-70). 
The following experiments were designed to expand on those of Holly and colleagues and 
to investigate the quantitative effect of decreased humidity on Schirmer wetting length, in 
the presence or absence of a protective sheath. The outcome of these studies was also 
relevant to studies on central nervous connectivity (Chapter 6).  
4.2 HYPOTHESIS   
It was proposed that, for a given, true tear flow rate, cladding the Schirmer strip in an 
impermeable plastic sheath would significantly increase the Schirmer wetting length 
compared to the unclad condition in inverse proportion to the relative humidity.  
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4.3 MATERIALS AND METHODS 
 
4.3.1 Subject enrolment 
Eight normal subjects were recruited, three male and five female, aged 36 years ± 24.22 
(mean ± SD) (see Chapter 2 for inclusion and exclusion criteria).  A closed-eye, sheathed 
vs. unsheathed Schirmer test was performed bilaterally in all eight subjects, in RH 
conditions of 5%, 15%, 25% and 45%.  Subject three also took part in the experiments 
featured in chapters five and six, and subject four also took part in the experiments 
featured in chapters four, five and six.  At least one month was allowed to elapse before 
these subjects were invited to participate in the other experiments.  The nature of the 
research was explained to the subjects and written informed consent was obtained at 
least 24 hours before commencement of the experiment.  Table 4.1 contains the ocular 
profiles of the right eye of normal subjects recruited for this experiment. 
Subject Age 
(years) 
Gender tOsm 
(mOsm/L) 
Corneal 
stain 
Schirmer 
wetting 
(mm) 
OSDI TBUT 
(seconds) 
Meibography 
1 20 F 292 0 19 6.25 10.7 0 
2 19 F 283 0 19 17.5 11.3 0 
3 22 F 293 0 28 2.08 10.6 0 
4 32 M 297 0 17 0 10.2 0 
5 21 F 298 0 24 4.16 11.8 0 
6 25 F 295 0 33 0 14.1 0 
7 79 M 301 1 17 12.5 10.2 0 
8 70 M 293 0 15 6.25 13.7 0 
Mean ± SD  
 
36 ± 
24.2 
5F:3M 294 ± 
5.37 
0.13 ± 
0.35 
21.5 ± 
6.28 
6.09 
± 
6.16 
11.58 ± 
1.53 
 
0 ± 0 
 
Table 4.1 Profiles of the normal subjects consented for this study. 
4.3.2 Equipment 
Construction of the Schirmer sheath 
Lightweight sheaths were constructed from plastic sheeting (Fellowes ImageLast) 
laminating pouch sheets.  The harder outer layer is made of polyethylene terephthalate 
plastic and the softer inner layer is made of ethylene-vinyl acetate plastic.  Briefly, each 
sheath was constructed in the following way: using a thin heating iron (BaByliss hair 
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straightener), the laminating sheets were sealed on three sides after 3 seconds of heat 
contact.  The sheaths were then cut into 4cm by 2cm pockets, 80 microns thick, which 
permitted the insertion of a Biotech® Schirmer strip (Figure 4.2), an unbonded, porous 
paper strip 35mm by 5mm (Whatman No. 41), allowing 6 mm of the insertion end of the 
strip to project beyond the top edge of the plastic housing. In use, the top end of the strip 
was folded at the first mark on the Biotech® Schirmer strip at a right angle (Figure 4.3), in 
order to hang the strip over the lid margin at the time of placement.  When the sheathed 
Schirmer strip was in place for measurement of reflex tearing, its presence was generally 
indistinguishable by the subject, from that of an unsheathed strip.  The steps involved in 
inserting the Schirmer strip into the sheath are shown in Figure 4.4 A-F. 
 
 
 
Figure 4.2 A Biotech® Schirmer strip, an unbonded, porous paper strip 35mm by 5mm (Whatman No. 41). 
 
                                              
     
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 A Biotech® Schirmer strip, enclosed in a lightweight sheath constructed from plastic sheeting. 
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Figure 4.4 A-F Images of how the Schirmer strip was inserted into the sheath before use on a subject.  This 
was completed approximately 10 minutes before use.  New sheaths were created for each subject. 
 
4.3.3 Protocol 
The experiments were conducted in the Weiss-Gallenkamp controlled environment 
chamber (CEC).  Tests were conducted over a range of RH in two sessions on different 
days, with the temperature set to 23°C and a laminar airflow of 0.08 m/s. In session one 
the Schirmer test was conducted at RH of 25%, 15% and 5%, with a 10 minute break 
between each test, to facilitate a change to the CEC RH setting and time for re-
equilibration to the new RH level; this also provided a comfort break for the subject.  
Session two was conducted at a RH of 45% on a separate day.  Eyes received either a 
standard Schirmer strip or a Schirmer strip clad in a waterproof sheath, on a random 
basis, decided by the toss of a coin.   
For each set of studies after entering the CEC, subjects were seated with their eyes open 
looking straight ahead and blinking spontaneously for ten minutes while the conditions of 
the CEC stabilised.  A closed-eye Schirmer test was then performed in both eyes as near 
simultaneously as possible, inserting the first strip in the right eye and the second in the 
A B 
C D 
E F 
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left eye with the eyes closed for 5 minutes immediately after insertion of both Schirmer 
strips. The time between the insertion of the first strip and the insertion of the second strip 
was measured and strips were removed for reading in the order of their insertion and at 
the same time interval, at the end of the 5 minute test.  The wetting length was marked 
with a black ballpoint and recorded.  If the wetting length of the Schirmer strip was oblique 
then the mid-point of the line was taken as the measured point.  If full wetting occurred 
before this time, the time was noted.  In subjects where the Schirmer wetting length 
reached 35mm before the end of the 5 minute (300 seconds) test period, an extrapolated 
value was used for analysis, as employed by Gupta et al., (1997), whereby the wetting 
length was divided by the number of seconds in which full wetting occurred and this value 
was then multiplied by 300 seconds (Gupta et al., 1997). Both Schirmer strips were 
retained in the subject‘s record.  Movement of all individuals present in the CEC was kept 
to the necessary minimum during the studies, in order to avoid turbulent airflow and to 
maintain standardisation of the environmental conditions. 
At the end of the series of experiments the eyes were examined with and without 
fluorescein and any findings were recorded in the subjects‘ records. Slit-lamp 
photographs, including fluorescein staining, were also taken; an example of a record card 
is shown in Appendix VIII.  Figure 3.5 shows a timeline of 70 minutes over which the 
subjects were exposed to the three different RH. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 Timeline of visit. 
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4.3.4 Statistical analysis 
A paired t-test was used to compare the wetting length of the sheathed and unsheathed 
Schirmer tests in the different conditions of RH.  The mean difference in Schirmer wetting 
lengths between the sheathed and unsheathed values in the four different experiments 
were analysed using a repeated measures one way ANOVA.  The Bonferroni method was 
used to make adjustments for multiple comparisons.  The Shapiro-Wilk test was used to 
evaluate normality of distribution.  Differences were considered statistically significant with 
P values less than 0.05.  Data is presented as mean ± standard deviation.  Analyses were 
performed using SPSS 20. 
4.4 RESULTS 
The results presented here show the comparison of the Schirmer wetting length between 
the two eyes in an individual, with one strip sheathed by an impermeable membrane and 
that in the fellow eye unsheathed.  
5% Relative Humidity 
The raw data of Schirmer wetting lengths for each participant at 5% RH can be found in 
Table 4.2.  The mean Schirmer wetting length in the sheathed condition was 23.9 ± 
14.9mm and in the unsheathed condition 11.9 ± 9.6mm (Figures 4.6 and 4.7).  The mean 
difference in wetting length was 11.9 ± 8.6mm, representing a 49.3 % mean increase in 
Schirmer wetting length on the sheathed side, t(7) = 3.911 (p = 0.006). 
 
Participants 
(gender/age) 
1 
F/20 
2 
F/19 
3  
F/22 
4 
M/32 
5  
F/21 
6   
F/25 
7   
M/79 
8 
M/70 
5% RH 
Sheathed side L L R R L L R R 
Test time (seconds) 300 300 300 300 300 185 300 300 
Sheathed wetting 
length (mm) 
7 
 
18 23 31 17 57* 21 17 
Unsheathed wetting 
length (mm) 
4 9 15 9 17 32* 5 4 
Time corrected 
difference in wetting 
length (mm) 
3 9 8 22 0 25* 16 13 
Mean difference in 
wetting length ± SD 
(mm) 
11.9 ± 8.6mm (p = 0.006) 
Difference in wetting 
length (%) 
42.9 50.0 34.8 71.0 0 43.8 76.2 76.5 
Mean difference in 
wetting length ± SD 
(%) 
49.3% ± 25.8 
 
Table 4.2 Sheathed and unsheathed wetting length results for each participant at 5% RH. 
* For statistical analysis, the extrapolated Schirmer value at 5 minutes was used for samples in which 
 the strip was completely wet before the 5 minutes. 
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Figure 4.6 Boxplot showing the Schirmer wetting length in the sheathed and unsheathed conditions at 5% 
RH. 
 
Figure 4.7 Stacked bar graph showing the Schirmer wetting length in the sheathed and unsheathed 
conditions of each participant at 5% RH.      These values represent extrapolated Schirmer value at 5 minutes 
and were used for samples in which the strip was completely wet before the 5 minutes. 
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15% Relative Humidity 
The raw data of Schirmer wetting length for each participant at 15% RH can be found in 
Table 4.3.  The mean Schirmer wetting length in the sheathed condition was 22.5 ± 
13.5mm and in the unsheathed condition 12.6 ± 8.6mm (Figures 4.8 and 4.9).  The mean 
difference in wetting length was 9.8 ± 6.7mm, representing a 44.3 % mean increase in 
Schirmer wetting length on the sheathed side, t(7) = 4.143   (p = 0.004). 
 
Participants 
(gender/age) 
1 
F/20 
2 
F/19 
3  
F/22 
4 
M/32 
5  
F/21 
6   
F/25 
7   
M/79 
8 
M/70 
15% RH 
Sheathed side R L R L R L L R 
Test time (seconds) 300 300 300 300 300 230 300 300 
Sheathed wetting 
length (mm) 
7 
 
19 33 34 15 46* 11 15 
Unsheathed wetting 
length (mm) 
2 14 14 15 8 31* 9 8 
Time corrected 
difference in wetting 
length (mm) 
5 5 19 19 7 15* 2 7 
Mean difference in 
wetting length ± SD 
(mm) 
9.8 ± 6.7mm (p = 0.004) 
Difference in wetting 
length (%) 
71.4 26.3 57.6 55.9 46.7 32.6 18.2 46.7 
Mean difference in 
wetting length ± SD 
(%) 
44.3% ± 17.8 
 
Table 4.3 Sheathed and unsheathed wetting length results for each participant at 15% RH. 
* For statistical analysis, the extrapolated Schirmer value at 5 minutes was used for samples in which 
 the strip was completely wet before the 5 minutes. 
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Figure 4.8 Boxplot showing the Schirmer wetting length in the sheathed and unsheathed conditions at 15% 
RH. 
 
 
Figure 4.9 Stacked bar graph showing the Schirmer wetting length in the sheathed and unsheathed 
conditions of each participant at 15% RH.     These values represent extrapolated Schirmer value at 5 minutes 
and were used for samples in which the strip was completely wet before the 5 minutes. 
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25% Relative Humidity 
The raw data of Schirmer wetting length for each participant at 25% RH can be found in 
Table 4.4.  The mean Schirmer wetting length in the sheathed condition was 25.2 ± 
11.5mm and in the unsheathed condition 15.1 ± 7.8mm (Figures 4.10 and 4.11).  The 
mean difference in wetting length was 10.1 ± 6.0mm, representing a 39.2 % mean 
increase in Schirmer wetting length on the sheathed side, t(7) = 4.718  (p = 0.002). 
 
Participants 
(gender/age) 
1 
F/20 
2 
F/19 
3  
F/22 
4 
M/32 
5  
F/21 
6   
F/25 
7   
M/79 
8 
M/70 
25% RH 
Sheathed side L R L R R R L R 
Test time (seconds) 300 262 261 300 300 300 300 300 
Sheathed wetting 
length (mm) 
19 40* 40* 19 24 34 11 14 
Unsheathed wetting 
length (mm) 
8 19* 24* 10 13 28 9 9 
Time corrected 
difference in wetting 
length (mm) 
11 21* 16* 9 11 6 2 5 
Mean difference in 
wetting length ± SD 
(mm) 
10.1mm ± 6.0 (p = 0.002) 
Difference in wetting 
length (%) 
57.9 52.5 40.0 47.4 45.8 17.7 18.1 35.7 
Mean difference in 
wetting length ± SD 
(%) 
39.2% ± 14.8 
 
Table 4.4 Sheathed and unsheathed wetting length results for each participant at 25% RH. 
* For statistical analysis, the extrapolated Schirmer value at 5 minutes was used for samples in which 
 the strip was completely wet before the 5 minutes. 
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Figure 4.10 Boxplot showing the Schirmer wetting length in the sheathed and unsheathed conditions at 25% 
RH. 
 
Figure 4.11 Stacked bar graph showing the Schirmer wetting length in the sheathed and unsheathed 
conditions of each participant at 25% RH.     These values represent extrapolated Schirmer value at 5 minutes 
and were used for samples in which the strip was completely wet before the 5 minutes. 
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45% Relative Humidity 
The raw data of Schirmer wetting length for each participant at 45% RH can be found in 
Table 4.5.  The mean Schirmer wetting length in the sheathed condition was 19.6 ± 
6.9mm and in the unsheathed condition 12.1 ± 3.9mm (Figures 4.12 and 4.13).  The mean 
difference in wetting length was 7.5 ± 3.8mm, representing a 36.6% mean increase in 
Schirmer wetting length on the sheathed side, t(7) = 5.557  (p = 0.001). 
 
Participants 
(gender/age) 
1 
F/20 
2 
F/19 
3  
F/22 
4  
F/32 
5 
M/21 
6   
F/25 
7   
M/79 
8 
M/70 
45% RH 
Sheathed side R L L L L L L R 
Test time (seconds) 300 300 300 300 300 300 300 300 
Sheathed wetting 
length (mm) 
12 10 26 17 15 25 26 26 
Unsheathed wetting 
length (mm) 
8 8 13 13 7 16 15 17 
Time corrected 
difference in wetting 
length (mm) 
4 2 13 4 8 9 11 9 
Mean difference in 
wetting length ± SD 
(mm) 
7.5 ± 3.8mm (p = 0.001) 
Difference in wetting 
length (%) 
33.3 20 50 23.5 53.3 36 42.3 34.6 
Mean difference in 
wetting length ± SD 
(%) 
36.6 ± 11.67 
 
Table 4.5 Sheathed and unsheathed wetting length results for each participant at 45% RH. 
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Figure 4.12 Boxplot showing the Schirmer wetting length in the sheathed and unsheathed conditions at 45% 
RH. 
 
 
 
Figure 4.13 Stacked bar graph showing the Schirmer wetting length in the sheathed and unsheathed 
conditions of each participant at 45% RH.        
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Unexpectedly, no significant difference was found in the mean difference in wetting 
lengths between the sheathed and unsheathed conditions compared over the four 
different exposure levels, in other words the difference in wetting length was not 
demonstrated to be proportional to the level of RH, F(3,21) = 0.631 (p = 0.603), although 
when viewed graphically a trend is discernable, indicating that the increased difference in 
Schirmer wetting lengths between the sheathed and unsheathed strips is found at the 
lower RH levels (Figure 4.14). 
 
 
 
Figure 4.14 Bar graph demonstrating the mean differences in Schirmer wetting length between the sheathed 
and unsheathed conditions across the four different exposure levels. 
 
4.4.1 Slit-lamp examination 
Figure 4.15 shows examples of the typical appearance found in both eyes following 
participation in the experiment.  Fluorescein examination revealed an expected confluent 
stain on the tarsal plates of both eyes laterally at the point of contact between the 
Schirmer strip and the tarsal conjunctiva.  However, there was no corresponding staining 
on the bulbar conjunctiva. The staining did not appear to be increased in the eye that had 
received the sheathed Schirmer strip. 
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Subject 2 - RE (sheathed strip)                                                      Subject 2 - LE   (unsheathed strip)                   
    
                       
 
                                 
    
Subject 3 – RE (unsheathed strip)                                                  Subject 3 – LE (sheathed strip) 
Figure 4.15 Examples of typical fluorescein staining of the palpebral conjuntiva following a sheathed and 
unsheathed Schirmer test.  
 
4.5 DISCUSSION 
The purpose of this study was to examine the influence of retarding evaporation, on the 
wetting length of the Schirmer strip.  The wetting length was found to be greater on the 
sheathed side in 31/32 tests, and there was a significant difference in wetting length 
between the sheathed and unsheathed strips found at each level of RH tested.  The study 
was single masked, and although each subject was masked to the location of the 
sheathed versus the unsheathed strip, in both sets of experiments, the investigator was 
fully aware of the location of the two strips.   
The experiments here demonstrated here were the first to be conducted in controlled 
environmental conditions with a novel approach to sheathing the Schirmer strip from 
Confluent staining on the 
tarsal plates of both eyes 
following Schirmer strip 
insertion 
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evaporation. It was demonstrated that the Schirmer wetting length was greater for the 
sheathed Schirmer strip compared to the unsheathed at all levels of relative humidity.  At 
5% RH the mean difference in wetting length was 11.9 ± 8.6mm (p = 0.006); at 15% RH 
the mean difference in wetting length was 9.8 ± 6.7mm (p = 0.004); at 25% RH the mean 
difference in wetting length was 10.1 ± 6.0mm (p = 0.002) and at 45% RH the mean 
difference in wetting length was 7.5 ± 3.8mm (p = 0.001).  These results are presented 
graphically in Figure 4.14. In interpreting these results, an assumption is made that the 
Schirmer Ia (without anaesthesia) secretory response, in the unclad state, is similar 
between the two eyes (Kallarackal et al., 2002).  Any further studies could be adjusted 
using a crossover design to account for a variable flow rate between the two eyes. 
Earlier studies by Holly et al., (Holly, Lamberts and Esquivel, 1982; Beebe, Esquivel and 
Holly, 1988; Holly, 1994) had indicated a relationship between water loss from the strip 
and wetting length, such that, the greater the evaporative loss, the greater the decrease in 
wetting length. A similar observation was made, more recently, by Buckmaster and 
Pearce (Buckmaster and Pearce, 2016). In this study an in vitro experiment was set up 
whereby the first 5mm of an unsheathed Schirmer strip was immersed in an unlimited 
water supply; the benefit of this approach was that it allowed pure observation of the 
effects of RH on Schirmer wetting since the influence of reflex tearing and biological 
variation was removed.  Measurements of wetting length after 5 minutes at RHs of 5%, 
20%, 35%, 50%, 65%, 80% and 95% and a temperature of 21°C were taken, using six 
Schirmer strips per RH level.  Results showed a significant decrease in wetting length as 
the RH reduced, ranging from 27mm at 5% to 39mm at 95%.  In a subsequent experiment 
the Schirmer strips were modified to prevent evaporation from the strip using a ―plastic 
film‖ that started at the 10mm notch and the experiments then repeated as above.  It was 
reported that in the sheathed condition the wetting length did not change at any of the RH 
levels.  Lastly an in vivo study was also conducted.  Ten normal subjects received both 
bilateral unsheathed and sheathed Schirmer tests at RHs of 20%, 50% and 80%.  There 
was a significant reduction in wetting length in the unsheathed Schirmer strip 
demonstrated between the 20% and 80% RH conditions, and a much lower variation in 
wetting lengths when the Schirmer strips were sheathed.  The overall conclusion was that 
in lower levels of Schirmer wetting lengths, such as those expected in DED, the effect of 
evaporation was negligible.  However, in those patients with borderline wetting lengths 
~10mm, there was the potential that they could be falsely diagnosed with DED, since 
these measures are often conducted in conditions of low humidity.  A recent poster 
presented at ARVO re-asserted the usefulness of the Schirmer Tear Test (STT), stating 
that with some adaptation to the methodology, and by enclosing the Schirmer strip in a 
water-proof sheath (transparent tape), it could provide a reliable, quantitative measure of 
tear production and aid in the differential diagnosis of ADDE and EDE (Radke et al., 
2017).  Results from this study indicated that, providing an initial phase of non-linear 
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wetting, due to the uptake of the tears present on the lid margin, was discounted, the 
following period of wetting that occurred at a much slower, linear rate, would allow the tear 
production rate to be calculated.  However, no comparison was made between a 
sheathed and unsheathed Schirmer wetting length condition.  The study endorsed the 
importance of sheathing the strip to obtain a more valid statement for the basal 
(anaesthetic) tear production and to obtain the best clinical results by reducing 
evaporation from the strip.  A similar conclusion had been drawn in the earlier work of 
Holly et al., (Holly, Lamberts and Esquivel, 1982). 
 
 
The effect of evaporation on the Schirmer wetting length described here and in the studies 
of Buckmaster and Pearce (Buckmaster and Pearce, 2016), and Radke et al., (Radke et 
al., 2017) was probably responsible for a paradoxical finding in a recent study, by 
Abusharha and Pearce (Abusharha and Pearce 2013).  It was found that exposure of 
normal subjects to prolonged desiccating stress, at a RH of 5%, caused, as expected, a 
marked increase in tear evaporation compared to that measured at 40% RH, together with 
symptoms of increased discomfort.  Increased discomfort could be explained by surface 
cooling and a rise in tOsm, due to the increased evaporation. However, a normally 
operating LFU in these subjects would be expected to offset these effects of increased 
evaporation by reflexly stimulating a rise in lacrimal secretion (Stern et al., 2004).  This 
would account for the finding that although the average tOsm was higher at 5% RH, it was 
not significantly different from that at 40% RH.  Surprisingly however, the Schirmer test 
value, used to measure the reflex tear secretory response at 5% RH at the end of the 
study, was reduced rather than increased, which conflicted with the prediction of a reflex 
increase in lacrimal secretion.  This result was most likely due to an artefact of 
measurement, caused by excessive evaporation from the Schirmer strip exposed at 5% 
RH.  It may be concluded that in those experiments, desiccating stress did indeed result in 
homeostasis of tOsm, due to the stimulation of lacrimal secretion, but that the lacrimal 
secretory response was masked by an artefact in the Schirmer test measurement.  In 
other words tOsm would have risen, were it not for a secretory response of the lacrimal 
gland.  As mentioned in the introductory chapter this evaporative artefact could also be 
responsible for similar, anomalous tear flow and tOsm responses to low RH reported by 
Teson et al., (2013) and López-Miguel et al., (2014) in subjects exposed to 5% RH for a 
period of  two hours (Teson et al., 2013; López-Miguel et al., 2014). 
An important issue of interpretation needs to be dealt with here.  In the above studies and 
in the work reported in this chapter, the Schirmer response, say at 5% RH, is spoken of as 
if it were reporting the lacrimal response to the exposed relative humidity, perhaps having 
reached a new steady state at the time of measurement.  Actually, that value can only be 
captured by a minimally-invasive technique such as fluorophotometry, or indirectly by 
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inferring changes in tear volume from a measurement of tear meniscus volume. It is not 
certain that the reflex Schirmer test (Ia) referred to here will tap into and reflect this effect. 
Therefore, in the study reported here, the Schirmer test is being used as a test-bed to 
explore the influence of sheathing on the recorded response, rather than to make a 
statement about the lacrimal response to different RH levels.  In the current study, 
although there was a  visual trend towards an increased difference in wetting lengths with 
decreasing RH, the relationship was not significant (p = 0.603).  Several possible reasons 
for this may be considered, including the small numbers of subjects in the study and the 
impact of repeated Schirmer tests on individual responses in one session, which was not 
predictable in terms of the effect of one Schirmer test on a subsequent one.  
Unrecognised variations in permeability of the sheathing may have occurred and local 
differences in air currents and other environmental factors may have operated in the 
neighbourhood of the Schirmer strips and been responsible for the unexpected findings. 
There are other factors that need to be taken into account in this study such as the fact 
that the sheathing of the Schirmer strip added extra weight resulting in the strip sitting 
closer to the cheek when compared to the unsheathed strip (Figure 4.16).  This could 
influence the final wetting result since gravity may have added to the speed of wetting.  
However, in a previous experiment by Holly et al., (1982) the difference in wetting length 
contributed by gravity was found to be ―barely detectable‖ (Holly, Lamberts and Esquivel, 
1982).  In a recent modelling paper by Telles et al., (2017), gravity is stated to increase 
wetting progression by approximately 10%, but only after the wetting front reaches the 
point at which the strip is bent for insertion into the eye, being negligible due to imbibition 
forces, before this point.  Eliminating the consideration of gravity from mathematical 
calculations still resulted in a tear production rate of 1.19 µL/min, a value still in line with 
previous estimates (Mishima et al., 1996: Cerretani and Radke, 2014). 
 
                    
 
 
 
 
 
 
 
 
 
 
Figure 4.16 Position of a sheathed and unsheathed Schirmer strip once in situ. 
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Figure 4.17 Schematic of a Schirmer strip inserted into the tear lake shown in cross section as an equilateral 
triangle. Curved lines with arrows indicate tear evaporation.  From Telles et al. (2017). Colloids Surf 
Physicochem Eng Aspects 521:61-68. 
 
 
It is also possible that evaporation from the Schirmer strip may have taken place to a 
greater extent on the superior surface.  The inferior surface may have been protected 
from evaporation by a possible pocket of increased humidity forming between the paper 
and the cheek. Modelling has demonstrated that evaporation can occur from the top and 
bottom of the Schirmer strip (Figure 4.17) once wetting emerges from the inferior fornix, 
slowing the progression of the wetted front (Telles et al., 2017). The sheath created for 
this study was assumed to be completely waterproof; however this was not tested and any 
deviation from this state could have contributed to an increased evaporation from the 
Schirmer strip. 
Airflow, temperature and relative humidity in clinic conditions can vary in different 
locations and environments and air-conditioning could play a negative role, influenced, for 
instance by subject placement within a room.  A wider variation in ambient conditions 
could exist on a global basis where, in the absence of air-conditioning, subjects could be 
exposed to seasonal variations in ambient conditions (Teson et al., 2013; López-Miguel et 
al., 2014). With these ambient conditions in a clinical setting varying from day-to-day, the 
effect of the phenomenon first described by Holly et al., (1984) on the results of the 
Schirmer test could dramatically influence the diagnosis of DED or be misleading for the 
development of treatment plans (Holly, Laukaitis and Esquivel, 1984).  Standardising the 
different RH conditions in this study was made possible by the use of the CEC and was 
the first study to employ this equipment in this context.     
To conclude, the current study (along with the work of Buckmaster and Pearce, 2016; 
Radke et al., 2017) supports the original work by the Holly group (Holly, Lamberts and 
Esquivel, 1982; Beebe, Esquivel and Holly, 1988; Holly, 1994), and suggests that in all 
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situations, particularly any study using the Schirmer test to examine the dynamic response 
of the LFU to changes in the physical environment, the strips should be sheathed, in order 
to demonstrate the true reflex secretory response to desiccating conditions and to free the 
test from a dependence on ambient conditions that can vary seasonally, geographically 
and locally from clinic to clinic.  
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Chapter 5: 
ESTIMATING BASAL TEAR OSMOLARITY IN NORMAL AND 
DRY EYE SUBJECTS 
 
These experiments were designed to ascertain whether it is possible to drive down tear 
osmolarity (tOsm) to a basal level by suppressing tear evaporation, with the prediction that 
such a value should lie close to that of plasma osmolality (pOsm).  In this study, both 
normal and dry eye disease (DED) subjects were assessed, using two different methods 
to suppress tear evaporation. 
5.1 INTRODUCTION 
Tear osmolarity (tOsm) measured from the tear meniscus is composed mainly of lacrimal 
fluid with lesser contributions from the conjunctiva and cornea, the degree of which is 
currently unknown.  This tear sample, routinely used as a diagnostic tool for DED, is 
assumed to be higher than that of the secreted tears as a result of evaporation from the 
ocular surface induced by exposure to ambient environments (Mishima et al., 1966; 
Mishima, 1965; Mishima and Maurice, 1961a; b).   
A fluctuation in tOsm levels has been shown to occur throughout the day.  Niimi et al., 
(2013) measured tOsm levels over an eight hour period in 38 normal subjects; Table 5.1 
shows the recorded levels of tOsm measured up to 8 hours following a minimum period of 
six hours sleep (Niimi et al., 2013). 
Time Tear Osmolarity (mOsm/L) 
20 minutes 287 ± 10 
40 minutes 292 ± 16 
1 hour 293 ± 12 
2 hours 292 ± 10 
4 hours 289 ± 10 
8 hours 286 ± 10 
 
Table 5.1 Mean tOsm over an 8 hour period.  From Niimi et al. (2013). Cornea 32(10): 1305-1310. 
Variation in tOsm demonstrated over the course of the day is reported to be more 
pronounced as the severity of the DED condition increases.  Sullivan et al., (2012) 
monitored DED subjects over a period of three months and showed tOsm varied by 5.9 
mOsm/L ± 3.1% in mild DED (n=16) and by 10.0 mOsm/L ± 6.9% in severe DED (n=36) 
(Sullivan et al., 2012). 
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Ambient conditions are responsible for evaporation, including personal behaviour e.g. 
VDU use, and can account for the variation of tOsm over the course of the day, and 
measurement of tOsm in uncontrolled conditions of humidity, temperature and airflow 
invites variation of tOsm and this effect is amplified in DED (Sullivan, Pepose and Foulks, 
2015).  This effect is intensified when the eyes are exposed to desiccating stress, such as 
low humidity, high temperature and high airflow (Gonzalez-Garcia et al., 2007; Madden, 
Tomlinson and Simmons, 2013; Teson et al., 2013; Peng et al., 2014; López-Miguel et al., 
2014). 
As noted in a few papers, tOsm has been shown to decrease following a period of eye 
closure, as in sleep, attributed to the suppression of evaporation.  Niimi et al., (2013) 
found tears to be significantly hypo-osmotic after a period of sleep: 264 ± 14 mOsms/L, 
compared with the pre-sleep value of 297 ± 15 mOsms/L (Niimi et al., 2013).  Terry and 
Hill (1978) reported the average daytime tear osmolarity in 6 young adults to be 310 ± 5.7 
mOsm/Kg (range 299-323 mOsm/Kg) which compared to a tOsm of 285 ± 2.4 mOsm/Kg 
(range 282-288 mOsm/Kg), measured immediately after a 6-8 hour period of sleep (Terry 
and Hill, 1978).  In the latter study the closed eye tOsm values, in given individuals, also 
showed less variability. 
The term basal tears was created for this study and refers to the mixture of lacrimal, 
conjunctival and cornea fluid predicted to exist with continued secretion, mixing and 
drainage of tears; and following a period of evaporative suppression wherein a state of 
equilibration occurs with the interstitial fluid across the ocular surface epithelia, and tOsm 
falls to levels close to that of the plasma. 
In a study by Fortes et al., (2011) a positive relationship between whole body hydration an 
tOsm was reported, measured as pOsm and tOsm, in a group of young adults during a 
period of imposed systemic dehydration and during restoration to euhydration (Fortes et 
al., 2011).  Using a tOsm reference value of 310 mOsm/L this estimated a sensitivity of 
80% and a specificity of 92% using this approach for the detection of sub-optimal 
hydration (Fortes et al., 2011).  
A problem arises in adopting the novel proposal of Fortes et al., (2011) to detect sub-
optimal body hydration in the elderly by means of measuring tOsm in open-eye conditions 
(Fortes et al., 2011).  Since the prevalence of body dehydration rises with age (Xiao, 
Barber and Campbell, 2004), as does the prevalence of dry eye (Schein et al., 1997), and 
hence that of tear hyperosmolarity due to local causes.  There is an increased likelihood 
of misdiagnosis of body dehydration with increasing age. 
A proposed adaptation to circumvent this difficulty is that of evaporative suppression 
achieved by either a period of eye closure (as in sleep), or by exposure of the open eyes 
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to an environment of high humidity (as with humidity goggles).  In these conditions it is 
anticipated that tOsm would be driven down to a basal level that would be individual to a 
given person and be subject to less variation than open-eye tOsm and represent a level of 
tOsm close to pOsm.   
5.2 HYPOTHESIS 
It was hypothesised that in the absence of tear evaporation and with continued tear 
secretion, mixing and drainage, the osmolarity of the tears, equilibrating with the interstitial 
fluid across the ocular surface epithelia, would fall to a basal level close to that of the 
plasma.  
It was predicted that this value, termed here the basal tear osmolarity (BTO), would show 
less variation than the tOsm measured in open eye conditions and would be individual to 
the subject and independent of the tOsm starting point.  Thus the presence of tear 
hyperosmolarity of any degree would not influence the final BTO value.  If these 
conditions prevailed, then it was expected that the BTO would be a better surrogate for 
pOsm than tOsm measured in open eye conditions and could serve as a useful diagnostic 
index of water-loss dehydration in the elderly.  Additionally, in DED, the differential 
between the BTO and the level of tear hyperosmolarity in that patient should provide a 
more accurate guide to DED severity. 
5.3 MATERIALS AND METHODS 
5.3.1 Subject enrolment 
Eight subjects with normal eyes were recruited, 4 male and 4 female, aged 30.88 years ± 
10.49 (mean ± SD) from students and staff at Anglia Ruskin University.  Participants were 
individuals with a normal ocular surface by history and examination, according to defined 
criteria (see Chapter 2 for screening inclusion/exclusion criteria).     
Eight subjects with DED were recruited, 1 male and 7 female (4 diagnosed with Sjögren 
Syndrome), aged 55.75 years ± 17.05 (mean ± SD) from staff at Anglia Ruskin University 
and from the Cambridgeshire British Sjögrens Syndrome Association (BSSA) group.  DED 
participants were individuals who fulfilled the internationally accepted definition of Dry Eye 
Disease (Lemp et al., DEWS I 2007) by history and by ocular surface examination (see 
Chapter 2 for screening inclusion/exclusion criteria).  Table 5.2 displays the recruitment 
credentials of the normal and DED subjects. 
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Parameter 
Mean ± SD 
(min-max) 
Subjects 
Normal (n=8) Sjögren syndrome 
DED (n=4) 
Non Sjögren 
syndrome DED (n=4) 
Gender 4 Male : 4 Female 4 Female 1 Male : 3 Female 
Age (years) 30.88 ± 10.49 
(20-53) 
66.75 ± 7.93 
(55-72) 
48.25 ± 18.73 
(24-67) 
tOsm (mOsm/L) 293.8 ± 6.34 
(285-301) 
314.3 ± 11.21 
(308-331) 
313 ± 5.42 
(309-321) 
Corneal staining 0.13 ± 0.35 
(0-1) 
3.5 ± 2.38 
(2-7) 
2.0 ± 0.0 
(2-2) 
Schirmer 
wetting (cm) 
20.3 ± 2.71 
(17-24) 
5.3 ± 2.5 
(2-8) 
6.0 ± 1.83 
(4-8) 
OSDI 5.08 ± 6.07 
(0-15) 
64.9 ± 25.49 
(43.75-95) 
41.9 ± 22.42 
(27.08-75) 
TBUT (seconds) 11.35 ± 0.94 
(10.24-12.83) 
2.39 ± 0.67 
(1.44-3.01) 
4.99 ± 1.15 
(3.57-6.34) 
Meibography 
grading 
0 ± 0.0 
(0-0) 
1 ± 0.0 
(1-1) 
0.5 ± 0.58 
(0-1) 
 
Table 5.2 Profiles of the DED and normal subjects at the screening visit 
All subjects were instructed not to use ocular cosmetics on the day of assessment, and if 
contact lens wearers, not to use their lenses for at least 8 hours before the procedure; 
they were also asked not to use artificial tears for at least 4 hours prior to data collection.  
5.3.2 Equipment 
A controlled environment chamber (CEC) was employed for the two visits made by the 
subjects on separate days.  In this study experiments were conducted in two different 
controlled, environmental conditions: i. ‘Standard room‘ conditions and, ii. ‗Evaporative 
Suppression‘ conditions.  Tear osmolarity was also routinely measured in all subjects prior 
to entry into the CEC, in uncontrolled environmental conditions, in the clinic area 
immediately outside the chamber.  These tOsm measurements are referred to as taken in 
‗clinic conditions‘ (Table 5.3).  Actual room temperature and RH% were recorded at the 
time of these measurements.  
 Temperature Relative 
Humidity 
Airflow 
‗Standard room‘ conditions 23°C 45% 0.08m/s 
‗Evaporative Suppression‘ conditions 23°C 70% 0.08 m/s 
‗Clinic conditions‘ Uncontrolled environment: temperature and 
relative humidity recorded at each visit 
 
Table 5.3 Defined environmental conditions used in the current study.  
After the subject and examiner had entered the CEC, a period of 10 minutes was allowed 
to pass to allow for equilibration.  A slit-lamp examination was carried out following each 
visit to check for adverse events.  The TearLab® machine was modified for this 
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experiment (see Chapter 2) so that low osmolarity values (below 270 mOsm/L) which 
would ordinarily trigger a ―Below Range‖ error message could be read.   
5.3.3 Protocol 
The eye closure visit lasted approximately 90 minutes. Once seated in the CEC (set to 
standard room conditions) the subject was provided with a set of headphones playing 
classical music and when comfortable was asked to close the eyes for a period of 45 
minutes, during which time they were encouraged to keep the eyes moving behind closed 
eyelids to facilitate tear mixing.  After 45 minutes the subject was asked to open the eyes 
and tOsm was measured, first in the right then in the left eye, immediately on eye 
opening.  The subject was then instructed to keep both eyes open (exposed to standard 
room conditions), blinking spontaneously for a further 45 minutes, over which time tOsm 
was measured in each eye, first on the right and then the left, at 15 minute intervals.   
The exposure to 70% RH visit occurred on a subsequent day and lasted approximately 45 
minutes.  After entering the CEC (set to high humidity conditions) the subject was seated 
and instructed to keep the eyes open, blinking spontaneously for 45 minutes over which 
time tOsm was measured in each eye, first on the right and then the left, at 15 minute 
intervals, as in the first session.  See Figure 5.1 for a timeline of the experiments and 
Appendix IX for a sample record card. 
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Figure 5.1 Timeline of eye closure and exposure to 70% RH visits. 
5.3.4 Statistical analysis 
The change in mean tOsm measured in clinic conditions from that measured after eye 
closure or at the end of 45 minutes exposure to 70% RH, was analysed independently for 
right (RE) and left eye (LE) and, additionally, averaged between the two eyes (BE) (as in 
the study of Holland et al., 2017). 
The effect of eye closure 
In the normal group (RE and LE individually), differences in tOsm were compared using a 
one-way repeated measure ANOVA. 
In the DED group, differences in tOsm were compared using a one-way repeated 
measure ANOVA for the RE and a non-parametric Friedman test for the LE (with post hoc 
testing due to 3 outliers). 
When the average tOsm values for both eyes (BE) were used, the changes in tOsm in the 
normal and DED groups were compared using a one-way repeated measure ANOVA in 
both instances. 
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The effect of 70% relative humidity 
In the normal group (RE and LE individually), differences in tOsm were compared using a 
one-way repeated measure ANOVA.  In the DED group (RE and LE individually) 
differences in tOsm were compared using a non-parametric Friedman test (with post hoc 
testing as 1 outlier in the RE and 2 outliers in the LE).  When the tOsm values for BE were 
averaged, the changes in the normal group were compared using a one-way repeated 
measure ANOVA and with a non-parametric Friedman test in the DED group (with post 
hoc testing as 2 outliers). 
Differences in the effects of eye closure and 70% relative humidity 
Differences in tOsm measured between the two conditions of evaporative suppression in 
the normal group (RE and LE individually and BE averaged) (45 minutes of eye closure 
and 45 minutes of exposure to 70% RH) were compared using a paired t-test and in the 
DED group RE individually and BE averaged using the non-parametric Sign test (as 2 
outliers and data not symmetrically distributed) and LE individually using a non-parametric 
Wilcoxon signed-rank test (as 1 outlier).  
Inter-eye differences in tOsm for the normal and DED groups in uncontrolled environment 
conditions and after evaporative suppression (eye closure and after 45 minutes in 70% 
RH) were compared using a paired t-test.   
A Shapiro-Wilk test was used to evaluate normality of distribution.  Differences were 
considered statistically significant for P values less than 0.05.  Data is presented as mean 
± standard deviation.  Analyses were performed using SPSS 20.  
5.4 RESULTS 
Details of the clinic conditions for all 32 experiments (16 experiments for the normal group 
and 16 experiments for the DED group) are presented in Table 5.4.  The temperature 
fluctuated between 16°C and 27°C, and the RH between 20% and 69% during tOsm 
measurements prior to CEC entry in clinic conditions, for the normal and DED groups.  
These measures were recorded to show the variation encountered in the uncontrolled 
clinic environment on a day to day basis, compared to those created in the controlled 
environment of the CEC, or during eye closure. 
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Experiment 
Number 
Temperature (°C) Relative Humidity (%) 
Normal DED Normal DED 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
24 
23 
21 
23 
24 
23.3 
22 
22.3 
16 
18 
22 
24 
25 
22.7 
22 
22 
21 
23 
23 
26 
23 
27 
22.4 
22.7 
21 
23 
23 
24 
24 
26 
21.9 
22.9 
22 
20 
21 
30 
28 
62 
41 
63 
37 
29 
31 
33 
28 
55 
63 
65 
21 
24 
39 
27 
23 
48 
62 
41 
63 
55 
63 
65 
69 
56 
67 
57 
Range 9.0 6.0 45.0 49.0 
Min/Max 16°C / 25°C 21°C / 27°C 20% / 65% 20% / 69% 
 
Table 5.4 Temperature and RH levels recorded in the uncontrolled, clinic conditions at the time of tOsm 
sampling in each subject. 
The tOsm values for the normal and DED subjects in the two different environments of 
evaporative suppression are presented in Tables 5.5-5.8. 
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The effect of eye closure on tear osmolarity  
In the normal group, there was a significant decrease in tOsm in both the RE and LE from 
that measured in clinic conditions immediately on eye opening, following 45 minutes of 
eye closure (RE F(4,28) = 6.839 p = 0.001; LE F(4,28) = 3.591 p = 0.017).  The average clinic 
tOsm in the RE was 292.9 ± 2.91 mOsm/L and fell to 286.3 ± 2.71 mOsm/L (p = 0.015) on 
eye opening.  The average clinic tOsm in the LE was 293.1 ± 5.54 mOsm/L, falling to 
285.9 ± 5.16 mOsm/L (p = 0.006) on eye opening.  The tOsm returned towards the clinic 
value in both the RE and LE eyes (RE p = 0.50; LE p = 0.51) in the period of exposure to 
45% RH that followed. 
In the DED group, there was a significant decrease in tOsm in the RE and LE from that 
measured in clinic conditions, to that obtained immediately on eye opening (RE F(4,28) = 
10.421 p = 0.000; LE X2(4) = 17.139 p = 0.002).  The average clinic tOsm in the RE was 
301.3 ± 7.36 mOsm/L, falling to 283.8 ± 3.99 mOsm/L (p = 0.0002).  The average clinic 
tOsm in the LE was 302.3 ± 12.4 mOsm/L. falling to 286.1 ± 6.60 mOsm/L (p = 0.01).  As 
with the normal group, tOsm returned towards the clinic value in both the RE and LE eyes 
(RE p = 0.182; LE p = 1.0) in the period of exposure to 45% RH that followed.  This is 
presented graphically in Figures 5.2-5.7. 
Figure 5.2 Bar graph displaying mean tOsm values for normal and DED subjects (right eye) after 45 minutes 
of eye closure and then every 15 minutes with eyes open (exposure to 45% RH). 
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Figure 5.3 Bar graph displaying mean tOsm values for normal and DED subjects (left eye) after 45 minutes of 
eye closure and then every 15 minutes with eyes open (exposure to 45% RH). 
  
Figure 5.4 Scattergraph displaying mean tOsm values for normal and DED subjects (right eye) after 45 
minutes of eye closure and then every 15 minutes with eyes open (exposure to 45% RH).   
          Normal subjects 
          DED subjects 
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Figure 5.5 Scattergraph displaying mean tOsm values for DED patients (right eye) after 45 minutes of eye 
closure and then every 15 minutes with eyes open (exposure to 45% RH).  Lines highlight the tOsm values in 
clinic conditions of individuals and the subsequent levels of tOsm achieved following eye closure. 
 
Figure 5.6 Scattergraph displaying mean tOsm values for normal and DED subjects (left eye) after 45 minutes 
of eye closure and then every 15 minutes with eyes open (exposure to 45% RH).   
          Normal subjects 
          DED subjects 
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Figure 5.7 Scattergraph displaying mean tOsm values for DED patients (left eye) after 45 minutes of eye 
closure and then every 15 minutes with eyes open (exposure to 45% RH).  Lines highlight the tOsm values in 
clinic conditions of individuals and the subsequent levels of tOsm achieved following eye closure. 
The effect exposure to 70% relative humidity on tear osmolarity 
In the normal group, there was a decrease in tOsm measured in the RE and LE from that 
measured in clinic conditions, to that obtained following 45 minutes exposure to 70% RH.  
This reached significance in the LE only (RE F(1.241,8.686) = 2.083 p = 0.133; LE F(1.235,8.646) = 
5.056 p = 0.047).  The average clinic tOsm in the RE was 298.8 ± 8.91 mOsm/L and fell to 
295.0 ± 5.50 mOsm/L (p = 1.108).  The average clinic value in the LE was 300.3 ± 7.48 
mOsm/L, falling to 294.6 ± 4.31 mOsm/L (p = 0.045). 
In the DED group, there was a decrease in tOsm measured in the RE and LE from clinic 
conditions, compared to that obtained following 45 minutes exposure to 70% RH, but 
neither eye reached significance (RE X2(3) = 3.716 p = 0.294; LE X
2
(4) = 6.722 p =0.081).  
The RE started at 297.9 ± 7.01 mOsm/L and fell to 296.0 ± 9.47 mOsm/L (p = 0.294).  The 
LE started at 298.9 ± 7.14 mOsm/L and fell to 295.0 ± 14.7 mOsm/L (p = 0.081).  This is 
presented graphically in Figures 5.8-5.11. 
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Figure 5.8 Bar graph displaying mean tOsm values for normal and DED subjects (right eye) every 15 minutes 
with eyes open (exposure to 70% RH).  
Figure 5.9 Bar graph displaying mean tOsm values for normal and DED subjects (left eye) every 15 minutes 
with eyes open (exposure to 70% RH). 
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Figure 5.10 Scattergraph displaying mean tOsm values for normal and DED subjects (right eye) every 15 
minutes with eyes open (exposure to 70% RH). 
 
Figure 5.11 Scattergraph displaying mean tOsm values for normal and DED subjects (left eye) every 15 
minutes with eyes open (exposure to 70% RH). 
          Normal subjects 
          DED subjects 
          Normal subjects 
          DED subjects 
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Effect of eye closure on tear osmolarity - averaged between right and left eyes 
There was a significant decrease in tOsm, averaged between the two eyes from that 
measured in clinic conditions, to that obtained immediately on eye opening (Normal 
F(2.23,15.608) = 8.272 p =0.003; DED F(4,28) = 15.268 p = 0.000).  The average clinic value in 
the normal group fell from 293.0 ± 4.05 mOsm/L to 286.1 ± 3.57 mOsm/L (p = 0.045) and 
in the DED group, from 301.1 ± 9.11 mOsm/L to 284.9 ± 4.98 mOsm/L (p = 0.000118).  
The tOsm returned towards the clinic value in both the RE and LE eyes (normal p = 1.06; 
DED p = 0.25), in the period of exposure to 45% RH, that followed.  This is presented 
graphically in Figures 5.12-5.14. 
 
Figure 5.12 Bar graph displaying mean tOsm values for normal and DED (both eyes averaged) subjects after 
45 minutes of eye closure and then every 15 minutes with eyes open (exposure to 45% RH). 
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Figure 5.13 Scattergraph displaying mean tOsm values for normal and DED subjects (both eyes averaged) 
after 45 minutes of eye closure and then every 15 minutes with eyes open (exposure to 45% RH). 
 
Figure 5.14 Scattergraph displaying mean tOsm values for DED patients (both eyes) after 45 minutes of eye 
closure and then every 15 minutes with eyes open (exposure to 45% RH).  Lines highlight the tOsm values in 
clinic conditions of individuals and the subsequent levels of tOsm achieved following eye closure. 
          Normal subjects 
          DED subjects 
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Effect of 70% relative humidity – averaged between right and left eyes 
In the normal and DED, group there was a decrease in tOsm, averaged between the two 
eyes from that measured in clinic conditions, compared to that obtained following 45 
minutes exposure to 70% RH however, this did not reach significance (Normal F(1.174,8.216) 
= 3.553 p = 0.92; DED X2(3) = 3.514 p = 0.319).  The average clinic value in the normal 
group fell from  299.5 ± 7.78 mOsm/L to 294.9 ± 4.48 mOsm/L (p = 0.92), and in the DED 
group from 297.8 ± 6.76 mOsm/L to 296.2 ± 11.75 mOsm/L (p = 0.319).  This is presented 
graphically in Figures 5.15-5.16. 
 
Figure 5.15 Bar graph displaying mean tOsm values for normal and DED subjects (both eyes averaged) every 
15 minutes with eyes open (exposure to 70% RH). 
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Figure5.16 Scattergraph displaying mean tOsm values for normal and DED subjects (both eyes averaged) 
every 15 minutes with eyes open (exposure to 70% RH). 
Comparison of the effect eye closure exposure to 70% relative humidity on tear osmolarity 
Normal subjects 
The tOsm measured on eye opening after 45 minutes of eye closure was significantly 
lower than that obtained after 45 minutes exposure to 70% RH in the RE (t(7) = -4.129 p = 
0.004) and LE (t(7) = -3.055 p = 0.018).  
DED patients 
The tOsm measured on eye opening was lower than that obtained after 45 minutes 
exposure to 70% RH; however, only the RE reached significance (RE Z = 2.268 p = 
0.016; LE Z = 1.863 p = 0.063).  This is presented graphically in Figures 5.17 and 5.18. 
 
 
 
 
 
          Normal subjects 
          DED subjects 
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Figure 5.17 Bar graph displaying mean tOsm values for normal and DED subjects (right eye) in clinic 
conditions, after 45 minutes exposure to 70% RH and immediately after eye opening. 
 
Figure 5.18 Bar graph displaying mean tOsm values for normal and DED subjects (left eye) in clinic 
conditions, after 45 minutes exposure to 70% RH and immediately after eye opening. 
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Comparison of the effect of eye closure and exposure to 70% relative humidity on tear 
osmolarity – averaged between right and left eyes 
The averaged tOsm measured on eye opening was significantly lower than that obtained 
after 45 minutes exposure to 70% RH in both the normal group (t(7) = -3.699 p = 0.008) 
and the DED group (Z = 2.68 p = 0.016).  This is presented graphically in figures 5.19. 
 
Figure 5.19 Bar graph displaying mean tOsm values for normal and DED subjects (both eyes averaged) in 
clinic conditions, after 45 minutes exposure to 70% RH and immediately after eye opening. 
Inter-eye differences  
The tOsm in clinic conditions was compared in both groups, with that following 45 minutes 
of eye closure and following 45 minutes exposure to 70% RH.  A significant inter-eye 
difference was found in the DED group in clinic conditions: RE 295.9 ± 8.17 mOsm/L and 
LE 301.6 ± 10.63 mOsm/L (p = 0.017); but not in the normal group: RE 296.9 ± 6.86 
mOsm/L and LE 297.8 ± 6.66 mOsm/L (p = 0.268).  Significance was not demonstrated in 
inter-eye tOsm in either group after eye closure: normal group: RE 286.3 ± 2.93 mOsm/L  
and LE 287.1 ± 4.02 mOsm/L  (p = 0.383); DED group: RE 285.5 ± 6.12 mOsm/L  and LE 
286.1 ± 6.60 mOsm/L  (p = 0.809), or exposure to 70% RH: normal group: RE 295.3 ± 
2.93 mOsm/L  and LE 287.1 ± 4.02 mOsm/L  (p = 0.383); DED group: RE 295.3 ± 10.58 
mOsm/L  and LE 291.0 ± 5.76 mOsm/L  (p = 0.170). 
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No adverse events were recorded on slit-lamp examination following any of the 
experiments. 
 
5.5 DISCUSSION 
The current literature indicates that in normal human eyes, tear osmolarity (tOsm) 
measured in uncontrolled environmental conditions is higher than that of the secreted 
tears (Rolando and Refojo, 1983; Tsubota and Yamada, 1992; Mathers, 2004; Saleh et 
al., 2012).  This effect is amplified when the eyes are exposed to ambient conditions of 
desiccating stress, such as low humidity, high temperature and high airflow (Gonzalez-
Garcia et al., 2007; Madden, Tomlinson and Simmons, 2013; Teson et al., 2013; Peng et 
al., 2014; López-Miguel et al., 2014), and probably accounts for the fluctuations of tOsm 
over the course of the day (Farris, Stuchell and Mandel, 1986; Sullivan et al., 2012). 
Modelling considerations have further predicted that the tOsm of the preocular tear film is 
normally slightly higher than that of the tear meniscus and that this discrepancy is 
amplified in dry eye (Gaffney et al., 2010).  In the current study it is assumed that this 
difference is abolished by the period of evaporative suppression, and is therefore absent 
at the time of sampling, so that the meniscus tOsm represents that of the tear fluid as a 
whole.  In those studies where tOsm has been measured immediately, or shortly after, a 
prolonged period of eye closure, as in sleep, tears have been reported to be iso- or hypo- 
osmolar, with respect to plasma (Terry and Hill, 1978; Niimi et al., 2013).  This is 
interpreted here as elsewhere, as a response to the total suppression of evaporation, but 
also to an equilibration of the tears during eye closure, with the vascular circulation across 
the conjunctival epithelium.  It is assumed that this value of tOsm represents the lowest 
achievable at the surface of the eye and for this reason it is referred to here as the Basal 
Tear Osmolarity (BTO) although this concept will require further experimentation to 
validate.     
The present study supports the prediction that evaporative suppression can drive down 
tOsm.  It was found that following a period of 45 minutes of eye closure, tOsm measured 
in the tear meniscus was significantly reduced in each eye, from that measured in 
uncontrolled clinic conditions in both the normal and DED groups.  A smaller fall was 
recorded after exposure to 70% RH in open-eye, but only reached significance in the LE 
of the normal group (p = 0.045).  It is acknowledged that in this study the male to female 
ratio in the DED group (1M:7F) differed from that in the normal group (4M : 4F) and the 
mean age of the DED group was greater.  However, there was no expectation that this 
would influence the overall results. 
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In the closed eye study in the normal group, tOsm fell significantly in the RE, from an 
average clinic value of 292.9 ± 2.91 mOsm/L to 286.3 ± 2.71 mOsm/L (p = 0.015), and in 
the LE from an average clinic level of 293.1 ± 5.54 mOsm/L, to 285.9 ± 5.16 mOsm/L (p =  
0.006) on eye opening. In the DED group there was a significant decrease in tOsm in the 
RE from 301.3 ± 7.36 mOsm/L to 283.8 ± 3.99 mOsm/L (p = 0.0002), and in the LE from 
302.3 ± 12.4 mOsm/L to 286.1 ± 6.60 mOsm/L (p = 0.01). Importantly, all tOsm values 
recorded on eye opening fall within the range accepted for plasma osmolality, 285-295 
mOsm/Kg (Cheuvront et al., 2010b; Matz, 1996; Stookey, 2005), which supports the 
hypothesis that complete evaporative suppression, for the period selected here, is 
capable of driving down tOsm to a value which is both basal, and close to that of pOsm, in 
both normal and DED patients.  It is noted here that although the DED patients studied 
here at the time of recruitment had a tOsm of ≥308 mOsm/L, in the event, at the time of 
the experiments, their clinic tOsm values, except in the case of two subjects, were within 
the normal range. This may reflect the day-to-day variation of tOsm that occurs in DED. 
Additionally, seven of the DED patients were actively using a topical artificial tear 
preparation containing hyaluronate, which has been reported, after long-term use, to 
cause a prolonged fall in tOsm (Montani, 2013). This may be relevant here, despite the 
fact that all subjects were instructed to cease drop instillation for at least 4 hours prior to 
their assessments. 
The 70% RH level employed in the present study was at the time the maximum 
achievable by the controlled environment chamber (CEC) used in the study, but although 
Madden et al., (2013) had concluded that tear evaporation was almost completely 
suppressed at this level of humidity (Madden, Tomlinson and Simmons, 2013), it is 
apparent from the current results that 70% RH did not achieve the complete suppression 
produced by eye closure.  It is likely that this fact along with the small subject numbers 
recruited into the study are the reasons for a lack of significance found in this evaporative 
suppression condition for the majority of the experimental groups.    
The two approaches selected here to achieve evaporative suppression, lid closure and 
exposure to high humidity would not be expected to give identical results, even had it 
been possible to expose eyes to 100% humidity. For one thing, the exposure times differ; 
the initial 10 minutes of the humidity experiment are needed for chamber equilibration (the 
time taken for the CEC to reach the specified conditions after subject entry), so that the 
period of exposure to high humidity is slightly curtailed.  Despite this, it may be expected 
that the fall in osmolarity towards the BTO would be faster in the open-eye state than 
during eye closure, because tear mixing will be encouraged by spontaneous blinking and 
tear flow is likely to be higher in the absence of eye closure.  It is also worth noting that in 
some people during eye closure, and in the absence of lid pathology, it has been shown 
that there is not always contact between the upper and lower lid margins, leading to a 
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potential failure of the eyelids to form an adequate moisture seal and protect against a 
degree of evaporation.  Blackie and Korb (2015) used a halogen fibre optic 
transilluminator placed on the closed upper eyelid of healthy adults (n=116) to detect 
visible light emanation from between the lid margins (Blackie and Korb, 2015).  Thus, 
even in a closed eye state some people may still experience a level of evaporation from 
the ocular surface. 
For dry eye diagnosis it has been recommended that tOsm is measured bilaterally, since 
for instance, the inter-eye difference is increased in DED (Lemp et al., 2011).  The current 
study as predicted,  demonstrated less inter-eye variation in tOsm after eye closure and 
exposure to 70% RH in the DED group (eye closure p = 0.809; 70% RH p = 0.170), than 
that shown in uncontrolled, clinic conditions (p = 0.0017).  A significant difference in inter-
eye variability was not demonstrated in the normal group in uncontrolled clinic conditions 
(p = 0.268), or after complete evaporative suppression (eye closure p = 0.383; 70% RH p 
= 0.70).   
Tear osmolarity in open eye conditions has been proposed by Fortes et al., (2011) as a 
non-invasive surrogate for plasma osmolality, of potential use in the rapid detection of 
dehydration in the elderly (Fortes et al., 2011).  In the present study it has been predicted 
that complete evaporative suppression for a suitable period of time will drive down tOsm 
to a basal level that will more accurately reflect that of the pOsm.  Although this can only 
be established by a direct comparison of the BTO with pOsm, the current results are 
encouraging.  The tOsm measured following eye closure in the normal groups was 286.3 
± 2.71in the RE and 285.9 ± 5.16 in the LE, and in the DED group 283.8 ± 3.99 in the RE 
and 286.1 ± 6.60 in the LE.  After 45 minutes exposure to 70% RH the tOsm in the normal 
group was 295.0 ± 5.5 in the RE and 294.6 ± 4.31 in the LE, and in the DED group 296.0 
± 9.47 in the RE and 295.0 ± 14.7 in the LE. 
The results from this study have implications for the use of tOsm measurements as a 
means to determine body hydration. It is contended that the measurement of tOsm after a 
period of evaporative suppression will provide an osmolarity value that is closer to pOsm, 
is personal to the individual, and has a lower variance than that measured in open eye, 
uncontrolled environmental conditions.  With the approach described here, a raised tOsm 
measured in open eye conditions can be taken at face value and interpreted, in 
conjunction with other clinical features, as a manifestation of DED.  If this measurement is 
then followed with that of the tOsm after a period of lid closure, to obtain the BTO, then 
this tOsm value can be interpreted in terms of body hydration.  The quick and easy 
measure of tOsm could be of use in rapid detection of dehydration, particularly in the Care 
Home setting (Wolff, Stuckler and McKee, 2015).  
104 
 
The results presented here support the view that in DED patients, as in normals, tOsm will 
be driven down to a basal level during the hours of sleep.  Based on this research, the 
tOsm obtained following evaporative suppression could also provide a method of gauging 
DED severity.  A comparison of an individual‘s presenting tOsm with their BTO, which is 
believed to represent the lowest tOsm value achievable in that individual could be 
calculated.  The larger the interval between the two values would represent a greater 
degree of severity of the condition.  
In terms of achieving a measure of the BTO, there is a practical value in adopting lid 
closure for the purposes of a clinical test, since it does not require specialist equipment 
such as a CEC or goggles to create a humid environment. The original selection of 45 
minutes for eye closure was initially chosen as an arbitrary timescale, however this does 
fit within with the modelling consideration of Zhu and Chauhan (2007) who predicted that 
on returning to a normal level of evaporation after exposure to four times that rate, tOsm 
was found to return to baseline within 13 minutes (Zhu and Chauhan, 2007).  Based on 
further calculations, it is anticipated that the time for eye closure in a practical test might 
be as low as 15 minutes (Willshire et al., 2018).  
It will also be important to extend these studies, including measurement of the BTO at 
95% RH, which should allow tracking of the reduction in tOsm over time, during exposure, 
since meniscus sampling can be conducted at any point throughout the exposure period.  
This would also serve to better define the period of eye closure required to devise a 
clinical test. If it transpires from future studies that the BTO can be acquired after a short 
period of eye closure, say 15 minutes or less, regardless of the starting level of tOsm, 
then the utility of the test will be greatly enhanced, e.g. for sports hydration medicine. This 
approach was recently investigated by Ungaro et al., (2015) who compared mean tOsm 
(averaged between right and left eyes), with pOsm in a group of male athletes before and 
after exercise tasks conducted on a stationary cycle ergometer (Ungaro et al., 2015). 
These tasks were carried out under controlled environmental conditions, with or without 
water restriction leading to up to 3% of body mass loss, and also after rehydration. They 
found that tOsm tracked group changes in hydration status similar to pOsm, but that 
individual responses of tOsm were less predictable. They concluded that tOsm is a valid 
indicator of hydration status at the group level, but that large differences among subjects 
in the response of tOsm to changes in hydration status limited its validity at the individual 
level. A similar conclusion was drawn in another study conducted under field conditions, 
involving a self-paced 10 km run in which participants were exposed to varied conditions 
of temperature, humidity and wind speed (Holland et al., 2017). In that study, although 
significant reductions in body mass and increases in pOsm, tOsm and urine specific 
gravity were observed, the pre- to post-exercise change in tOsm was not significantly 
correlated with pOsm, relative body mass loss, or urine osmolality or specific gravity. It 
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may be surmised that exclusion of environmental exposure, as proposed for a closed eye 
BTO test, might have revealed a correlation between tOsm and pOsm in such studies. 
The time taken to achieve the BTO value in a closed eye test will be important in 
determining its practicality, particularly under field conditions. 
It is also important to observe the recovery of tOsm to pre-suppression levels on return to 
uncontrolled clinic conditions or, as performed here, to specified environmental conditions.  
The latter is of particular relevance to the real-life situation in DED where it may be 
supposed that tOsm is suppressed by overnight eye closure and climbs back to a 
condition of tear hyperosmolarity over the course of the day.  The closed eye test allows 
this response to be observed closely, whether the eyes are returned to conditions of a 
standard office environment or to those of desiccating stress. The study by Niimi et al., 
(2013) demonstrated following a period of sleep, on eye opening the tOsm elevated to 
within those levels measured pre-sleep within 40 minutes (p = 0.085) (Niimi et al., 2013).  
This restoration phase may be predicted to differ between the major subtypes of DED, 
with a faster rise in EDE, in which the barrier to evaporative loss is compromised.  It will 
be necessary to perform repeatability experiments in larger groups of subjects showing a 
wide range of tOsm, and also to perform additional studies comparing the BTO with the 
pOsm to strengthen conclusions. 
To conclude, this is the first study to demonstrate that the tOsm of the tear film can be 
driven down to a lower level (BTO) employing the technique of eye closure.  It seems that 
a period of 45 minutes of eye closure, or possibly less, should be sufficient to create a 
basal level of tOsm at the surface of the eye, although this conclusion requires 
confirmation in a larger group of subjects, including DED patients showing a greater 
degree of tear hyperosmolarity.  It also gives confidence in the provisional conclusion that 
these values may not only represent a basal value, but that this value is close to and 
presumably determined in large part by plasma / extracellular fluid osmolarity levels. The 
BTO value achieved after eye closure promises to provide a personal norm against which 
the severity of DED in an individual and its response to treatment may be judged.  It may 
also offer the opportunity to detect water-loss dehydration in the elderly using a simple 
bedside test. 
 
The material presented here is reported in the publications:  
Willshire, C., Buckley, R.J. and Bron, A.J., 2017b. Estimating basal tear osmolarity in 
normal and dry eye subjects. Contact Lens and Anterior Eye. [online] Available at: 
http://linkinghub.elsevier.com/retrieve/pii/S1367048417301790.doi: 
10.1016/j.clae.2017.09.005  
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Willshire, C., Bron, A., Gaffney, E. and Pearce, E.I., 2018. Basal Tear Osmolarity as a 
metric to estimate body hydration and dry eye severity. Progress in Retinal and Eye 
Research. doi.org/10.1016/j.preteyeres.2018.02.001 
Copies of these articles are contained in Appendix XIV. 
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Chapter 6: 
CENTRAL CONNECTIONS OF THE LACRIMAL FUNCTIONAL UNIT 
 
This study was designed to explore the relative contributions of each eye to the reflex tear 
response, measured by the Schirmer test in standard room conditions, after unilateral and 
bilateral topical anaesthetic blockade.  The concept referred to here as ‗cross-connectivity‘ 
relates to whether the afferent inputs from one cornea are processed in the ipsilateral 
superior salivatory nucleus (SSN) only, or have some input to the contralateral side also.  
This concept is relevant to many conditions that result in unilateral ocular anaesthesia 
such as neurotrophic keratitis (NK) and refractive surgery, where not only the affected eye 
may be compromised but also the fellow eye.  Conversely, the unaffected fellow eye may 
be capable of a compensatory response that offsets the lack of sensory feedback from the 
affected eye. 
 
6.1 INTRODUCTION 
The tear film is constantly replenished by aqueous secretion from the lacrimal glands 
(main, palpebral and accessory), and is regularly refreshed by blinking and to a small 
extent by eye movements.  The conjunctival epithelium makes a small contribution to 
aqueous tears.  Secretion is finely adjusted in response to environmental conditions by 
the neural reflex arc of the Lacrimal Functional Unit (LFU) (Stern et al., 2004).  This 
homeostatic mechanism ensures that a stable tear film moistens the ocular surface at all 
times.  The lacrimal and meibomian glands, the conjunctival epithelium and goblet cells all 
receive a parasympathetic efferent nerve supply, but the role of the LFU in regulating the 
secretions of the non-lacrimal appendages is uncertain.  For practical purposes, this 
chapter will refer to reflex tear secretion as if this were reflex lacrimal secretion. 
There are other inputs to the lacrimal gland that act via the SSN in conjunction with those 
from the cornea, i.e. from the nasal mucosa, skin (not only pain but also including lid 
margin and ciliary/lash ‗tickle‘), retina (bright lights), acute pain and emotional stimuli, that 
not only influence lacrimal secretion but also determine the responsiveness of the gland to 
other sensory stimuli (Figure 6.1).   
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Figure 6.1 A schematic of the neural reflex arc and possible cross-sensory innervation input from the 
ipsilateral and contralateral afferents resulting in lacrimal gland stimulation.  Additional inputs to lacrimal 
secretion include (clockwise from top left) skin, emotion, nasal mucosa, and retina. 
Spontaneous blinking and the blink response are served by a similar reflex arc whereby 
the central connections of trigeminal neurones of corneal origin, synapse centrally in the 
nuclei of the IIIrd and VIIth cranial nerves, which give rise to somatic efferents whose 
activity determines the upstroke and the downstroke of the blink, respectively. 
Bilateral topical anaesthesia reduces but does not abolish both lacrimal secretion and 
blinking, implying that there is an additional reflex contribution to these mechanisms 
(Lamberts, Foster and Perry, 1979; Jordan and Baum 1980; Pellegrini and Evinger, 1995; 
Li et al. 2012; Meng and Kurose, 2013).  Emotional tearing is similarly dependent on the 
activity of higher centres.  Importantly, the trigeminal neurones that supply the cornea also 
serve a trophic function which is essential to the turnover, maintenance and repair of the 
corneal epithelium, mediated for instance by the release of peptides such as nerve growth 
factor (NGF).  
Loss of sensory drive to the lacrimal gland due to any form of trigeminal anaesthesia, 
including NK, results in a reduction of lacrimal secretion, which favours the occurrence of 
an aqueous-deficient dry eye (ADDE).  A fall in blink rate, by extending the blink interval 
and increasing evaporative water loss, amplifies the degree of dry eye, and loss of 
sensation over the ocular surface may remove the protective action of the blink reflex.  
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Additionally, removing the trophic support of sensory neurones impairs the maintenance 
of a healthy ocular surface epithelium and its repair, and renders it vulnerable to external 
trauma.  In NK, severity ranges from a punctate epithelial keratitis, to a persistent 
epithelial defect (PED) with severe inflammation, leading to an intractable corneal ulcer 
which may perforate.  Because the eye is insensitive, minimising symptoms, diagnosis 
may be delayed.  
When trigeminal anaesthesia is bilateral, it is predicted that the risk of precipitating an 
ADDE is high, since there is no opportunity for either lacrimal compensation or 
compensation of the blink response: lacrimal secretion and blink rate will both be reduced.  
When the trigeminal anaesthesia is unilateral, the extent to which a normal sensory 
function in the fellow eye compensates for and limits the risk of dry eye in the anaesthetic 
eye is not established, but ipsilateral aqueous deficient dry eye has been reported in this 
situation (Sacchetti and Lambiase, 2014).  The hypothesis put forward here is that its 
occurrence will depend on the degree to which the central connections of afferents from 
one cornea influence efferent outputs from the contralateral lacrimal gland.  This is 
referred to here as ‗cross-innervation‘.  With a 50:50 level of cross-innervation, 50% of 
central afferents would feed into and synapse with ipsilateral, second order efferent 
neurones in the SSN and 50% would feed to the contralateral SSN.  If cross-innervation is 
substantial then it would be expected that, with unilateral corneal anaesthesia, in 
conditions of ocular surface stress, such as exposure to desiccating environmental 
conditions or exposure to dust or chemical fumes, the reflex response from the normal, 
non-anaesthetic eye, would lead to a compensatory, reflex lacrimal response from both 
eyes.  This would be protective to the anaesthetised eye.  If there were no cross-
innervation, then compensation would be confined to the normal eye and the 
anaesthetised eye would remain unprotected.  In the absence of any reflex input to the 
lacrimal gland on the affected side, desiccation would be expected to drive tear osmolarity 
(tOsm) upwards, favouring the development of dry eye.   
Along with acquired anaesthesia affecting reflex tearing, bilateral topical anaesthesia has 
also been shown to reduce but not abolish lacrimal secretion in both eyes, measured by 
the Schirmer I test (Lamberts, Foster and Perry, 1979; Jordan and Baum 1980; Li et al., 
2012) or by fluorophotometry (Jordan and Baum, 1980).  Since the nature of any sensory 
input from a normal cornea to the contralateral SSN is not known and its potential to 
influence contralateral lacrimal gland secretion is uncertain, the following experiments 
were designed to study the relative contribution of each eye to the reflex tear response, 
measured by the modified, sheathed, Schirmer I test (see Chapter 4) in controlled 
environmental conditions, after unilateral and bilateral topical anaesthesia.  
 
110 
 
6.2 HYPOTHESIS 
It was proposed that in the steady state, when the eyes are open and exposed to the 
environment, sensory inputs from each eye stimulate lacrimal secretion both ipsilaterally 
and contralaterally via central connections of the trigeminal nerve with the SSN on each 
side.  The study explored the effect of withdrawing sensory input, either by unilateral or 
bilateral topical anaesthesia, on the secretory responses of the two eyes, to learn how the 
output from the affected eye and that of the control fellow eye are modified.   
6.3 MATERIALS AND METHODS 
 
6.3.1 Subject enrolment 
Eight subjects with normal eyes were recruited, 3 male and 5 female, aged 23.1 years ± 
4.3 (mean ± SD) from students and staff at Anglia Ruskin University.  Participants were 
individuals with a normal ocular surface by history and examination, according to defined 
criteria (see Chapter 2 for inclusion and exclusion criteria).  After a preliminary visit, 
subjects were screened for the following inclusion criteria: tear osmolarity <308 mOsm/L 
(Sullivan et al., 2010); OSDI score <20; TBUT >10 seconds, and corneal staining <grade 
2 using the Oxford clinical grading scale (Bron, Evans and Smith, 2003).  Subjects were 
excluded if they had any active ocular disease, any clinically significant lid or conjunctival 
abnormalities (corneal scars or opacities), any clinically significant limbal or bulbar 
injection or conjunctival staining, any ocular surgery or injury within the previous 6 months, 
any systemic disease affecting ocular health, any nasolacrimal occlusion, or were using 
any topical ocular medications.  Subjects were instructed not to use ocular cosmetics on 
the day of assessment and, if they were contact lens wearers, not to use their lenses for 
at least 8 hours before the procedure.  Subjects six and seven also took part in the 
experiments featured in chapters four, five and six, and subjects four and five also took 
part in the experiments featured in chapter four.  At least one month was allowed to 
elapse before these subjects were invited to participate in the other experiments.  Table 
6.1 contains the ocular profiles of the right eye of normal subjects recruited for this 
experiment. 
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Subject Age 
(years) 
Gender tOsm 
(mOsm/L) 
Corneal 
stain 
Schirmer 
wetting 
(mm) 
OSDI TBUT 
(seconds) 
Meibography 
1 19 F 300 0 30 13.64 12.42 0 
2 23 F 293 0 23 11.37 11.34 0 
3 22 F 301 0 18 2.77 14.79 0 
4 24 F 297 0 23 2.77 22.25 0 
5 21 M 292 0 25 0 17.01 0 
6 20 M 299 0 20 9.09 25.31 0 
7 23 F 293 0 28 2.08 10.6 0 
8 33 M 297 0 17 0 10.02 0 
Mean ± SD 
 23.1 ± 
4.32 
5F:3M 296.5 ± 
3.46 
0 ± 0 23.0 ± 
4.59 
5.22 
± 
5.35 
15.49 ± 
5.65 
0 ± 0 
 
Table 6.1 Profiles of the normal subjects consented for this study 
 
6.3.2 Equipment 
Studies were performed in a PSR ―B‖ Series, Weiss Gallenkamp, controlled environment 
chamber (CEC), set to ‗standard room conditions‘ based on guidelines (Workplace Health 
Committee Report 1998; Fang et al., 2004) at a temperature of 23°C, 45% relative 
humidity and 0.08 m/s airflow.  As in the other studies, a period of 10 minutes was 
required for CEC conditions to be restored to their set values after the subject and 
examiner entered.  Therefore, a period of 10 minutes after entry was allowed for CEC 
equilibration before the start of data collection. 
The Schirmer I test without anaesthesia is considered to measure the reflex response of 
the lacrimal gland to ocular surface stimulation, acting through the LFU (Cho and Yap, 
1993).  This, therefore, is a measure of lacrimal secretory potential, assuming that the 
sensory and motor elements of the reflex apparatus are intact; this is referred to here as 
the reflex Schirmer test.  The Schirmer I test can also be performed after instilling a topical 
anaesthetic, in which case, when it is performed bilaterally, in resting environmental 
conditions, it reflects the constitutive secretory activity of the lacrimal glands, modified by 
non-ocular inputs, sometimes referred to as basal tear secretion (Jones, 1966).  It is 
referred to here as the Schirmer test with anaesthesia.  In the current study, each subject 
underwent the Schirmer I test after topical anaesthesia bilaterally, and the Schirmer I test 
bilaterally, without anaesthesia, but proceeded by instillation of two saline drops as a 
control for the instillation of anaesthetic drops in the previous study.  A further Schirmer I 
test was performed, with one eye receiving topical anaesthetic and the other, saline.  
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Because the instillation of a topical anaesthetic induces reflex tearing and the instilled 
volume itself could contribute to wetting of the Schirmer strip (Clinch et al., 1983; Afonso 
et al., 1999), the test is usually performed after removal of excess fluid from the 
conjunctival sac with an absorbent tissue.  In this study, however, whether the Schirmer I 
test was conducted with anaesthesia or with saline, removal of excess fluid from the 
conjunctival sac (as opposed to the eyelid skin) was not performed because of the 
uncertainty of the adequacy of removal, and to avoid the effects of lid manipulations on 
tear production (Yokoi and Komuro, 2004).  Instead, 10 minutes were allowed to elapse 
between drop instillation and performance of the test, on the basis that, in the presence of 
spontaneous blinking, excess fluid would be drained away over this period.  This strategy 
is supported by the study of Bandlitz et al., (2014) which showed that meniscus curvature, 
a measure of tear volume (Yokoi et al., 2004), was restored to normal within 5 minutes of 
instillation of a 35µL drop of an artificial tear solution containing hydroxypropyl-guar and 
glycol (Bandlitz et al., 2014).  The protocol used here involved instilling one drop of either 
a topical anaesthetic or of saline (Minims®) followed by another drop 30 seconds later.  
The average volume of each eye drop instilled was as follows: saline 41μL, tetracaine 
34μL, and proxymetacaine 41μL.  Using fluorophotometry, Mishima et al., (1966) 
determined that the average tear volume present in the eye was 6.2 ± 2.0 μL, and that the 
maximum capacity of the cul-de-sac for added volume was 30 µL; any fluid above this 
level was observed to overflow (Mishima et al., 1966).  In this study, any overflow of fluid 
was dabbed away by the examiner, using a tissue applied to the lid margins and canthi 
while the eyes were closed.  After the instillation of eye drops and allowing 10 minutes for 
drainage, the closed-eye (Serin et al., 2007), modified sheathed Schirmer test was then 
performed in both eyes of each subject (see Chapter 4).  A Schirmer strip was hooked 
over the lid margin at its lateral third in the right eye, then the left, and the wetting length 
was recorded 5 minutes after the moment of insertion for each eye i.e. the left eye was 
read at a defined interval after the right eye.  If full wetting occurred within the 5 minutes, 
the time at which this occurred was noted.  
For topical anaesthesia, a procedure was adopted to achieve the minimum reflex tearing 
and the densest level of anaesthesia with the anaesthetics used (See Chapter 2 and 3 for 
details).  A single drop of the short-acting anaesthetic 0.5% proxymetacaine (Minims®) 
was first instilled in the right eye and then in the left.  This drop stings only slightly.  This 
was followed, 30 seconds later, by 1 drop of 1% tetracaine (Minims®).  To maximize 
spreading and mixing of the drops, the subject was asked to look up while each drop was 
instilled into the lower fornix and then asked to blink with the lower lid still drawn 
downward; this distributes the drop without overflow (Fraunfelder, 1976).  Finally, the eyes 
were closed to allow excess fluid to be dabbed away from the lid margins and canthi (but 
not from the conjunctival sac).  This sequence was followed by a period of 10 minutes of 
spontaneous blinking before any experimental procedure.  This is in keeping with the 
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approach of Xu and Tsubota, who performed the anaesthetic Schirmer test at an interval 
of 5 minutes after drop instillation and without previous removal of tear fluid from the 
conjunctival sac (Xu and Tsubota, 1995).  The same protocol was adopted for the 
instillation of saline, and the protocol followed for each phase of the experiment.   
6.3.3 Protocol 
Subjects made two visits on separate days; Figure 6.2 illustrates the timeline of each visit 
and Table 6.2 the order of the experiments for each subject.  The first visit lasted 
approximately 1 hour.  The subject and the examiner entered the CEC, and after seating 
the subject comfortably, saline was instilled into each eye as per protocol, and was 
followed, after an interval of 10 minutes, by a Schirmer test.  After this, the examiner and 
the subject remained in the CEC for a 10-minute recovery period.  This recovery period 
was over three times longer than that considered sufficient for the eye to recover after 
multiple Schirmer tests and obtain independent measures, as specified in the Loran et al., 
(1987) study.  It was then randomly decided whether the subject would undergo either 
unilateral or bilateral afferent blockade and the protocol for instillation of the appropriate 
eye drops was carried out.  The second visit occurred on a subsequent day and lasted 
approximately 30 minutes.  After entering the CEC, the subject received either unilateral 
or bilateral anaesthesia depending on which regime had been undertaken at the previous 
visit.  Subjects were masked as to whether they were receiving topical saline or 
anaesthetic, or the combination, but the same examiner was responsible for drop 
instillation and Schirmer test measurements.  A slit-lamp examination was performed 
following all procedures to check for adverse events.  An example record card for this 
experiment is shown in Appendix X.        
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Figure 6.2 Timeline of bilateral saline, bilateral anaesthetics or unilateral saline and anaesthetic visits. 
Subject Age Gender Visit 1 Visit 2 Experimental Key 
1 19 F ¥  § ¶ ¥ = Saline control phase: At zero time, one 
drop of saline was instilled into each eye, 
followed by another at 30 seconds to 
control for subsequent anaesthetic 
studies. 
§ = Unilateral afferent block phase: one 
drop of proxymetacaine 0.5% was instilled 
into one eye (randomly selected) and a 
drop of saline into the fellow eye, followed 
after 30 seconds by tetracaine 1% into the 
first eye and saline into the fellow eye. 
¶ = Bilateral afferent block phase: one 
drop of proxymetacaine 0.5% is instilled 
into both eyes, followed after 30 seconds 
by tetracaine 1% into both eyes. 
2 23 F ¥  ¶ § 
3 22 F ¥  § ¶ 
4 24 F ¥  ¶ § 
5 21 M ¥  ¶ § 
6 20 M ¥  ¶ § 
7 23 F ¥  § ¶ 
8 33 M ¥  ¶ § 
 
Table 6.2 Summary of experimental design for each subject. 
 
Minutes → 
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6.3.4 Statistical Analysis 
The differences in Schirmer wetting lengths when compared across the three conditions 
were analysed using a repeated measures one way ANOVA with simple contrasts.  The 
Bonferroni method was used to make adjustments for multiple comparisons.  The 
differences in Schirmer wetting lengths within the individual conditions were analysed 
using a paired t-test.  The Shapiro-Wilk test was used to evaluate normality of distribution.  
Differences were considered statistically significant with P values less than 0.05.  Data is 
presented as mean ± standard deviation.  Analyses were performed using SPSS 20. 
 
6.4 RESULTS 
Eight subjects with normal eyes were recruited; three male and five female, aged 23.1 
years ± 4.3 (mean ± SD).  The Schirmer wetting test scores for all eight participants in 
each phase of the experiment are presented in Table 6.3 and Figure 6.3.  To make data 
more accessible, the eye receiving anaesthesia in the unilateral experiment was 
designated ‗Eye 1‘ and the fellow eye was designated ‗Eye 2‘, throughout the study.   
The Schirmer wetting lengths in the saline control experiment were: Eye 1 = 23.1 ± 
7.2mm; Eye 2 = 24.9 ± 4.1mm.  There was no significant difference in between-eye 
wetting lengths: 1.8 ± 5.4mm (p = 0.394).  In the unilateral anaesthesia experiment, the 
average wetting length was 11.3mm ± 4.1 in the anaesthetised eye, and 19.4mm ± 7.4 in 
the saline control eye.  The wetting length was reduced in the anaesthetised eye when 
compared to the control (bilateral saline experiment) by 11.9 ± 4.0mm (p = <0.0005), and 
its fellow eye by 8.1 ± 5.6mm (p = 0.005).  The fellow eye response was also reduced 
compared to its control (bilateral saline experiment) by 5.5 ± 5.7mm, however this did not 
quite reach significance (p = 0.06).  In the bilaterally anaesthetised eyes the average 
wetting length was 8.7 ± 5.2mm in Eye 1 and 10.0 ± 3.8mm in Eye 2.  There was no 
significant difference in the between-eye wetting lengths: 1.3 ± 2.4mm (p = 0.171).  The 
wetting length was reduced in both eyes after bilateral anaesthesia compared to their 
bilateral saline controls (p = 0.0003; p = <0.0005).  
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Subject Saline control 
n = 8 
Unilateral 
anaesthesia 
n = 8 
Bilateral 
anaesthesia 
n = 8 
 Schirmer wetting length – mm 
Eye1 Eye2 Eye1 Eye2 Eye1 Eye2 
1 33 30 18 RE 25 7 10 
2 24 28 12 LE 15 4 7 
3 16 21 5 LE 15 4 5 
4 15 23 8 LE 12 5 7 
5 17 25 10 RE 23 7 9 
6 20 18 9 RE 15 10 12 
7 28 29 15 RE 34 14 16 
8 32 25 13 RE 16 18 14 
Mean wetting 
length 
23.1 ± 
7.2 
24.9 ± 
4.1 
11.3 ± 
4.1 
19.4 ± 
7.4 
8.7 ± 
5.2 
10.0 ± 
3.8 
Mean 
difference in 
Schirmer 
wetting length 
& significance 
 
1.8 ± 5.4mm 
 
p = 0.394 
 
8.1 ± 5.6mm 
 
p = 0.005 
 
1.3 ± 2.4mm 
 
p = 0.171 
Percentage 
change in 
Schirmer 
wetting length 
Eye 1 unanaesthetised 23.1 ± 7.2 vs.           62.4% 
Eye 1 anaesthetised 8.7 ± 5.2                                                                              
Eye 2 unanaesthetised 24.9 ± 4.1 vs.           59.8%                                             
Eye 2 anaesthetised 10.0 ± 3.8                                                                     
 
Table 6.3 Summary of raw data for all subjects. 
Average 
61.1% 
117 
 
Figure 6.3 Schirmer wetting test scores for all 8 participants, after bilateral saline, unilateral anaesthesia, and 
bilateral anaesthesia phases.  ǂ Statistically significant difference from the fellow eye (paired t-test).  
* Statistically significant difference between eye 1 and eye 2 between each experiment (repeat measures one 
way ANOVA). Values are mean ± SD. 
 
6.5 DISCUSSION 
The focus of this study was to determine whether there is sensory cross-connectivity 
between the cornea of one side and the opposite superior salivatory nucleus (SSN).  It 
has yet to be investigated in humans as to whether the concept of cross-connectivity 
exists and this experiment was designed to elucidate this topic.  It is a familiar experience 
that a foreign body in one eye can induce tearing from both eyes.  Is this due to sensory 
cross-connectivity of the kind discussed here, or is it mediated through pain pathways?  
The same can be asked concerning irritation of the nasal mucosa, where, when 
performing the nasolacrimal Schirmer II test, the response of both eyes is recorded after 
stimulation of the nasal mucosa on one side only (Tsubota, 1998).  In the current study it 
was confirmed, as in other reports that bilateral topical anaesthesia results in a bilateral 
reduction of the Schirmer wetting length compared with the reflex Schirmer response in 
* 
* 
* 
* ǂ 
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control eyes (Siganos et al., 2002; Lamberts, Foster and Perry, 1979; Jordan and Baum, 
1980; Konomi et al., 2008; Jones, 1966).  The wetting length of the strip was also shorter 
after bilateral anaesthesia than after unilateral anaesthesia, although there was no 
significant difference between these values (11.3mm-unilateral and 8.7mm-bilateral p = 
0.60).  This is in line with a previous study by Jordan and Baum showing evidence that 
when sensory input is decreased by the use of topical anaesthesia, tear secretion is 
reduced (Jordan and Baum, 1980).  It was found that unilateral topical anaesthesia 
resulted in an ipsilateral reduction of Schirmer wetting of a similar degree.  It can be 
interpreted that these results were due to the withdrawal of the reflex sensory drive from 
the ocular surface to the ipsilateral SSN and lacrimal gland.  However, some interpretative 
caution must be exercised because instilled anaesthetic drops, which drain into the 
nasolacrimal duct, are likely to cause some degree of anaesthesia of the nasal mucosa, 
and the study of Gupta et al., indicated that nasal anaesthesia alone can inhibit lacrimal 
secretion (Gupta, Heigle and Pflugfelder, 1997). Therefore, the possibility arises that 
some of the effect of topical ocular anaesthesia on lacrimal secretion could be due to loss 
of sensory drive from the nose.  Heigle and Pflugfelder (1996) demonstrated an ipsilateral 
reduction in the reflex Schirmer response of 90.8%, compared with normal controls, in 
patients with unilateral neurotrophic keratitis (NK), in whom nasal mucosal anaesthesia 
was combined with dense corneal anaesthesia (Heigle and Pflugfelder, 1996).  This 
contrasted with the findings in four patients with herpes zoster ophthalmicus (HZO) 
without keratitis, in whom, although there was a moderate reduction in corneal sensitivity, 
nasal sensation was normal and there was no reduction in the reflex Schirmer response 
with or without nasolacrimal stimulation.  They concluded that there was an ipsilateral, 
sensory stimulus to lacrimal secretion arising from the nasal mucosa.  These authors also 
showed that the Schirmer wetting length was reduced by 60.7% in the contralateral eyes 
of those patients with NK, which they considered to be evidence of sensory cross-
innervation from the nasal mucosa of one side, to the SSN of the opposite side.  It could 
not be excluded, however, that the original or activated infection had caused subclinical 
nerve damage on the clinically unaffected side. 
This was supported by a further study by this group, in which the Schirmer wetting length, 
compared with baseline, was reduced to a similar degree on both sides, after unilateral 
nasal anaesthesia induced by insufflation (36.4% on the ipsilateral and 29.7% on the 
contralateral side) (Gupta, Heigle and Pflugfelder, 1997).  These authors concluded that 
sensory stimulation of the nasal mucosa was an important contributor to basal tear 
production.  Because the effects were demonstrated using the reflex Schirmer I test, 
which is not relevant to basal tear secretion, it would be more appropriate to conclude that 
this study provided evidence for modulatory influence of nasal sensory input on the reflex 
tear response, with evidence of cross-innervation.  The studies by Heigle and Pflugfelder 
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(1996), Gupta et al., (1997) (Heigle and Pflugfelder, 1996; Gupta, Heigle and Pflugfelder, 
1997), and the current study, used the Schirmer test to measure reflex tear flow in the 
clinic, for reasons of cost and technical difficulty.  This is a test both of the integrity of the 
reflex arc of the lacrimal functional unit (LFU), and of the functional state of the lacrimal 
gland, without the possibility of determining their relative contributions to the outcome.  In 
the normal eye, the Schirmer paper tip stimulates the ocular surface, increases afferent 
drive and results in a reflex lacrimal tear response.  The volume of secretion will therefore 
be higher than the resting tear secretion.  Thus the Schirmer test can only be used in a 
limited way to explore this situation because the reflex Schirmer test is a measure of the 
response of the eye to a particular irritative stimulus to the ocular surface.  The test does 
not provide any information about the tear secretory status of the eye in everyday 
environmental conditions but merely the ability of the lacrimal apparatus to respond to a 
mechanical and nociceptive stimulus of that magnitude.  Such information can only be 
obtained by techniques such as fluorophotometry, which allow tear secretion to be 
measured in a controlled environment. 
The existence of sensory cross-innervation is relevant to the health of the fellow eye in 
conditions that affect the sensory innervation of the ocular surface unilaterally, such as 
unilateral refractive surgery, Herpes simplex keratitis (HSK), HZO, and in NK from 
whatever cause.  The aim of this study was to explore the contribution of each eye to the 
Schirmer response of its fellow eye, measured after unilateral and bilateral topical 
anaesthesia.  It was hypothesised that in the steady state, when the eyes are open and 
exposed to the environment, sensory inputs from each eye stimulate lacrimal secretion 
both ipsilaterally and contralaterally through central connections of the trigeminal nerve 
with the SSN on each side.  This sensory drive would be concerned with maintaining a 
steady state in a given environment, and by withdrawing one of the major sensory inputs 
through corneal topical anaesthesia, it was hoped to understand how the output would be 
modified.  There is evidence for contralateral, central trigeminal projections in animals, but 
this cannot be taken as supportive of such a condition in humans (van der Werf et al., 
1996; Clarke and Bowsher, 1962; Pfaller and Arvidsson, 1988; Jacquin, Chiaia and 
Rhoadest, 1990).  If there were a significant level of central, sensory cross-innervation, 
then it could be predicted that when the Schirmer test is performed simultaneously in the 
two eyes, with one eye anaesthetised and the other not, the fall in reflex secretion by the 
anaesthetised eye would be offset by an afferent drive from the unanaesthetised fellow 
eye; and conversely, in the unanaesthetised eye, the reflex response would be reduced, 
owing to a lack of drive from the now anaesthetised fellow eye.  The results here 
demonstrated a reduction in the Schirmer wetting length after bilateral topical 
anaesthesia, averaged for the two eyes, of 61.1% (Table 6.3).  This compares to a 
reduction of the Schirmer test response of between 28% and 53% reported in the 
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literature (Siganos et al., 2002; Lamberts, Foster and Perry, 1979; Jordan and Baum, 
1980; Li et al., 2012).  After unilateral topical anaesthesia in this study, the effects on the 
Schirmer wetting length were in the direction predicted by an assumption that there is 
sensory cross innervation to the SSN, that is the fall in secretion in the anaesthetised eye 
was less than that which occurred when there was bilateral anaesthesia, and the wetting 
length in the fellow unanaesthetised eye was lower than in its control eye after the 
bilateral Schirmer test, after saline.  However, the differences shown in each case were 
not significant (p = 0.6; p = 0.06).  Because the numbers were small, this does not entirely 
exclude the existence of sensory cross-innervation.  However, the possibility that those 
topical anaesthetics may induce a degree of nasal mucosal anaesthesia, which could 
itself reduce the secretory drive to the lacrimal gland of a fellow eye, could weigh further 
against the existence of cross-innervation from the cornea to the contralateral SSN.  
A number of studies in the literature could be interpreted as supportive of ocular cross-
innervation.  Several investigators have reported a bilateral reduction in the reflex 
Schirmer response in the presence of unilateral HSK, noting that the diminished response 
in the fellow eye was often not significantly different from that in the affected eye (Simard-
Lebrun et al., 2010; M‘Garrech et al., 2013; Keijser et al., 2002).  However there is 
evidence that in both HSK and HZO, unilateral clinical disease is accompanied by 
contralateral loss of trigeminal innervation of the clinically unaffected cornea.  The Hamrah 
group has compared clinical indices in the affected and unaffected eyes of 25 patients 
with unilateral HSK (Hamrah et al., 2010) and 27 patients with unilateral HZO with those in 
healthy controls (Hamrah et al., 2013).  In each condition, they demonstrated a significant 
decrease in a range of sub-basal nerve parameters, not only in the affected eye but also, 
to a lesser degree, in the clinically unaffected eye.  These observations are consistent 
with the findings in patients with herpes zoster infections at other sites in the body (Clarke 
and Bowsher, 1962; Watson et al., 1991).  Regardless of the basis for the involvement of 
contralateral sensory neurones after clinically unilateral herpes simplex or herpes zoster 
infections, the finding of a reduced contralateral Schirmer response in such conditions 
cannot be interpreted as evidence for sensory cross-innervation in the ophthalmic division 
of the trigeminal nerve. 
However the influence of trigeminal sensory deprivation, confined to a single cornea, on 
the reflex Schirmer response, can be examined in another clinical scenario.  Various 
forms of refractive surgery (e.g. photorefractive keratectomy and LASIK) cause loss of 
corneal sensitivity for a period of 6 to 12 months after the procedure (Özdamar et al., 
1999; Aras et al., 2000; Siganos et al., 2002; Battat et al., 2001), and a small number of 
studies have demonstrated a reduction in the reflex Schirmer response after such 
procedures.  In healthy individuals, in whom the lacrimal glands and the neural pathways 
of the LFU may be assumed to be intact, any effect of such surgery on the ipsilateral 
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reflex Schirmer response may be interpreted as a result of a blockade of the afferent limb 
of the LFU on the side of surgery. (See Table 6.4 for a summary of the results for the 
above studies.)  These various reports support the view that, in human subjects, corneal 
anaesthesia alone leads to an ipsilateral reduction of lacrimal secretion by decreasing the 
sensory drive from the cornea to the ipsilateral lacrimal gland, independent of any action 
on the nasal mucosa.  There is also a suggestion of a graded response to corneal 
anaesthesia, because in one study comparing refractive lenticule extraction (using the 
femtosecond laser) with LASIK, the effect of surgery on corneal sensitivity was smaller in 
the former procedure, and the reduction of the reflex Schirmer response was less (Gao et 
al., 2014).  Similarly, in studies of LASIK surgery, the Schirmer wetting length was further 
reduced after an anaesthetic Schirmer test, which suggests that refractive surgery does 
not cause complete corneal anaesthesia and the effect can be fortified by the addition of 
topical anaesthesia (Siganos et al., 2002; Konomi et al., 2008).  In the current study, 
however, as noted, we cannot exclude an effect due to a degree of coincident, nasal 
anaesthesia.  Overall, the proposition of Heigle and Pflugfelder that; ‗Perhaps lacrimal 
gland stimulation results from the sum of sensory inputs from the adnexal skin, cornea, 
nasal mucosa, contralateral eye and even central stimulation‘ may be accepted (Heigle 
and Pflugfelder, 1996), although the current study indicates that if there is an input from 
the contralateral ocular surface, it is limited compared with that from the contralateral 
nasal mucosa.  This result is likely to be due to the small number of subjects recruited into 
the study.  The effects of inputs that maintain lacrimal secretion in non-stressful 
environmental conditions should be distinguished from those that occur in more extreme 
environmental conditions such as exposure to noxious chemical and physical stimuli, 
when it may be supposed that additional pathways are recruited. 
It is still of great importance to discover more about the afferent sensory connections to 
the SSN from one eye to the efferent lacrimal output of the fellow eye, as there are many 
clinical situations that result in unilateral anaesthesia, and further research is planned with 
expanded subject numbers, to clarify the concept of cross-connectivity. 
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Measure Subjects n Findings % 
change 
Authors 
Schirmer test: mm in 5 minutes 
Unanaesthetised and 
anaesthetised 
Schirmer 
 Normal patients n=223 
(N) 
Unanaesthetised Schirmer 19.6±9.2 vs.  
Anaesthetised Schirmer 11.9±7.8 
39.3% Lamberts et 
al., 1979
 
Unanaesthetised and 
anaesthetised 
Schirmer 
 Young patients (25-
45years) 
 Old patients (57-71 
years) 
n=15 
(N) 
Young, unanaesthetised Schirmer 30±6 vs.  
Young, anaesthetised Schirmer 14±6 
Old, unanaesthetised Schirmer 17±12 vs.  
Old, anaesthetised Schirmer 9±6 
53% 
 
47% 
Jordan and 
Baum,
 
1980 
Unanaesthetised 
Schirmer 
 Affected and unaffected 
eyes of NK patients 
 HZO patients 
 Normal controls 
n = 19 
(NK=5, 
HZO=4, 
N=10) 
NK 2.60±3.29 vs. Fellow 11.2±6.57 
NK 2.60±3.29 vs. HZO 30.75±7.22 
NK 2.60±3.29 vs. Normal 28.5±8.03 
Fellow 11.2±6.57 vs. Normal 28.5±8.03 
76.8% 
91.5% 
90.8% 
60.7% 
Heigle and 
Pflugfelder,
 
 
1996 
Unanaesthetised 
Schirmer following 
anaesthesia of R nasal 
mucosa 
 Normal patients n=12 
(N) 
Baseline 23.71mm vs. Ipsilateral eye 15.09mm 
Baseline 22.69mm vs. Contralateral eye 
15.95mm 
Saline 22.91mm vs. Ipsilateral eye 15.09mm 
Saline 19.36mm vs. Contralateral eye 
15.95mm 
36.4% 
29.7% 
34.1% 
17.6% 
Gupta et al., 
1997
 
Unanaesthetised 
Schirmer 
 PRK eye 
 Unoperated fellow eye 
n=32 
(PRK) 
PRK eye 14.45±7.79 vs. Unoperated eye 
28.33±5.89 
49% Ozdamar et 
al., 1999)
 
Unanaesthetised 
Schirmer 
 LASIK eye post-op*  
 Unoperated fellow eye 
n=28 
(LASIK) 
LASIK eye 16.17±2.50 vs. Unoperated eye 
21.07± 7.08 
23.26
% 
Aras et al., 
2000
 
Unanaesthetised 
Schirmer 
 LASIK patients pre-op 
and 1m post-op 
n=48 
(LASIK) 
Pre-op 23.95±10.05 vs. 1m post-op 
18.06±10.42 
24.6% Battat et al., 
2001
 
Unanaesthetised 
Schirmer 
 
 
vs. Anaesthetised 
Schirmer  
 LASIK patients pre-op 
and 
1m, 3m and 6m 
post-op 
n=42 
(LASIK) 
Pre-op 16.2±4.69 vs. 1m post-op 12.8±3.15 
Pre-op 16.2±4.69 vs. 3m post-op 15.25±4.2 
Pre-op 16.2±4.69 vs. 6m post-op 15.96±1.2 
Pre-op unanaesthetised  16.2±4.69   vs. 
Pre-op anaesthetised 11.6±3.45  
21% 
5.9% 
1.5% 
28.4% 
Siganos et 
al., 2002
 
Unanaesthetised and 
anaesthetised 
Schirmer 
 LASIK patients pre-op n=18 
(pre-
LASIK) 
Unanaesthetised 24.53±3.34 vs.  
anaesthetised 15.57±1.76 
36.5% Konomi et 
al., 2008
 
Unanaesthetised 
Schirmer 
 HSK affected eye 
 HSK unaffected fellow 
eye 
 Normal controls 
n=24 
(HSK) 
HSK affected 12.2±9.9 vs. Control 19.1±10.2 
HSK Unaffected eye 12.8±8.4 vs. Control 
18.5±10.6 
36.1% 
30.8% 
Simard-
Lebrun et 
al., 2010 
Unanaesthetised and 
anaesthetised 
Schirmer 
 ADDE 
 EDE 
Dry Eye 
n=110 
(ADDE=6
8, 
EDE=42) 
ADDE unanaesthetised 5mm
~
 vs.  
ADDE anaesthetised 3mm
~
 
EDE unanaesthetised 14mm
~
 vs.  
EDE anaesthetised 6mm
~
 
40%
~
 
 
57%
~
 
Li et al., 
2012
 
Unanaesthetised 
Schirmer 
 HSK affected eye 
 HSK unaffected fellow 
eye 
 Normal controls 
n=35 
(HSK) 
HSK affected 15.9±3.1 vs. Control 20.3±1.8 
HSK Unaffected eye 17.3±2.9 vs. Control 
20.8±1.7 
21.7% 
16.8% 
M‘Garrech 
et al., 2013
 
Unanaesthetised 
Schirmer 
 LASIK patients pre-op 
and 
1w, 1m and 3m 
post-op 
n=32 
(LASIK) 
Pre-op 13mm
~
 vs. 1w post-op 9mm
~
 
Pre-op 13mm
~ 
vs. 1m post-op 9
~
 
Pre-op 13mm
~
 vs. 6m post-op 10
~
 
30.7% 
30.7% 
23.1% 
Gao et al., 
2014
 
Unanaesthetised and 
anaesthetised 
Schirmer 
 Normal patients  n=8 
(N) 
Eye 1 unanaesthetised 23.13±7.22 vs.  
Eye 1 anaesthetised 8.69±5.20 
Eye 2 unanaesthetised 24.88±4.12 vs. 
Eye 2 anaesthetised 10.00±3.78 
62.4% 
 
59.8% 
Current 
study  
 
Table 6.4 Summary of unilateral anaesthesia studies. 
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Measure Subjects n Findings % 
change 
Authors 
In Vivo Confocal Microscopy: number of nerve trunks 
Total number of nerve 
trunks and branches in 
a coronal section,  
(460 x 345µm) 
 HSK affected eye 
 HSK unaffected fellow 
eye 
Normal controls 
n=25 
(HSK) 
HSK affected 5.2±4.5 vs. Control 13.1±3.8 
HSK Unaffected eye 7.8±3.3 vs. Control 
13.1±3.8 
60.3% 
40.5% 
Hamrah et 
al., 2010 
Total number of nerve 
trunks and branches in 
a coronal section  
(460 x 345µm) 
 HZO affected eye 
 HZO unaffected fellow 
eye 
Normal controls 
n=27 
(HZO) 
HZO affected 5.4±2.8 vs. Control 13.1±3.8 
HSK Unaffected fellow 8.3±2.9 vs. Control 
13.1±3.8 
58.8% 
36.6% 
Hamrah et 
al., 2013 
Fluorophotometry: tear turnover %/minute 
Fluorophotometry with 
and without 
anaesthesia 
 Young patients (25-
45years) 
Old patients (57-71 
years) 
n=15 
(N) 
Young, unanaesthetised 0.9±0.4 vs.  
Young, anaesthetised 0.2±0.1 
Old, unanaesthetised 0.9±0.2 vs.  
Old, anaesthetised 0.4±0.2 
77% 
 
55% 
Jordan 
and 
Baum, 
1980 
Fluorophotometry 
without anaesthesia 
 HSK affected eye 
 HSK unaffected fellow 
eye 
Normal controls 
n=16 
(HSK) 
HSK affected 7.9±4.9 vs. Control 14.3±6.5 
HSK unaffected fellow 7.9±5.6 vs. Control 
14.3±6.5 
HSK affected 7.9±4.9 vs. HSK unaffected eye 
7.9±5.6 
44.8% 
44.8% 
0% 
Keijser et 
al., 2002 
Central corneal sensitivity: mm 
Cochet-Bonnet  LASIK patients pre-op 
and 1w, 1m and 
3m post-op 
 
 ReLEx patients pre-op 
and 1w, 1m and 
3m post-op 
n=47 
(LASIK=3
2, 
ReLEx=1
5) 
Pre-op 58mm
~
 vs. 1w post-op 20mm
~ 
Pre-op 58mm
~
 vs. 1m post-op 22mm
~ 
Pre-op 58mm
~
 vs. 3m post-op 30mm
~ 
Pre-op 58mm
~
 vs. 1w post-op 50mm
~ 
Pre-op 58mm
~
 vs. 1m post-op 52mm
~ 
Pre-op 58mm
~
 vs. 3m post-op 56mm
~ 
65.5% 
62.1% 
48.3% 
13.8% 
10.3% 
3.4% 
Gao et al., 
2014
 
Cochet-Bonnet  LASIK patients pre-op 
and 1w, 1m and 
6m post-op 
n=48 Pre-op 36mm
~
 vs. 1w post-op 3mm
~ 
Pre-op 36mm
~
 vs. 1m post-op 18mm
~ 
Pre-op 36mm
~
 vs. 6m post-op 12mm
~ 
91.7% 
50.0% 
66.7% 
Battat et 
al., 2001
 
Central corneal sensitivity: gm/cm
2
 
Cochet-Bonnet  LASIK patients pre-op 
and 1w, 3m and 
9m post-op 
n=24 Pre-op 1gm/cm
2~
 vs. 1w post-op 2.3gm/cm
2~ 
Pre-op 1gm/cm
2~
 vs. 3m post-op 1.5gm/cm
2~ 
Pre-op 1gm/cm
2~
 vs. 9m post-op 1 gm/cm
2~
 
56.5% 
33.3% 
0.0% 
Konomi et 
al., 2008
 
ADDE=aqueous deficient dry eye; EDE=evaporative deficient dry eye; HSK=Herpes simplex keratitis; HZO=Herpes zoster ophthalmicus; 
LASIK=Laser-Assisted In-Situ Keratomileusis; N=normal; NK=neurotrophic keratitis;  PRK=photorefractive keratectomy; ReLEx=Refractive 
Lenticule Extraction 
~
Approximate from figures;  * Timescale of test not stated 
 
Table 6.4 (Continued) Summary of unilateral anaesthesia studies. 
 
The material presented here is reported in the publication: Willshire, C., Buckley, R.J. and 
Bron, A.J., 2017. Central Connections of the Lacrimal Functional Unit. Cornea, 36 (8), 
pp.898-907.  This article is contained in Appendix XIV.  
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Chapter 7: 
 
THE EFFECT OF DESICCATING STRESS ON TEAR OSMOLARITY 
WITH AND WITHOUT SENSORY BLOCKADE 
 
The experiments described in this chapter were designed to study the effect of desiccating 
stress (low humidity) on tear osmolarity (tOsm) in open eye conditions, with and without 
sensory blockade, in normal and dry eye disease (DED) subjects.   
7.1 INTRODUCTION 
Osmolar homeostasis of the tears is closely regulated by the lacrimal functional unit (LFU) 
and is considered to be the primary drive for homeostasis of the tear film (Mathers, 2000). 
Tear production is up- or down-regulated in response to changes in sensory inputs from 
the ocular surface representing increased or decreased environmental stress. Desiccating 
stress can result in ocular surface damage in the form of staining (Abelson et al., 2012; 
Alex et al., 2013).  There is an increased likelihood of this response in DED patients who 
exhibit greater than normal evaporation from the tear film, resulting in higher tOsm (Craig 
et al., 2000), or who, with their compensatory system already partially engaged by the 
disease, are unable to compensate further. Injury to the epithelial cells as a result of 
hyperosmolarity stimulates an increased sensory response from the corneal nerves via 
the LFU.  As DED progresses, a state of corneal hypersensitivity is thought to exist that 
reduces the threshold for stimulation and results in a compensatory increase in 
lacrimation and blinking but this phase is followed by corneal hyposensitivity (Xu et al., 
1996; De Paiva and Pflugfelder, 2004; Bourcier et al., 2005; Tuisku et al., 2008) and a 
consequent loss of compensation. This is considered to amplify the level of tOsm in the 
later stages of DED (Bron et al., 2009).  
In recent studies in which normal and DED subjects were exposed to 1 or 2 hour periods 
of desiccating stress at 5% relative humidity (RH), an increase in corneal staining 
occurred but was not accompanied by a significant increase in tOsm (Abusharha and 
Pearce, 2013; Teson et al., 2013; López-Miguel et al., 2014). One explanation for this 
could be that although induced tear hyperosmolarity at the corneal surface was the basis 
of the corneal damage in the blink interval, compensatory reflex tearing had diluted tOsm 
overall, so that a rise did not occur in the meniscus. It is argued here, that if sensory drive 
from the ocular surface were to be blocked by topical anaesthesia, in conditions of 
desiccating stress, absence of the compensatory increase in tear production would allow 
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an increase in tOsm to occur that would be detected in the meniscus. This is the basis of 
the research presented below. 
7.2 HYPOTHESIS  
It was hypothesised that desiccating stress to the ocular surface, in the absence of a 
compensatory, reflex tear response via the LFU, would result in a rise in tOsm detectable 
in the tear meniscus. A secondary proposition was that this would be accompanied by 
signs of epithelial corneal damage in the form of a punctate epithelial keratopathy.  In the 
experiments described below, desiccating stress was induced by exposure to a low RH 
and epithelial damage was quantified by observing punctate epithelial staining. Since the 
responses might be expected to differ in normal subjects and patients with DED, both 
groups of subjects were studied. Subjects were exposed to two sessions of desiccating 
stress in the form of an RH of 5%, for a period of 60 minutes each. In one session, both 
eyes were anaesthetised with topical anaesthetic and in the other, both eyes received a 
saline control drop. It was predicted that tOsm would rise significantly during the period of 
topical anaesthesia and afferent blockade, likely to be in the order of 30 minutes duration. 
7.3 MATERIALS AND METHODS 
7.3.1 Subject enrolment 
Eight subjects with normal eyes were recruited, 4 male and 4 female, aged 37.0 years ± 
23.57 (mean ± SD) from students and staff at Anglia Ruskin University.  Participants were 
individuals with a normal ocular surface by history and examination, according to defined 
criteria (see Chapter 2 for inclusion/exclusion criteria).  Subjects three and four also took 
part in the experiments featured in chapters four, five and six, and subjects six and seven 
also took part in the experiments featured in chapter four.  At least one month was 
allowed to elapse before these subjects were invited to participate in the other 
experiments.     
Eight patients with DED were recruited, 2 male and 6 female (4 diagnosed with Sjögren 
Syndrome), aged 58.88 years ± 17.13 (mean ± SD) from staff at Anglia Ruskin University 
and from the Cambridgeshire British Sjögrens Syndrome Association (BSSA) group.  The 
Sjögren patients who volunteered for this study also participated in the cross-connectivity 
study reported in Chapter 5; there was at least two months between the data collection of 
the two experiments.  DED patients were individuals who fulfilled the internationally 
accepted definition of DED (Lemp et al., DEWS I 2007) by history and by ocular surface 
examination (see Chapter 2 for screening inclusion/exclusion criteria).  All but one of the 
DED patients were the same as those recruited for the experiment outlined in Chapter 4; a 
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profile of their DED status at recruitment can be viewed in this chapter. Table 7.1 contains 
the ocular profiles of the right eye of subjects recruited for this experiment.    
Parameter 
Mean ± SD 
(min-max) 
Subjects 
Normal (n=8) Sjögren syndrome 
DED (n=4) 
Non Sjögren 
syndrome DED (n=4) 
Gender 5 Male : 3 Female 4 Female 2 Male : 2 Female 
Age (years) 40.00 ± 24.6 
 
66.75 ± 7.93 
 
50.75 ± 21.03 
 
tOsm (mOsm/L) 294.0 ± 3.66 
 
314.3 ± 11.21 
 
313.75 ± 4.86 
 
Corneal staining 1.25 ± 1.16 
 
3.5 ± 2.38 
 
2.0 ± 0.0 
 
Schirmer 
wetting (cm) 
23.3 ± 7.19 
 
5.3 ± 2.5 
 
7.0 ± 2.16 
 
OSDI 5.36 ± 6.51 
 
64.9 ± 25.49 
 
40.1 ± 23.28 
 
TBUT (seconds) 12.17 ± 1.71 
 
2.39 ± 0.67 
 
5.63 ± 0.66 
 
Meibography 
grading 
0 ± 0.0 
 
1 ± 0.0 
(1-1) 
0.5 ± 0.58 
 
 
Table 7.1 Profiles of the normal subjects consented for this study 
7.3.2 Equipment 
The controlled environment chamber (CEC) was employed for the two visits made by 
each subject, on separate days. It was decided randomly, on the toss of a coin, whether 
the subject would receive saline or anaesthetic drops on his or her first visit.  Tear 
osmolarity was routinely measured in all subjects prior to entry into the CEC, in 
uncontrolled clinic conditions, in the area immediately outside the chamber.  Room 
temperature and RH were recorded at the time of these measurements (Table 7.3).  
Experiments were conducted in controlled, ‗desiccating‘ environment conditions of 5% 
RH, temperature 23°C, and airflow 0.08 m/s (Table 7.2). A 10 minute period was required 
after the subject and examiner had entered the CEC to allow for equilibration of the 
environmental conditions.  Tear osmolarity was measured using the TearLab® 
osmometer.  Corneal anaesthesia was achieved using topical anaesthetic eye drops, 
proxymetacaine 0.5% and tetracaine 1%, and saline was used in the control studies (see 
Chapters 2 and 3 for details).  To minimise reflex tearing, a single drop of the short-acting 
anaesthetic 0.5% proxymetacaine (Minims®) (Jones, 1966) was instilled first, followed 30 
seconds later by a drop of 1% tetracaine (Minims®). It was assumed that a deep to 
moderately deep anaesthesia would last approximately 30 minutes with a lesser degree of 
corneal anaesthesia remaining for up to one hour.  The protocol was repeated with the 
saline eye drops serving as a control.  
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 Temperature Relative Humidity Airflow 
‗Desiccating conditions‘ 23°C 5% 0.08m/s 
‗Clinic conditions‘ Uncontrolled environment: temperature and relative 
humidity recorded at each visit 
 
Table 7.2 Environmental conditions employed in this study. 
7.3.3 Protocol 
The saline control visit lasted approximately one hour; the subject and the examiner 
entered the CEC and at zero time one drop of saline (control) was instilled into each eye, 
followed by another at 30 seconds (to control for the anaesthetic studies). Excess tears 
were dabbed away with tissues by the investigator and the subjects remained with their 
eyes open, blinking spontaneously to facilitate tear drainage.  Tear osmolarity was 
measured first in the right eye followed by the left eye every 20 minutes for one hour, 
during which time the subject was instructed to keep the eyes open looking straight ahead 
and blinking spontaneously. 
The topical anaesthesia visit lasted approximately one hour and took place on a different 
day, but at a similar time of day.  The subject and the examiner entered the CEC and at 
zero time, one drop of proxymetacaine 0.5% was instilled into each eye followed after 30 
seconds by one drop of tetracaine 1% into each eye. Excess tears were dabbed away 
with tissues by the investigator and the subjects remained with their eyes open, blinking 
spontaneously to facilitate tear drainage. Tear osmolarity was measured first in the right 
eye, then the left eye, every 20 minutes for one hour, during which time the subject was 
instructed to keep the eyes open looking straight ahead and blinking spontaneously. 
A slit-lamp examination was carried out following each visit to check for adverse events.  
The Oxford scale was used to grade any corneal staining present following exposure to 
desiccating conditions on a scale from 0-5 (See Figure 7.1 for a timeline of the 
experiments and Appendix XI for an example record card). 
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Figure 7.1 Timeline of anaesthetic and saline visits.  
 
7.3.4 Statistical analysis  
A non-parametric Friedman test (due to outliers, indicated in the Tables 7.4-7.7) was used 
to analyse the mean of tOsm values, which were compared across the 3 time points in the 
CEC and with the value measured in clinic conditions; the values were analysed in the 
right eye (RE) and left eye (LE), in normal and DED subjects and in the saline and 
anaesthesia conditions.  An exception to this pathway of analysis was the data for DED in 
the LE following saline instillation; in this instance there were no outliers and the data was 
normally distributed at each time point, and a one-way repeated measures ANOVA test 
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was used.  A related samples sign test was used to calculate the difference in corneal 
staining graded with the Oxford staining scale, before and after exposure to desiccating 
conditions and following saline or anaesthetic instillation; the right eye in each subject was 
used for analysis and presented in this chapter.  The Bonferroni method was used to 
make adjustments for multiple comparisons.  Shapiro-Wilk test was used to evaluate 
normality of distribution.  Differences were considered statistically significant with P values 
less than 0.05.  Data is presented as mean ± standard deviation.  Analyses were 
performed using SPSS 20. 
 
7.4 RESULTS 
Details of the uncontrolled clinic conditions for all 32 experiments (16 from the 
experiments with normal subjects and 16 from the DED patients) are presented in Table 
7.3.  The temperature ranged from 18°C to 27°C and the RH ranged from 26% to 60%.  
These measures were recorded to show the variation encountered in a clinical 
environment on a day-to-day basis in comparison to the controlled environment created in 
the CEC. 
 
Experiment 
number 
Temperature (°C) Relative Humidity (%) 
Normal DED Normal DED 
1 23 22 50 43 
2 18 26 42 35 
3 23 27 50 39 
4 18 24 42 33 
5 22 22.8 38 45 
6 24 22.9 37 44 
7 21 22.4 45 54 
8 26 22.8 37 52 
9 21 21.6 45 45 
10 26 22.6 36 51 
11 27 22 37 40 
12 26 21 42 60 
13 22 23 44 47 
14 22.2 22.5 26 49 
15 22 23 41 40 
16 22 22.7 49 54 
Range 9.0 6.0 24.0 27.0 
Min/Max 18°C  to 27°C 21°C  to   27°C 26%   to   50% 33% to 60% 
 
Table 7.3 Temperature and RH levels recorded in the uncontrolled clinic conditions.  
Normal subjects - topical anaesthetic 
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The tOsm data for both eyes in normal subjects are presented in Table 7.4 and Figure 
7.2.  The mean RE tOsm started at 297.1 ± 5.67 mOsm/L in clinic conditions, decreased 
to 293.4 ± 7.93 after 20 minutes exposure to 5% RH, 293.5 ± 7.67 after 40 minutes 
exposure and was at 292.0 ± 7.07 after 60 minutes.  The differences in tOsm across the 
time points were not statistically significant: χ2(3) = 3.627, p = 0.305.  In the LE tOsm 
started at 298.6 ± 7.78 mOsm/L in clinic conditions, decreased to 296.5 ± 6.35 after 20 
minutes exposure, 295.4 ± 7.80 after 40 minutes exposure and was at 291.8 ± 6.98 after 
60 minutes.  The differences were not statistically significant: χ2(3) = 4.948, p = 0.176. 
 
Subject tOsm @ clinic 
conditions 
tOsm @ 20 
minutes 
tOsm @ 40 
minutes 
tOsm @ 60 
minutes 
R L R L R L R L 
1 300 289 309 283 279∞ 303 280∞ 279∞ 
2 305 307 296 300 290 294 290 293 
3 292 299 289 300 293 296 292 293 
4 299 289 289 301 301 291 293 294 
5 304 311 * 295 294 310 301 302 
6 294 301 293 292 293 293 290 293 
7 290 297 300 301 293 285 288 285 
8 293 296 306 300 305 291 302∞ 296 
Mean ± SD 297.1 
± 5.67 
298.6 
± 7.78 
293.4 
± 7.93 
296.5 
± 6.35 
293.5 
± 7.67 
295.4 
± 7.80 
292.0 
± 7.07 
291.8 
± 6.98 
* Value discarded due to sampling problems 
∞ Data outlier 
Table 7.4 Data for normal subjects in ‗clinic conditions‘ and at three time points with topical anaesthetic 
instillation and exposure to ‗desiccating conditions‘. 
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Figure 7.2 Tear osmolarity in normal subjects following instillation of topical anaesthetic in clinic conditions 
and at 20 minutes time points during exposure to ‗desiccating conditions‘ for 60 minutes. 
 
Normal subjects - saline 
The tOsm data for both eyes in normal subjects are presented in Table 7.5 and Figure 
7.3.  In the RE tOsm started at 300.5 ± 5.98 mOsm/L in clinic conditions, decreased to 
295.1 ± 3.13 after 20 minutes exposure, increased again to 299.0 ± 7.37 after 40 minutes 
exposure and was at 291.4 ± 5.44 after 60 minutes exposure to desiccating conditions.  The 
differences across the time points were not statistically significant: χ2(3) = 5.644, p = 
0.130.  In the LE tOsm started at 299.1 ± 8.08 mOsm/L in clinic conditions, decreased to 
292.6 ± 5.50 after 20 minutes exposure, increased again to 296.1 ± 4.52 after 40 minutes 
exposure and was at 297.1 ± 9.98 after 60 minutes.  The differences were not statistically 
significant: χ2(3) = 3.987, p = 0.263. 
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Subject tOsm @ clinic 
conditions 
tOsm @ 20 
minutes 
tOsm @ 40 
minutes 
tOsm @ 60 
minutes 
R L R L R L R L 
1 301 289 291 287 * 301 283 293 
2 297 292 295 294 297 297 292 293 
3 294 299 293 284 299 293 297 287 
4 298 299 300 296 302 299 299 301 
5 298 300 293 291 299 293 292 290 
6 314 316 * 302 311 301 * 317 
7 301 302 296 294 286∞ 297 289 305 
8 301 296 298 293 299 288 288 291 
Mean ± SD 300.5 
± 5.98 
299.1 
± 8.08 
295.1 
± 3.13 
292.6
± 5.50 
299.0 
± 7.37 
296.1 
± 4.52 
291.4 
± 5.44 
297.1 
± 9.98 
* Value discarded due to sampling problems 
∞ Data outlier 
Table 7.5 Data for normal subjects in ‗clinic conditions‘ and at three time points with saline (control) instillation 
and exposure to ‗desiccating conditions‘. 
 
Figure 7.3 Tear osmolarity in normal subjects following instillation of topical saline in clinic conditions and at 
20 minutes time points during exposure to ‗desiccating conditions‘ for 60 minutes. 
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DED Subjects - topical anaesthetic  
The tOsm data for the right and left eyes in DED patients are presented in Table 7.6 and 
Figure 7.4.  In the RE tOsm started at 298.3 ± 13.67 mOsm/L in clinic conditions, 
decreased to 294.5 ± 16.19 after 20 minutes exposure, 293.5 ± 14.35 after 40 minutes 
exposure and was at 295.9 ± 14.57 after 60 minutes exposure to desiccation.  The 
differences across the time points were not statistically significant: χ2(3) = 3.329, p = 
0.344.  In the LE tOsm started at 298.9 ± 6.29 mOsm/L in clinic conditions, decreased to 
293.4 ± 11.34 after 20 minutes exposure, increased to 296.4 ± 12.70 after 40 minutes 
exposure and was at 292.8 ± 9.11 after 60 minutes.  The differences were not statistically 
significant: χ2(3) = 0.846, p = 0.838. 
 
Subject tOsm @ clinic 
conditions 
tOsm @ 20 
minutes 
tOsm @ 40 
minutes 
tOsm @ 60 
minutes 
R L R L R L R L 
1 313 298 298 298 298 317 306 299 
2 296 295 287 302 297 296 296 297 
3 ~ 299 297 296 281 293 284 294 284 
4 ~ 300 302 285 283 280 282 276 281 
5 ~ 277 300 331∞ 306 323∞ 309 321 301 
6 ~ 282 288 282 282 283 284 282 281 
7 302 301 281 308 278 297 287 302 
8 317 310∞ 296 287 296 302 305 297 
Mean ± 
SD 
298.3 
± 13.67 
298.9
± 6.29 
294.5 
± 16.19 
293.4 ± 
11.34 
293.5 ± 
14.35 
296.4 ± 
12.70 
295.9 ± 
14.57 
292.8 
± 9.11 
∞ Data outlier 
~ Subject diagnosed with Sjogren syndrome 
Table 7.6 Data for DED patients in ‗clinic conditions‘ and at three time points with topical anaesthetic 
instillation and exposure to ‗desiccating conditions‘. 
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Figure 7.4 Tear osmolarity in DED subjects following instillation of topical anaesthetic in clinic conditions and 
at 20 minutes time points during exposure to ‗desiccating conditions‘ for 60 minutes. 
 
DED subjects - saline 
The tOsm data for both eyes in DED patients are presented in Table 7.7 and Figure 7.5.  
In the RE tOsm started at 296.6 ± 13.85 mOsm/L in clinic conditions, increased to 304.3 ± 
15.14 after 20 minutes exposure, decreased to 297.5 ± 9.58 after 40 minutes exposure 
and was at 297.0 ± 10.01 after 60 minutes of exposure to desiccation.  The differences 
across the time points were not statistically significant: χ2(3) = 2.338, p = 0.505.  In the LE 
tOsm started at 298.0 ± 6.14 mOsm/L in clinic conditions, increased to 298.8 ± 8.94 after 
20 minutes exposure, increased again to 300.4 ± 8.94 after 40 minutes exposure and was 
at 293.9 ± 7.85 after 60 minutes.  The differences were not statistically significant: F(1.689, 
11.824) = 1.499, p = 0.260. 
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Subject tOsm @ clinic 
conditions 
tOsm @ 20 
minutes 
tOsm @ 40 
minutes 
tOsm @ 60 
minutes 
R L R L R L R L 
1 312 309 321 307 319∞ 317 314 290 
2 290 298 298 300 299 301 306 300 
3 ~ 292 296 292 288 289 309 286 291 
4 ~ 282 294 302 301 292 292 286 293 
5 ~ 312 297 329 298 292 291 296 286 
6 ~ 290 290 285 286 292 295 290 284 
7 281 295 295 297 296 302 295 300 
8 314 305 312 313 301 296 303 307 
Mean ± SD 296.6 ± 
13.85 
298.0 
 ± 6.14 
304.3 
± 15.14 
298.8
± 8.94 
297.5
± 9.58 
300.4 
± 8.94 
297.0 ± 
10.01 
293.9  
± 7.85 
∞ Data outlier 
~ Subject diagnosed with Sjögren syndrome 
Table 7.7 Data for DED patients in ‗clinic conditions‘ and at three time points with saline (control) instillation 
and exposure to ‗desiccating conditions‘. 
 
Figure 7.5 Tear osmolarity in DED subjects following instillation of topical saline in clinic conditions and at 20 
minutes time points during exposure to ‗desiccating conditions‘ for 60 minutes. 
A slit-lamp examination was carried out after each visit in the CEC to monitor for any 
adverse effects of exposure to the low RH environment; the Oxford grading scale was 
used to grade any corneal staining present pre and post exposure to desiccating 
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conditions (Appendix V).  The right eye of each subject in the anaesthetic study was used 
for analysis and presented here. 
Normal group 
The mean corneal staining grade in the normal group pre-exposure was 1.25 ± 1.16.  
After 60 minutes exposure to desiccating conditions and saline instillation the mean 
corneal staining grade was 1.50 ± 1.19 and after 60 minutes exposure to desiccating 
conditions and instillation of anaesthetics the mean corneal staining was 1.50 ± 1.19.  
Neither post-exposure corneal staining values reached significance when compared to the 
pre-exposure level (p = 0.50).  Figures 7.6 and 7.7 show images for the eight subjects 
demonstrating the pre-exposed cornea staining levels and post-exposure to desiccating 
stress plus anaesthetic instillation corneal appearance of the right eye.  
DED group 
The mean corneal staining grade in the DED group pre exposure was 2.63 ± 3.50. After 
60 minutes exposure to desiccating conditions and saline instillation the mean corneal 
grading was 2.75 ± 3.46; this difference did not reach significance compared to the pre 
exposure level (p = 0.50).  Following instillation of anaesthetics and 60 minute exposure to 
desiccating conditions the mean corneal staining grade was 4.63 ± 3.96, which was 
significantly increased when compared to the level at pre-exposure level (p = 0.031) and 
was observed particularly in the inferior portion of the cornea, and more profoundly in the 
DED patients diagnosed with Sjögren syndrome.  Figures 7.8 and 7.9 show images for the 
eight subjects demonstrating the corneal appearances pre-exposure cornea staining 
levels and post-exposure to desiccating stress plus anaesthetic instillation of the right eye.   
Subjects who displayed corneal staining of over Grade 1 were instructed to return on the 
next day for a further corneal examination, at which time it was observed in every case 
that the corneal appearance had returned to the pre-exposure level.  Images of the left 
cornea following anaesthetic instillation and of both eyes following saline instillation in 
both the normal and DED groups are shown in Appendix XIII.  
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Figure 7.6 Slit-lamp images with fluorescein pre and post CEC exposure to desiccating conditions for 60 
minutes and after anaesthetic instillation in right eyes of normal subjects 1-4. 
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Figure 7.7 Slit-lamp images with fluorescein pre and post CEC exposure to desiccating conditions for 60 
minutes and after anaesthetic instillation in right eyes of normal subjects 5-8. 
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Figure7.8 Slit-lamp images with fluorescein pre and post CEC exposure to desiccating conditions for 60 
minutes and after anaesthetic instillation in right eyes of DED patients 1-4. 
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Figure 7.9 Slit-lamp images with fluorescein pre and post CEC exposure to desiccating conditions for 60 
minutes and after anaesthetic instillation in right eyes of DED patients 5-8. 
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7.5 DISCUSSION 
Exposure to desiccating conditions, especially low relative humidity has been found to 
increase symptoms and signs of dry eye disease (DED) (Tsubota and Yamada, 1992; 
Tsubota, 1998; Uchiyama et al., 2007).  In a healthy eye hyperosmolarity triggers an 
afferent sensory response from the ocular surface that, via the lacrimal functional unit 
(LFU) stimulates a compensatory reflex tearing, which re-establishes homeostasis.  In 
DED the system that allows the compensatory mechanism to function becomes 
increasingly faulty, and subsequently a prolonged state of hyperosmolarity may 
compromise the corneal sensitivity and hence reduce afferent signals.  A positive 
correlation between loss of sensation and the degree of ocular surface staining and a 
negative correlation between surface damage and symptoms, suggests a progressive 
increase in sensory loss with disease progression (Adatia et al., 2004). 
This is the first experiment to use topical anaesthetics, theorised to temporarily block the 
afferent signals from the cornea with the result that in conditions of desiccating stress the 
LFU could not respond, and to include DED subjects in the protocol. It was hypothesised 
that this would lead to a deficiency in compensatory tearing and a consequent rise in tear 
osmolarity (tOsm), the effect being more pronounced in DED than in normal subjects.  
The experiment using saline eye drops was designed to serve as a control for the use of 
anaesthetic drops. It was expected that, following the instillation of topical saline, tOsm 
would not change significantly over the period of an hour exposed to desiccating 
conditions, since a normally functioning LFU would be expected to compensate for the 
adverse conditions. 
There was no significant increase in the tOsm from pre-exposure levels to that measured 
over the course of one hour exposure to desiccating conditions in the control experiment 
(saline), in either eye of the normal group (RE p = 0.130; LE p = 0.263) or the DED group 
(RE p = 0.505; LE p = 0.260). Unexpectedly, the tOsm pre and post exposure following 
anaesthetic instillation also did not show a significant increase in tOsm in either eye of the 
normal group (RE p = 0.305; LE p = 0.176) or in either eye of the DED group (RE p = 
0.344; LE p = 0.838).  Although these findings are in line with those of previous workers 
involving exposure to desiccating conditions (Abusharha and Pearce, 2013; Teson et al., 
2013; López-Miguel et al., 2014), it is noted that in those studies, topical anaesthesia was 
not employed.  
A lack of significant change in tOsm here after anaesthetic use and exposure to 
desiccation could be due to many factors, most likely due to the small numbers of subjects 
recruited into the study but also the possibility that the desiccating stress created in the 
CEC was not sufficient to elicit a tOsm response.  Previous pilot studies (Chapter 3) had 
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indicated that adding a level of increased airflow for 5 minutes, induced significant corneal 
response and resulted in grade 5 corneal staining; as a result this was not incorporated 
into the final protocol presented here. More likely, the period of topical anaesthesia was 
insufficient to permit the loss of compensatory response to influence osmolarity. Blink rate 
was not recorded during the study and may have increased, which would have had a 
protective effect.  An additional factor could have been that clearance of instilled 
anaesthetic drops was inadequate so that they had a diluting effect on the tears, or that 
the level of reflex tear response to the instilled proxymetacaine was greater than 
anticipated.  Additionally, the osmolarity of the instilled drops was unknown and could 
have influenced the final measured tOsm result.  The expectation that an effect, if it 
occurred, would be amplified in the DED patients exposed to anaesthetic was not realised 
and it may be noted that, despite recruitment of all DED patients at a tOsm of ≥308 
mOsm/L or more, their tOsms on the days of the experiments were rarely at or above 
these levels, implying that disease severity was mild.  
An approach to circumvent the problems cited above could be to recruit patients with 
dense unilateral anaesthesia, as in neurotrophic keratitis (NK), to the study.  In this case 
bilateral anaesthesia could be achieved by the instillation of topical anaesthetic into the 
normal fellow eye, and anaesthesia in this fellow eye could be topped up during the period 
of exposure to desiccating stress without inducing reflex tearing.  In this way it might be 
possible to extend the period of observation under full anaesthesia, in the NK eye, to an 
hour and problems of diluting tears by instilling drops into the experimental eye would be 
avoided. 
Sensory inputs from the nasal mucosa could also play a role in the compensatory effects 
observed here.  Studies by Heigle and Pflugfleder (1996) and Gupta et al., (1997) have 
demonstrated that anaesthesia of the nasal mucosa resulted in a decrease in lacrimal 
secretion measured by the Schirmer test (Heigle and Pflugfelder, 1996; Gupta, Heigle and 
Pflugfelder, 1997).  In the case of the subjects here, an assumed functioning sensory 
input from this area could have been sufficient to offset the lack of input from the ocular 
surface and stimulate lacrimal secretion. Studies in animals (Brinton et al., 2015; Kossler 
et al., 2015) and in humans (Friedman et al., 2016; Gumus and Pflugfelder, 2017) have 
reinforced the idea that there is a reflex link to lacrimal secretion from the nasal mucosa.  
The intranasal tear stimulator (Allergan Plc, Dublin, Ireland) that has been developed 
applies an electrical stimulus to the trigeminal sensory nerves in the nasal cavities, which 
initiates the afferent limb of the nasolacrimal reflex response.  Friedman et al., (2016) 
measured the effect of using this device for three minutes on 40 mild to severe DED 
patients (Friedman et al., 2016).  The group reported a Schirmer wetting of 9.4 ± 1.3mm 
unstimulated and 22.4 ± 1.9mm stimulated in the right eye and 10.5 ± 1.1mm 
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unstimulated and 22.5 ± 1.8mm stimulated in the left eye.  This represented an increase in 
aqueous tear production of 138.3% and 114.3% in the right and left eye respectively. 
Following exposure in the CEC a slit-lamp examination was carried out routinely to check 
for adverse events.  In the normal group there was no significant change in corneal 
staining at recruitment (pre-exposure) compared to that recorded following exposure to 
desiccating conditions and instillation of either saline or anaesthetic drops (p = 0.50).  No 
significant change in corneal staining was also observed in the DED group from the pre-
exposure recruitment stage compared to exposure and instillation of saline eye drops (p = 
0.50).  However, in the DED group the corneal staining observed at recruitment was 
measured at 2.63 ± 3.50 and following exposure to desiccating conditions and instillation 
of anaesthetic eye drops increased to 4.63 ± 3.96 which reached significance (p = 0.031).  
The corneal staining was observed mainly in the inferior portion of the cornea and 
primarily in the DED patients who suffered from Sjögren syndrome (see Figures 7.8 and 
7.9).  These subjects did present with a higher level of corneal staining prior to exposure 
but as a likely consequence of an inherently reduced aqueous volume caused by their 
underlying disease this damage was compounded. Sjögren syndrome patients have also 
been shown to have a higher prevalence of meibomian gland dysfunction (MGD), reported 
as 57.9% in the Sjögren group versus 18.5% in a normal group (Shimazaki et al., 1998) 
which could have contributed the effect due to a higher evaporation from the ocular 
surface, although in the present study the patients recruited did not have significant MGD.  
Incomplete blinking could explain why the staining following exposure to the desiccating 
conditions occurred more readily in the inferior portion of the cornea since this appears to 
encourage thinning of the pre ocular tear film in an area that is not refreshed by the tear 
film after an incomplete blink, enhancing the opportunity for further evaporation.  It may 
also follow that subsequent to the incomplete blink event, if a full blink is attempted this 
may increase the insult to the corneal surface via friction (McMonnies, 2007).  All subjects 
exhibiting corneal staining of grade >1 were re-examined the next day, when the corneal 
staining was found to have resolved or reduced to baseline levels within this 24 hour 
period, which is in line with previous studies that have documented punctate staining to be 
transient, appearing and disappearing over a matter of hours (Caffery and Josephson, 
1991; Garofalo et al., 2005). 
The findings of this experiment did not elicit the results predicted, since there was no 
significant rise in tOsm in either group of subjects after one hour exposure to 5% RH with 
sensory blockade.  This could have been due to a number of the factors discussed earlier.  
However, the presence of corneal staining following this exposure and sensory blockade 
in the DED group did indicate that a change was occurring at the ocular surface, which 
was not reflected in the osmolarity of the tears sampled in the meniscus.  It has previously 
been indicated by modelling considerations that the tOsm measured at the level of the 
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meniscus does not necessarily reflect that occurring across the whole corneal surface, the 
tear film osmolarity exceeding that of the meniscus and being more pronounced in DED 
subjects (Gaffney et al., 2010). Thus it may be hypothesised that in the current studies, in 
the DED patients desiccating stress caused tOsm to rise to a damaging level locally, but 
that the magnitude of this effect was not sufficient to influence the bulk of the tears or at 
least that portion sampled from the meniscus. This could also be the reason for the often 
reported discordance between signs and symptoms when related to DED and could have 
implications for the monitoring of individual responses to treatment on the basis of tOsm 
(Bartlett et al., 2015).  In other studies the highest correlation between signs and 
symptoms was found between staining in the inferior portion of the cornea and evening 
intensity of discomfort and dryness (Begley et al., 2003; Rodriguez et al., 2016).  
To conclude, it would be of great use to be able to sample the tear film from the surface of 
the eye directly to gain a fuller picture of the tOsm levels at a tissue level, and since these 
experiments were conducted, a new device that measures tOsm at the level of the 
conjunctiva, the i-Pen®, has become available.  This device measures tOsm of the tears 
from a sample taken from the palpebral conjunctiva, and reported to reflect the osmolarity 
of the tissue at this site, although recent reports differ as to the accuracy of the instrument 
(Reis, Greiner and Albuquerque, 2017; Rocha et al., 2017).  
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Chapter 8: 
General Conclusions and Future Work 
 
Tear Dynamics relates to the exquisitely sensitive homeostatic system that maintains a 
steady state at the ocular surface, ensuring stability of the tear film despite an array of 
potentially disturbing, internal and external influences.  In dry eye disease (DED) this 
homeostatic mechanism is disrupted and the resulting tear hyperosmolarity leads to 
ocular surface damage and debilitating ocular surface symptoms (Lemp et al., DEWS I 
2007; Craig et al., 2017).  The lacrimal functional unit (LFU), responsible for 
compensatory tear production and adjustments to the blink rate, can mitigate the effects of 
adverse environments (Tsubota and Nakamori, 1995; Stern et al., 2004).  When the eyes 
are open and the ocular surface is exposed to a variety of stresses (low humidity, wind, 
cold and other physical or chemical agents), the reflex pathway adjusts lacrimal secretion 
and blink rate to achieve osmolar homeostasis.  In conditions of high humidity, equable 
temperature, zero airflow and absent chemical exposure, the secretion will be low and 
may be considered to be ‗basal‘.  In conditions of desiccating stress, sensory drive is 
predicted to rise in proportion to the severity of the conditions and results in increased 
lacrimal secretion, working by activation of the LFU.  
In the experiments presented here a controlled environment chamber (CEC) was utilised 
to simulate a variety of different ambient conditions e.g. standard/office room conditions, 
conditions of evaporative suppression and conditions of desiccating stress.  The research 
investigated the LFU responses to adverse environmental conditions, in particular tear 
physiology and its relationship to DED, using either tear osmolarity (tOsm) or production 
(measured by the Schirmer test) as outcome measures to represent changes in 
functioning.  
The first experiments (Chapter 4) studied the influence of desiccation on Schirmer test 
results.  The Schirmer test has long been used as a diagnostic tool for DED; however, 
many studies have reported poor reproducibility and high levels of variability in this test 
(Kallarackal et al., 2002; Loran et al., 1987; Serin et al., 2007; Sullivan et al., 2010).  Holly 
et al., (1984) showed that the wetting length of the Schirmer strip was influenced by 
evaporation and would therefore be affected by ambient humidity (Holly, Laukaitis and 
Esquivel, 1984).  The experiments in this chapter explored whether exposure to 
desiccating stress would result in a falsely low Schirmer value.  It was hypothesised that 
by preventing evaporation from the strip, the response would be freed from the influence 
of ambient conditions, of particular importance in a desiccating environment.  Normal 
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subjects were exposed to different ambient levels of humidity and Schirmer tests were 
performed with and without an encasing sheath, designed to reduce evaporation from the 
strip during the test.  It was expected that the lower levels of relative humidity (RH) would 
result in an increased loss of wetting length from the Schirmer strip.  The results showed 
that the wetting length was greater on the sheathed side in 31/32 tests.  This difference 
between the wetting lengths in the sheathed and unsheathed Schirmer test strips were 
found to be significant at each level of RH tested.  However, disappointingly, no significant 
difference was found in the mean difference in wetting lengths between the two eyes, 
compared across the four different conditions of humidity.   
Various factors could have contributed to this unexpected result. It may be that the 
variance in wetting length between the two eyes, in the small number of subjects studied, 
masked the effect of sheathing on wetting length.  This could have been amplified by an 
additional impact of repeated Schirmer tests carried out in succession.  Also, for the 
unsheathed Schirmer test there may have been variations from test to test in the 
evaporation from the exposed strip, dependent on the disposition of the Schirmer paper 
when in position.  A greater rate of evaporation would be expected from the upper surface 
exposed directly to ambient conditions than the lower surface, facing the skin and for this 
surface there would be variation from experiment to experiment, which would include 
variations in air currents.  For the sheathed test some evaporation was likely from the 
region of the Schirmer strip not covered by the sheathing material, at the bend of the 
paper near the site of insertion.  This will have varied from subject to subject and from test 
to test.  Additionally the plastic sheathing material was assumed to be completely 
impermeable to water but its properties were not measured.  Nonetheless, the general 
concept that sheathing will limit variation in the Schirmer response dependent on 
differences in ambient humidity and airflow is supported by the in vitro studies of 
Buckmaster and Pearce (Buckmaster and Pearce, 2016).  In this experiment a method 
was established that involved immersing the first 5mm of a standard Schirmer strip in an 
unlimited water supply.  Results showed a significant decrease in wetting length as the 
RH reduced in the unsheathed Schirmer test, ranging from 27mm at 5% RH to 39mm at 
95% RH.  Once the Schirmer strip was modified with a ―plastic film‖ the wetting length did 
not change significantly at any of the RHs tested.  More recently Radke et al., (2017) also 
conducted in vitro work in which they created a sheath for the Schirmer strip and found 
reduced evaporation from the strip in this condition.  The group concluded that that a 
sheathed version of the Schirmer test should be used to obtain the best clinical results 
(Radke et al., 2017).  
Improvements to the protocol used in the current studies would include study of a larger 
population and probably, use of a smaller number of RH settings on separate visits, at, 
say, 5%, 45% and 95% RH.  The laboratory studies cited and the clinical studies reported 
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here suggest that sheathing of the Schirmer strip would provide a test of tear production 
that is more precise than that of the unsheathed test.  The beneficial effect of sheathing 
should be equally applicable to the reflex Schirmer (Ia) and the anaesthetic Schirmer tests 
(Ib and II).  
In the longer term, the approach must be tested in the field, using a sophisticated 
(standardised manufacture with defined properties of the material to evaporation) version 
of the test in large populations, comparing variation of wetting lengths with sheathed and 
unsheathed versions of the test, over a wide age span.  In this way it is hoped that better 
standardisation of the sheathed Schirmer test could be achieved, applicable in clinics 
independent of ambient conditions, where environments can normally be dependent on 
season, geography or the physical conditions of a clinic.  Improvements to the technique 
can be envisaged, such as taking serial measurements of wetting during the test in order 
to derive a true flow rate (Holly, Lamberts and Esquivel, 1982; Radke et al., 2017).  
The second set of experiments (Chapter 5) explored the possibility of driving down tOsm 
to a basal level by suppressing tear evaporation.  It was predicted that such a value would 
be the lowest achievable in an individual and for this reason it is referred to as the basal 
tear osmolarity (BTO).  It was further predicted that this value would lie close to and be 
determined by plasma osmolality (pOsm).  For both reasons it was expected that the BTO 
would show less variance than tOsm measured in open eye conditions where osmolarity 
is modified by exposure to the external environment.  The BTO is a measure of tOsm 
obtained after a sufficient period of evaporative suppression and allowing equilibration of 
the tears with the vascular circulation across the conjunctival epithelium.  
Two scenarios of evaporative suppression were employed; eye closure and exposure to 
70% RH.  The results demonstrated that tOsm was reduced after eye closure and to a 
lesser and less significant degree in the 70% RH, in both the normal and DED groups 
when compared to tOsm measured in uncontrolled clinic conditions.  The tOsm values 
obtained after evaporative suppression fell within the range accepted for normal pOsm of 
285-295 mOsm/Kg, (Matz, 1996; Stookey, 2005; Cheuvront et al., 2010b).  It is proposed 
that calculating the BTO could provide a more personal baseline against which to gauge 
the severity of tear hyperosmolarity in DED patients and also permit a more accurate 
assessment of whole body hydration of potential value in diagnosing dehydration in the 
elderly.  
Some caution must be exercised in interpreting the results of the closed eye test in the 
current study here.  The studies reported here should be repeated in larger groups of 
normal and DED subjects showing a wide range of tOsms, in order to establish the 
repeatability of the measure and to strengthen the conclusions that BTO can be achieved 
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in severe DED patients and that inter-eye differences are reduced in all subjects following 
exposure to evaporative suppression.   
Also, the TearLab® device used to measure tOsm in these studies calculates tOsm on the 
basis of electrical impedence, dependent on the presence of charged ions.  It therefore 
does not respond to the presence of urea and glucose molecules in the tears and might 
be expected to under-read the level of plasma osmolality/osmolarity by approximately 6-7 
mOsm/L in a non-diabetic, non-uraemic subject.  The precise level of this discrepancy will 
become apparent when future studies are conducted directly comparing closed eye BTO 
values with pOsm values.  By including the measurement of plasma composition in such 
studies, the precise contribution of urea and glucose to pOsm can be identified.  Although, 
for the reasons stated, the TearLab® value for the BTO may not precisely correspond to 
pOsm this would not detract from the value of the measure as a test for dehydration.  
Here again, a study of the BTO versus pOsm in the field, in patients experiencing clinical 
dehydration, should allow thresholds for the BTO relevant to different levels of dehydration 
to be set and compared with standard measures of assessment. 
Certain improvements in the proposed test may be envisaged in the future.  Collaborative 
studies at another site are planned, which will allow tOsm to be tracked in open-eye 
conditions during evaporative suppression at 95% RH.  This should permit the optimum 
period for a closed-eye BTO test to be defined more clearly and allow the time course of 
tOsm restoration to be explored, on return to clinic conditions, which is of interest in DED 
patients.  At present it is envisaged that a BTO test could aid in the detection of 
dehydration in the elderly in the care home environment.  However, if it transpires, from 
future studies, that the BTO can be acquired after a short period of eye closure, say 15 
minutes or less, regardless of the starting level of tOsm, then the utility of the test will be 
greatly enhanced and it could find a place in the study of body hydration in sports 
medicine, under laboratory conditions (Ungaro et al., 2015) and in field conditions, in both 
sports medicine (Holland et al., 2017) and military environments (Sollanek et al., 2012). 
The third set of experiments (Chapter 6) addressed the relative contribution of each eye to 
the reflex secretory response using the Schirmer test in normal subjects.  There are many 
instances that can lead to unilateral trigeminal sensory loss that can be temporary or 
permanent, for example LASIK, trigeminal nerve section or ablation, Herpes zoster 
ophthalmicus or Herpes simplex keratitis.  It is currently unknown as to what extent the 
sensory drive from a normal eye can compensate for any defective lacrimal response in 
the fellow affected eye, and hence compensate and limit the risk of DED developing.  It 
was hypothesised that in the steady state, when the eyes were open and exposed to the 
environment, sensory inputs from each eye stimulate lacrimal secretion both ipsilaterally 
and contralaterally, via central connections of the trigeminal nerve with the superior 
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salivatory nucleus (SSN) on each side.  This arrangement was referred to as sensory 
cross-innervation.  The results presented here, as in other reports, showed that bilateral 
topical anaesthesia resulted in a bilateral reduction in Schirmer wetting length (Lamberts, 
Foster and Perry, 1979; Jordan and Baum, 1980).  Following unilateral topical 
anaesthesia, the effects on the Schirmer wetting length were in the direction predicted, i.e. 
assuming a sensory cross-innervation to the SSN.  There was a fall in secretion in the 
anaesthetised eye that was less than that which occurred when there was bilateral 
anaesthesia and the wetting length in the fellow, unanaesthetised, eye was lower than in 
its control eye following bilateral saline.  However, the differences shown in each case 
were not significant.  Despite the lack of significance the concept of sensory cross-
connectivity cannot be totally ruled out, but the current study suggests that if there is an 
input from the contralateral ocular surface, it is limited compared to that from the 
contralateral nasal mucosa, as discussed in the papers by Heigle and Pflugfelder, (1996) 
and Gupta et al., (1997) (Gupta, Heigle and Pflugfelder, 1997; Heigle and Pflugfelder, 
1996).  As mentioned in Chapter 7, this could have reflected a problem created by 
instillation of two drops prior to conducting the Schirmer test.  If the instilled drops were 
not cleared adequately prior to the test, the wetting length could have been extended 
artefactually.  Another factor affecting the lack of significance may have been the small 
subject numbers.   
The difficulty related to drop instillation could be circumvented if subjects with dense, 
unilateral trigeminal anaesthesia as present in neurotrophic keratitis (NK), were recruited 
and exposed to the desiccating environment of 5% RH.  Following the induction of topical 
anaesthesia in the normal, fellow eye, it would be possible to follow the response of the 
NK eye to exposure without the complication of instilling a drop into the clinically 
anaesthetic, NK eye.  This would remove the problem of the original protocol in this 
experiment that anaesthetic drop instillation might dilute the tears and mask the effect of 
desiccation on tOsm.  The use of fluorophotometry instead of the Schirmer test would also 
remove the reflex tearing effect inherent in the latter approach that has the potential to 
confound the results.  A further expansion of this study could also investigate how 
combinations of nasal mucosal and ocular anaesthesia influence the steady state level of 
lacrimal secretion.  The purpose of that study would be to further explore how the sensory 
inputs from each eye are integrated centrally to influence the ipsilateral and contralateral 
steady state tear production and to what degree the nasal mucosa contributes.  
 
The fourth experiments (Chapter 7) monitored tOsm under conditions of desiccating 
stress, with and without anaesthesia.  The use of topical anaesthetics was designed to 
create a sensory blockade of signals from the cornea, allowing the effects of defined 
levels of stress on tOsm without secretory compensation via the LFU to be determined.  
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This approach was designed to reinforce understanding of the mechanism of DED.  A 
study by Abusharha and Pearce (2013) suggested that in normal subjects, compensatory 
mechanisms, stimulating lacrimal secretions via the LFU, were able to prevent a 
significant rise in tOsm following exposure to low RH (Abusharha and Pearce, 2013).  
These responses in subjects with normal eyes would be a guide to the expectations of 
such individuals to cope with desiccating stress encountered in everyday life.  In this 
experiment it was anticipated that in the DED patients a rise in tOsm would occur, 
superimposed on the already raised value that characterises DED, as a result of the 
increased evaporation induced by the desiccating stress.  The effect was expected to be 
amplified further in these subjects after sensory blockade where sufficient reserves of LFU 
compensation would have already been utilised.  Unexpectedly, the results did not show 
any significant increase in tOsm at the height of the anaesthetic effect (approximately 30 
minutes) in either the normal or DED groups.  It is possible that integrity of the pathway 
linking the nasal mucosa to the lacrimal secretory system was involved in this paradoxical 
response. A number of recent studies have confirmed, in both animals (Kossler et al., 
2015; Brinton et al., 2015) and humans (Friedman et al., 2016; Gumus and Pflugfelder, 
2017) that controlled nasal mucosal stimulation, of a mild degree, stimulates tear 
secretion.  It is possible that in the experiments described, stimulation of the nasal 
mucosa by the desiccating condition of 5% RH compensated for the decrease in tear 
production that would otherwise have occurred due to withdrawal of sensory drive from 
the ocular surface.  It would therefore be of interest to repeat the experiments during a 
period of combined, bilateral, nasal and ocular anaesthesia. 
Despite a lack of change to the tOsm after exposure to desiccation, temporary punctate 
epithelial keratitis (PEK) was recorded in the Sjögren syndrome subjects following 
instillation of anaesthetics.  This suggested that the tOsm values sampled from the tear 
meniscus were not necessarily representative of the tOsm occurring over the whole of the 
central cornea.  Previous publications have reported that tOsm is not evenly distributed 
between the tear compartments of the conjunctival sac, preocular tear film and tear 
meniscus (Bron, Yokoi and Gouveia, 2002; Gaffney et al., 2010).  With rapid evaporation 
and thinning of the exposed preocular tear film, it has been purported in models that tOsm 
could reach up to 900 mOsm/L (King-Smith et al., 2008).  This could contribute 
significantly to localised interpalpebral increases in tOsm especially between blinks (Liu et 
al., 2009) and create conditions sufficient to induce epithelial cell damage.  Further 
investigation into the variation in tOsm in the different compartmental areas following 
episodes of desiccating stress is warranted, although instrumentation presently available 
for measuring tOsm may limit this possibility.  There is currently no method to measure 
tOsm in the precorneal tear film or in the corneal epithelium itself. A device for the 
measurement of conjunctival osmolarity is available, but its accuracy is yet to be 
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established (Rocha et al., 2017).  In future research that expanded on this study and 
incorporated a larger dataset, further analytical methods would be appropriate to use, for 
example a mixed ANOVA or two-way ANOVA.  In addition, further information about 
demographics and other covariates could be collected.  With this data a linear mixed 
model with random intercepts could be applied to explain any changes in the tOsm 
measures over time. 
The body of work presented here derives from a set of pilot studies, with small numbers of 
subjects in each experiment. It is acknowledged, therefore, that interpretations and 
conclusions drawn must be provisional and that the novel concepts presented will require 
further validation.  The means to achieve this and some areas for future research have 
been outlined above. 
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Figures A12 a-d show slit-lamp photography with fluorescein (from Chapter 6) of the left 
corneas of the normal and DED subjects following instillation of anaesthetic and after 1 
hour exposure to desiccating conditions.  Figures A12 e-l show slit-lamp photography with 
fluorescein of the right and left corneas of the normal and DED subjects following 
instillation of saline and after 1 hour exposure to desiccating conditions. 
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Figure A12a Slit-lamp images with fluorescein pre and post CEC exposure to desiccating conditions for 60 
minutes and after anaesthetic instillation in the left eyes of normal subjects 1-4. 
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Figure A12b Slit-lamp images with fluorescein pre and post CEC exposure to desiccating conditions for 60 
minutes and after anaesthetic instillation in the left eyes of normal subjects 5-8. 
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Figure A12c Slit-lamp images with fluorescein pre and post CEC exposure to desiccating conditions for 60 
minutes and after anaesthetic instillation in the left eyes of DED patients 1-4. 
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Figure A12d Slit-lamp images with fluorescein pre and post CEC exposure to desiccating conditions for 60 
minutes and after anaesthetic instillation in the left eyes of DED patients 5-8. 
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Figure A12e Slit-lamp images with fluorescein pre and post CEC exposure to desiccating conditions for 60 
minutes and after saline instillation in the right eyes of normal subjects 1-4. 
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Figure A12f Slit-lamp images with fluorescein pre and post CEC exposure to desiccating conditions for 60 
minutes and after saline instillation in the left eyes of normal subjects1-4. 
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Figure A12g Slit-lamp images with fluorescein pre and post CEC exposure to desiccating conditions for 60 
minutes and after saline instillation in the right eyes of normal subjects 5-8. 
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Figure A12h Slit-lamp images with fluorescein pre and post CEC exposure to desiccating conditions for 60 
minutes and after saline instillation in the left eyes of normal subjects 5-8. 
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Figure A12i Slit-lamp images with fluorescein pre and post CEC exposure to desiccating conditions for 60 
minutes and after saline instillation in the right eyes of DED subjects 1-4. 
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Figure A12j Slit-lamp images with fluorescein pre and post CEC exposure to desiccating conditions for 60 
minutes and after saline instillation in the left eyes of DED subjects 1-4. 
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Figure A12k Slit-lamp images with fluorescein pre and post CEC exposure to desiccating conditions for 60 
minutes and after saline instillation in the right eyes of DED subjects 5-8. 
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Figure A12l Slit-lamp images with fluorescein pre and post CEC exposure to desiccating conditions for 60 
minutes and after saline instillation in the left eyes of DED subjects 5-8. 
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APPENDIX XIII: THE UTILITY OF THE TEARLAB® DEVICE AS A 
LABORATORY INSTRUMENT AND IN CLINICAL USE 
A13.1 Introduction of tear osmolarity as a measure of dry eye disease 
The purpose of this appendix is to appraise the reliability of the TearLab® osmometer and 
its utility in clinical use.  Aspects of normal tear osmolarity values, diurnal variation and 
inter-eye differences are discussed in Chapter 1 (1.11 and 1.12) and Chapter 2 (2.7.4). 
Tear osmolarity (tOsm) has been of interest since the 1940s when a balance between 
evaporation and tear flow was shown to determine its outcome (von Bahr, 
1941).  Mishima and Maurice (1961b) showed the importance of the meibomian oil in 
retarding evaporation and later, Gilbard et al., (1989) indicated that obstruction of the total 
complement of meibomian glands in a rabbit model led to a rise in tear film osmolarity.  By 
this point a new technique for measuring tOsm was in use, the Clifton Nanolitre 
osmometer.  This machine helped to establish that hyperosmolarity played an important 
role in inducing the corneal and conjunctival features of keratoconjunctivitis sicca (KCS) 
(Gilbard et al., 1978).  Subsequent experiments showed a relationship between tear 
hyperosmolarity and Rose Bengal staining in dry eye disease (DED) (Gilbard and Farris, 
1979) and a reduction in conjunctival goblet cell density (Gilbard et al., 1988).   
Experimentally, corneal epithelial cells in culture were morphologically altered following 
exposure to hyperosmolar solutions (Gilbard et al., 1984). 
Tear osmolarity is now considered to be the best single measure of DED and has been 
proposed as the gold standard in diagnosis in DED (Farris, 1994; Lemp, 2011; Wolffsohn 
et al., 2017). Hyperosmolarity has been shown to be the primary cause of ocular surface 
damage and is a pivotal pathophysiological factor in both aqueous deficient dry eye 
(ADDE) and evaporative dry eye (EDE) (Bron et al., 2017). 
A13.2 Types of osmometer 
Various instruments have been used to measure osmolarity over the years, based on the 
principle that the osmolarity of a sample can be determined by the colligative properties of 
a solution, i.e. it is dependent on the number of dissolved particles in a solution but not on 
their size or weight. 
A13.2.1 Depression of freezing point 
Depression of freezing point osmometers use the principle that the total number of 
dissolved particles in a solution is directly proportional to its freezing point. The osmolarity 
is calculated from the depression in the freezing point and is the only method that 
measures concentration based solely on the number of dissolved particles in the sample.  
The benefit of these systems, in relation to the measurement of tOsm, is that a relatively 
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small tear sample is required, between 0.5-2µL, which reduces the risk of stimulating 
reflex tearing during sampling.  Transfer of the sample from the eye to the instrument and 
the initial time elapsing during processing, can still be a potential source of error due to 
the occurrence of evaporation.  Judging the point at which the melting point has been 
achieved is also subjective and can also be a problem. There are three commercially 
available instruments that utilise this technology: the Advanced® Micro-Osmometer 
(Advanced Instruments, MA, USA), the Otago Osmometer (Otago, Dunedin, New 
Zealand) and the Clifton Nanolitre Osmometer (Technical Physics of Hartford, NY, USA). 
A13.2.2 Vapour pressure 
In a similar way, the vapour pressure of a solution is a measure of its osmolarity since 
vapour pressure is directly proportional to the number of dissolved particles in the 
solution.  The only commercially available instrument is the Wescor vapour pressure 
osmometer (VAPRO, Wescor, Inc., UT, USA).  The sample here is analysed without the 
need to change its physical state, (as with depression of freezing point osmometers) 
which, increases the reliability of results, but the technique does require a larger sample to 
operate, (10µL), which is often unachievable from DED patients who by the very nature of 
their disease, in aqueous-deficient DED, will have a reduced tear supply. 
A13.2.3 Electrical impedance 
Lastly, osmolarity can also be measured as a function of electrical impedance.  This 
method measures the electrical conductivity of a tear sample, and is dependent on the 
number of charged particles in the solution.  A change in the composition or concentration 
of the ions in a sample will alter the conductivity and is an indirect function of osmolarity. 
Currently available machines include the TearLab® Osmolarity System (TearLab 
Corporation, CA, USA) and the i-Pen® (I-MED Pharma Inc., Montreal, QC).  These 
machines require the smallest samples of all the osmometers (50nL for the TearLab®) 
and allow an almost instantaneous analysis of the electrical properties of the solution, 
which can be converted into an osmolarity value. 
 
A13.3 Correlation between TearLab and other osmometers 
Results obtained from the TearLab® osmometer have been reported to compare well with 
commercially available devices considered to be the gold standard in the measurement of 
osmolarity in the laboratory by several authors (Versura et al., 2010; Versura and 
Campos, 2013; Tomlinson et al., 2010; Rocha et al., 2017). 
Tomlinson and colleagues compared the osmolarity of tears collected from a series of 15 
DED subjects with that of 21 normal controls, evaluated with both the TearLab® system 
and the Clifton Nanoliter osmometer (Tomlinson et al., 2010).  A good agreement between 
the two instruments was demonstrated (r = 0.904; p = 0.006) and the same cut-off level 
calculated between the two populations (316 mOsm/L). 
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In a further study, the repeatability of sampling from 20 normal subjects using the 
TearLab® was tested.  The TearLab® showed a good test-retest correlation between 
repeated measurements (r = 0.8, P < 0.05).  Additionally in this study, measurements 
were taken with the TearLab® and compared with those using the Wescor vapour 
pressure osmometer, in 52 healthy participants (who, incidentally, would be capable of 
supplying sufficient tear volume for this technique).  The mean tOsm in the subjects, using 
the TearLab®, was 299.2 ± 10.3 mOsm/L and with the Wescor instrument 298.4 ±10.0 
mOsm/L. These two results were not significantly different from one another (P < 0.05) 
(Gokhale et al., 2013). 
Later an in vitro study examined the comparison of results on contrived tear solutions 
designed to represent normal (297 mOsm/L), moderate DED (342 mOsm/L) and severe 
DED (383 mOsm/L) between the TearLab® and Wescor vapour pressure devices.  The 
TearLab® osmometer reported a linear regression of r2 = 0.96 and the Wescor vapour 
pressure r2 = 0.98.  The authors concluded that these two machines performed similarly in 
their ability to determine the osmolarity of these contrived solutions of known values 
(Rocha et al., 2017). 
A13.4 Precision and accuracy and of the TearLab® osmometer 
Understanding the reliability of an instrument is essential for confidence in its clinical use. 
The coefficient of variation (CV) is often reported as a measure of relative variability.  The 
Wescor vapour pressure osmometer, which requires a higher volume than the TearLab® 
machine, is regarded as a laboratory standard. The CVs from studies analysing the 
variation of the TearLab® and Wescor osmometers in vivo ranged from 1% to 4.1% 
(Eperjesi et al., 2012; Nolfi and Caffrey, 2017; Rocha et al., 2017; Reis et al., 2017).  The 
CV values stated above encapsulate those reported by the manufacturers of the 
TearLab® machine of 1.5% (US FDA. k083184, TearLab Osmolarity System. April 23, 
2009). 
Concerning the accuracy of the instrument, a more recent study by Nolfi and Caffrey 
(2017) measured the analytical performance of the TearLab® machine using Quality 
Control (QC) standard solutions, used to calibrate the machines, over a period of two 
months.  An average osmolarity of 335.8 mOsm/L ± 4.2 (target of 338 mOsm/L) was 
documented, yielding an accuracy for the TearLab® of 99.4%.  The mean osmolarity of 
the QC solutions analysed by the two TearLab® machines used in this thesis was 
336.9mOsm/L ± 1.15, yielding an accuracy of 99.7%. 
Positive predictive values (PPV) provide an index of performance which relates the 
proportion of positive results in a diagnostic test to the number of true positive 
results.  This value, along with sensitivity and specificity, are used to confirm the utility of a 
227 
 
measurement value for diagnostic purposes.  Several different index values have been 
documented in previous studies using the TearLab® that resulted in a high PPV level. 
Tomlinson et al., (2010) cited a cut-off of 316 mOsm/L with a PPV of 85%, sensitivity of 
73% and specificity of 90%; the tOsm results obtained in this study were similar to those 
reported by the same group in a previous meta-analysis of osmolarity values in DED 
subjects (Tomlinson et al., 2006).  The group also reported that values for the TearLab® 
correlated well with those from the Clifton Nanoliter osmometer using a cut-off of 317 
mOsm/L, which yielded a PPV of 65%, sensitivity of 73% and specificity 71% (Tomlinson 
et al., 2006).  Versura et al., (2010) cited a cut-off figure of 305 mOsm/L that yielded a 
PPV of 98.4%, sensitivity of 44% and specificity of 96% and Khanal et al., (2008) reported 
a cut-off figure of >317 mOsm/L and a PPV of 86%, sensitivity of 78% and specificity of 
78%.  For the current thesis a cut-off of 308 mOsm/L was chosen to distinguish between 
normal and DED subjects based on the Lemp et al., (2010) paper which concluded that 
this figure provided the most sensitive threshold to distinguish between normal and 
mild/moderate DED.  This was based on data from a multicentre, ten site study, of 314 
subjects, that evaluated the clinical utility of tOsm for assessing DED severity.  The most 
specific cut-off value from this study was 315 mOsm/L for tOsm exhibiting 73% sensitivity 
and 92% specificity. 
 
A13.5 Sources of TearLab® measurement variation in clinical use 
Variation of measurements using the TearLab® osmometer may arise from an assortment 
of factors, including instrument and biological variation, collection technique and 
environment. 
Khanal et al., (2012) stated that the variability of the TearLab® measures could be related 
to the machine itself.  In their study eight occasions out of approximately 160 produced 
either no readings or displayed an ‗out-of-range‘ report.  The TearLab® machine will only 
register osmolarity measures between 270-400 mOsm/L.  The machines used for this 
thesis were specially adapted in collaboration with the manufacturers to allow the out-of-
range values to be shown.  In the event, no ‗out-of-range‘ values were registered by the 
machines in all of the four studies reported in this thesis.  Khanal et al., (2013) also stated 
anecdotally that the readings that took longer to obtain produced higher results.  In this 
thesis as a way of minimising such errors, any readings that registered a discomfort score 
of three, indicating that there may have been more difficulty in obtaining the sample, were 
discarded, as a precaution. 
In the study of Nolfi et al., (2017) there was no evidence of analytical outliers using the 
TearLab®, the authors asserting that any elevated values obtained with this osmometer, 
both in this study and others (Bunya et al., 2015; Szczesna-Iskander 2016) were an 
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essential aspect of tOsm variation in the early stages or in mild DED.  These extreme data 
points, rather than being outliers should be considered important signals that indicate an 
unstable ocular surface before traditional clinical signs have revealed the disease.  The 
authors concluded that ―even if a perfectly accurate and precise osmometer existed, the 
specificity of tear osmolarity would be limited to the 90% range that is reported elsewhere, 
due to the inherent nature of the marker‖ and as such osmolarity measured using the 
TearLab® machine is still considered a valid measure of DED in clinics and experimental 
studies alike. 
The positioning of the pen tip of the handset when collecting tear samples has been cited 
as a potential source for variability (Wunderlich et al., 2011).  The authors designed an in 
vitro study whereby the angle of the TearLab® pen was changed between 70 - 120° with a 
liquid meniscus being created by applying a Ringer‘s solution at the junction of two clean 
glass plates that had been placed on top of each other and displaced sideways.  The 
tOsm differed by 8.9 mOsm/L between 90 to 120° from 314.4 ± 7 to 323.3 ± 5.4 
respectively.  Similarly, Szczesna-Iskander (2016) observed that there was less variability 
in tOsm values when a right-handed examiner took readings from the left eye and 
attributed this to increased comfort and more consistent and adequate positioning of the 
test card in obtaining the sample.  In this thesis every attempt was made to standardise 
conditions when measuring patients, the same practitioner (right-handed) was responsible 
for taking all samples at each visit and had received training on the technique of tear 
sampling from a TearLab® representative as well as practising the technique within the 
supervisory team for at least a year before patient recruitment.  In fact, as documented by 
the Khanal et al., (2012) study there was very low intra-observer variability when taking 
samples with the TearLab® machine. 
Environmental factors can contribute to errors in tOsm measurements. Reduced relative 
humidity can influence osmolarity by increasing evaporation from the ocular surface or 
inducing reflex tearing.  Tear meniscus has been shown to be reduced in presence of 
increased airflow exposure making sampling more difficult (Koh et al., 2012), which can 
potentially influence results further.  Temperature can also affect the outcome of 
impedance measures, with a difference of approximately 2% being reported for every 
change in degree (Calles, 1990).  Although in vitro studies measuring the osmolarity of 
biologic fluids with the help of electrical impedance have shown that a temperature 
variation between 20°C and 40°C led to only a minimal change of approximately 1.8% per 
degree centigrade (Fouke et al., 1987).  The TearLab® osmometer uses temperature-
compensated impedance calculations to measure tOsm.  Consequently, the 
manufacturers recommend that the analytical performance of the machines is tested on 
each day of data collection by calibrating with a National Institute of Standards and 
Technology traceable sodium chloride QC solution with a target of 338 mOsm/L (330-346 
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mOsm/L).   In the set of experiments for this thesis, two TearLab® machines were 
employed; one inside and one outside the controlled environment chamber (CEC).  The 
temperature inside the CEC was maintained between 21-23°C during experimentation, 
whilst the machine outside was situated in uncontrolled ‗clinic‘ conditions where the 
temperature ranged from 17-26°C.  Both machines passed the daily calibration 
procedures using the manufacturers‘ electronic test cards and saline control solution. 
Many of the experiments that report a variability of TearLab® results or that data from the 
machine should be viewed cautiously due to outliers were conducted in uncontrolled 
environmental clinic conditions (Khanal et al., 2013; Szalai et al., 2012; Alves et al., 2013; 
Amparo et al., 2014; Bunya et al., 2015; Baenninger et al., 2018) and as such did not 
control for these potentially confounding elements.  The experiments in this thesis 
engaged in the standardisation of environmental conditions in an attempt to minimise any 
effects on the osmolarity of collected samples. 
 
A13.6 Advantages of TearLab® sampling system 
Of the earlier available osmometers, the Wescor vapour pressure osmometer despite its 
ease of use was of little practical value in the diagnosis of DED because of its high sample 
volume requirement exceeding that likely to be available in ADDE.  The Clifton Nanoliter 
osmometer, of equal reliability and requiring a smaller and more relevant sample size, 
made an important contribution to our understanding of tOsm behaviour in normal and dry 
eyes, but because of its high cost and requirement for significant technical expertise in 
processing samples, was relegated to use as a research tool.  Even here, the volume 
requirement was such that there was some risk of stimulating reflex tear secretion during 
collection, with possible dilution of the sample and similarly, a risk of evaporative loss both 
during tear collection and processing, with possible concentration of the sample.  With the 
TearLab® osmometer, the tear sample is aspirated rapidly from the tear meniscus (within 
about 2-3 seconds) by capillary attraction and analysed almost immediately using lab-on-
a-chip technology.  An osmolarity readout is provided within a couple of minutes.  
Because of the small volume requirement and speed of sampling, the risk of reflex tearing 
is greatly reduced, although ease of sampling does vary on an individual basis.  The lab-
on-chip technology which acts as both the analytical system and collection device 
eliminates the evaporative element and source of potential error of previous machines 
during transfer of the samples (Nelson and Wright, 1986) and avoids the need for capillary 
tubes or acetate discs for tear sampling, improving the reliability of the procedure (Versura 
et al., 2010).  The TearLab® has been reported to have increased utility especially in 
subjects with a reduced tear lake, since sufficient samples could be obtained using the 
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TearLab® that could not be collected, even after repeated attempts, using the vapour 
pressure osmometry method (Gokhale et al. 2013). 
New instrumentation, such as the i-Pen®, has been designed to measure the osmolarity 
of the tears that bathe the orbital tissues such as the palpebral conjunctiva and  represent 
tOsm levels occurring at the tissue level.  The utility of this osmometer compared to other 
commercially available devices has been investigated in vitro and in vivo by several 
groups (Reis et al., 2017; Rocha et al., 2017; Nolfi et al., 2017).  These studies concluded 
that the i-Pen often reported random values and was unable to reproduce the expected 
range of normal tOsm values in subjects without DED.  The latter function is 
essential, to provide a criterion of hyperosmolarity.  However, the endeavour to identify 
osmolarity at the ocular surface rather than in the tear meniscus is  important, since it has 
previously been reported in modelling papers (Gaffney et al., 2010) that tOsm sampled at 
the meniscus does not necessarily reflect those values occurring at other places on the 
ocular surface.  The method of sampling used with the i-Pen however, is likely to induce 
more reflex tearing due to contact with the ocular surface during sampling.  This, along 
with a lack of daily calibration could lead to unreliable results (Nolfi et al., 2017) and may 
be responsible for an absence of correlation between this machine, the TearLab® and 
Wescor vapour pressure osmometers (Rocha et al., 2017). 
A13.7 Clinical utility of the TearLab® osmometer 
Tear film osmolarity has been shown to be the single best marker of disease severity 
(Sullivan et al., 2010; Versura et al., 2010; Lemp et al., 2011; Utine et al., 2011; Jacobi et 
al., 2011), with the ability to discriminate between normal controls and patients with mild, 
moderate or severe DED.  Studies have reported that tOsm reflects objective signs of 
inflammation as well as correlating significantly with subjective discomfort symptoms 
(VanDerMaid et al., 2012).  High levels of inflammatory mediators detected in ocular 
surface disease have also been estimated with the use of tOsm values obtained using the 
TearLab® device (Versura et al., 2011), further justifying its use in the clinical setting.   
The TearLab® osmometer allows tOsm to be measured quickly during an examination 
and has facilitated investigation of tear-related conditions, including both the diagnosis 
and effectiveness of treatments.  Clinical trials have reported a reduction in tOsm towards 
normal values following intervention with a variety of treatments, including hyaluronic acid 
based tear substitutes (Benelli et al., 2010), Cyclosporin A (Sullivan et al., 2010) and 
autologous serum (Na and Kim, 2012).  Jacobi et al., (2011) reported that testing the 
osmolarity of the tear film was an effective objective test for DED diagnosis, showing a 
significantly higher tOsm in patients with severe keratoconjunctivitis sicca compared with 
the healthy controls (Jacobi et al., 2011).  A positive correlation was reported between 
231 
tOsm and severity, using the TearLab® osmometer, comparing patients with primary 
Sjögren syndrome (SjS)  with control subjects (Utine et al., 2011).  More recently tOsm 
was shown to reflect both objective signs and symptom severity in SjS patients (Kim et al., 
2017). 
Along with its extensive use in the field of dry eye, the TearLab® osmometer has also 
been incorporated into study designs in other areas of Ophthalmology.  Tear osmolarity 
has been used as an outcome measure of ocular surface health following the use of 
Glaucoma pressure-lowering eye drops (Labbe et al., 2012; Januleviciene et al., 2012). 
A13.8 Conclusion 
The TearLab® instrument provides as precise a measure of osmolarity of a fluid mixture 
as instruments employed to measure osmolarity in larger volume.  The risk of dilution of a 
tear sample due to reflex tearing is minimised by rapid sampling and there is no risk of 
evaporative loss during processing and analysis. Possibly some of the unwanted variation 
referred to in the literature arises from a lack of standardisation of the sampling technique 
during use, the employment of multiple investigators and a lack of environmental 
standardisation. 
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